id	sid	tid	token	lemma	pos
aiua-5955	1	1	17archivio	17archivio	NUM
aiua-5955	1	2	italiano	italiano	PROPN
aiua-5955	1	3	di	di	X
aiua-5955	1	4	urologia	urologia	PROPN
aiua-5955	1	5	e	e	PROPN
aiua-5955	1	6	andrologia	andrologia	NOUN
aiua-5955	1	7	2017	2017	NUM
aiua-5955	1	8	;	;	PUNCT
aiua-5955	1	9	89	89	NUM
aiua-5955	1	10	,	,	PUNCT
aiua-5955	1	11	1	1	NUM
aiua-5955	1	12	original	original	ADJ
aiua-5955	1	13	paper	paper	NOUN
aiua-5955	1	14	the	the	DET
aiua-5955	1	15	efficacy	efficacy	NOUN
aiua-5955	1	16	of	of	ADP
aiua-5955	1	17	an	an	DET
aiua-5955	1	18	association	association	NOUN
aiua-5955	1	19	of	of	ADP
aiua-5955	1	20	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	1	21	and	and	CCONJ
aiua-5955	1	22	alpha	alpha	NOUN
aiua-5955	1	23	-	-	PUNCT
aiua-5955	1	24	lipoic	lipoic	NOUN
aiua-5955	1	25	acid	acid	NOUN
aiua-5955	1	26	in	in	ADP
aiua-5955	1	27	patients	patient	NOUN
aiua-5955	1	28	with	with	ADP
aiua-5955	1	29	chronic	chronic	ADJ
aiua-5955	1	30	prostatitis	prostatitis	NOUN
aiua-5955	1	31	/	/	SYM
aiua-5955	1	32	chronic	chronic	ADJ
aiua-5955	1	33	pelvic	pelvic	ADJ
aiua-5955	1	34	pain	pain	NOUN
aiua-5955	1	35	syndrome	syndrome	NOUN
aiua-5955	1	36	:	:	PUNCT
aiua-5955	1	37	a	a	DET
aiua-5955	1	38	randomized	randomized	ADJ
aiua-5955	1	39	clinical	clinical	ADJ
aiua-5955	1	40	trial	trial	NOUN
aiua-5955	1	41	bruno	bruno	PROPN
aiua-5955	1	42	giammusso	giammusso	PROPN
aiua-5955	1	43	1	1	NUM
aiua-5955	1	44	,	,	PUNCT
aiua-5955	1	45	rosaria	rosaria	PROPN
aiua-5955	1	46	di	di	PROPN
aiua-5955	1	47	mauro	mauro	PROPN
aiua-5955	1	48	2	2	NUM
aiua-5955	1	49	,	,	PUNCT
aiua-5955	1	50	renato	renato	PROPN
aiua-5955	1	51	bernardini	bernardini	PROPN
aiua-5955	1	52	2	2	NUM
aiua-5955	1	53	1	1	NUM
aiua-5955	1	54	policlinico	policlinico	NOUN
aiua-5955	1	55	morgagni	morgagni	NOUN
aiua-5955	1	56	,	,	PUNCT
aiua-5955	1	57	catania	catania	PROPN
aiua-5955	1	58	,	,	PUNCT
aiua-5955	1	59	italy	italy	PROPN
aiua-5955	1	60	;	;	PUNCT
aiua-5955	1	61	2	2	NUM
aiua-5955	1	62	biometec	biometec	NOUN
aiua-5955	1	63	,	,	PUNCT
aiua-5955	1	64	section	section	NOUN
aiua-5955	1	65	of	of	ADP
aiua-5955	1	66	pharmacology	pharmacology	NOUN
aiua-5955	1	67	,	,	PUNCT
aiua-5955	1	68	university	university	PROPN
aiua-5955	1	69	of	of	ADP
aiua-5955	1	70	catania	catania	PROPN
aiua-5955	1	71	school	school	PROPN
aiua-5955	1	72	of	of	ADP
aiua-5955	1	73	medicine	medicine	NOUN
aiua-5955	1	74	,	,	PUNCT
aiua-5955	1	75	catania	catania	PROPN
aiua-5955	1	76	,	,	PUNCT
aiua-5955	1	77	italy	italy	PROPN
aiua-5955	1	78	.	.	PUNCT
aiua-5955	2	1	background	background	NOUN
aiua-5955	2	2	:	:	PUNCT
aiua-5955	2	3	chronic	chronic	ADJ
aiua-5955	2	4	prostatitis	prostatitis	NOUN
aiua-5955	2	5	/	/	SYM
aiua-5955	2	6	chronic	chronic	ADJ
aiua-5955	2	7	pelvic	pelvic	ADJ
aiua-5955	2	8	pain	pain	NOUN
aiua-5955	2	9	syndrome	syndrome	NOUN
aiua-5955	2	10	(	(	PUNCT
aiua-5955	2	11	cp	cp	NOUN
aiua-5955	2	12	/	/	SYM
aiua-5955	2	13	cpps	cpps	NOUN
aiua-5955	2	14	)	)	PUNCT
aiua-5955	2	15	is	be	AUX
aiua-5955	2	16	a	a	DET
aiua-5955	2	17	complex	complex	ADJ
aiua-5955	2	18	condition	condition	NOUN
aiua-5955	2	19	,	,	PUNCT
aiua-5955	2	20	characterized	characterize	VERB
aiua-5955	2	21	by	by	ADP
aiua-5955	2	22	uncertain	uncertain	ADJ
aiua-5955	2	23	etiology	etiology	NOUN
aiua-5955	2	24	and	and	CCONJ
aiua-5955	2	25	by	by	ADP
aiua-5955	2	26	limited	limited	ADJ
aiua-5955	2	27	response	response	NOUN
aiua-5955	2	28	to	to	ADP
aiua-5955	2	29	therapy	therapy	NOUN
aiua-5955	2	30	.	.	PUNCT
aiua-5955	3	1	the	the	DET
aiua-5955	3	2	definition	definition	NOUN
aiua-5955	3	3	of	of	ADP
aiua-5955	3	4	cp	cp	PROPN
aiua-5955	3	5	/	/	SYM
aiua-5955	3	6	cpps	cpps	NOUN
aiua-5955	3	7	includes	include	VERB
aiua-5955	3	8	genitourinary	genitourinary	ADJ
aiua-5955	3	9	pain	pain	NOUN
aiua-5955	3	10	with	with	ADP
aiua-5955	3	11	or	or	CCONJ
aiua-5955	3	12	without	without	ADP
aiua-5955	3	13	voiding	void	VERB
aiua-5955	3	14	symptoms	symptom	NOUN
aiua-5955	3	15	in	in	ADP
aiua-5955	3	16	the	the	DET
aiua-5955	3	17	absence	absence	NOUN
aiua-5955	3	18	of	of	ADP
aiua-5955	3	19	uropathogenic	uropathogenic	ADJ
aiua-5955	3	20	bacteria	bacteria	NOUN
aiua-5955	3	21	,	,	PUNCT
aiua-5955	3	22	as	as	SCONJ
aiua-5955	3	23	detected	detect	VERB
aiua-5955	3	24	by	by	ADP
aiua-5955	3	25	standard	standard	ADJ
aiua-5955	3	26	microbiological	microbiological	ADJ
aiua-5955	3	27	methods	method	NOUN
aiua-5955	3	28	,	,	PUNCT
aiua-5955	3	29	or	or	CCONJ
aiua-5955	3	30	another	another	DET
aiua-5955	3	31	identifiable	identifiable	ADJ
aiua-5955	3	32	cause	cause	NOUN
aiua-5955	3	33	such	such	ADJ
aiua-5955	3	34	as	as	ADP
aiua-5955	3	35	malignancy	malignancy	NOUN
aiua-5955	3	36	.	.	PUNCT
aiua-5955	4	1	the	the	DET
aiua-5955	4	2	efficacy	efficacy	NOUN
aiua-5955	4	3	of	of	ADP
aiua-5955	4	4	various	various	ADJ
aiua-5955	4	5	medical	medical	ADJ
aiua-5955	4	6	therapies	therapy	NOUN
aiua-5955	4	7	,	,	PUNCT
aiua-5955	4	8	has	have	AUX
aiua-5955	4	9	been	be	AUX
aiua-5955	4	10	evaluated	evaluate	VERB
aiua-5955	4	11	in	in	ADP
aiua-5955	4	12	clinical	clinical	ADJ
aiua-5955	4	13	studies	study	NOUN
aiua-5955	4	14	,	,	PUNCT
aiua-5955	4	15	but	but	CCONJ
aiua-5955	4	16	evidence	evidence	NOUN
aiua-5955	4	17	is	be	AUX
aiua-5955	4	18	lacking	lack	VERB
aiua-5955	4	19	or	or	CCONJ
aiua-5955	4	20	conflicting	conflicting	ADJ
aiua-5955	4	21	.	.	PUNCT
aiua-5955	5	1	we	we	PRON
aiua-5955	5	2	compared	compare	VERB
aiua-5955	5	3	serenoa	serenoa	ADJ
aiua-5955	5	4	repens	repen	NOUN
aiua-5955	5	5	in	in	ADP
aiua-5955	5	6	monotherapy	monotherapy	NOUN
aiua-5955	5	7	versus	versus	ADP
aiua-5955	5	8	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	5	9	(	(	PUNCT
aiua-5955	5	10	pea	pea	NOUN
aiua-5955	5	11	)	)	PUNCT
aiua-5955	5	12	in	in	ADP
aiua-5955	5	13	combination	combination	NOUN
aiua-5955	5	14	with	with	ADP
aiua-5955	5	15	alpha	alpha	NOUN
aiua-5955	5	16	-	-	PUNCT
aiua-5955	5	17	lipoic	lipoic	NOUN
aiua-5955	5	18	acid	acid	NOUN
aiua-5955	5	19	(	(	PUNCT
aiua-5955	5	20	ala	ala	PROPN
aiua-5955	5	21	)	)	PUNCT
aiua-5955	5	22	and	and	CCONJ
aiua-5955	5	23	evaluated	evaluate	VERB
aiua-5955	5	24	the	the	DET
aiua-5955	5	25	efficacy	efficacy	NOUN
aiua-5955	5	26	of	of	ADP
aiua-5955	5	27	these	these	DET
aiua-5955	5	28	treatments	treatment	NOUN
aiua-5955	5	29	in	in	ADP
aiua-5955	5	30	patients	patient	NOUN
aiua-5955	5	31	with	with	ADP
aiua-5955	5	32	cp	cp	NOUN
aiua-5955	5	33	/	/	SYM
aiua-5955	5	34	cpps	cpps	NOUN
aiua-5955	5	35	.	.	PUNCT
aiua-5955	6	1	methods	method	NOUN
aiua-5955	6	2	:	:	PUNCT
aiua-5955	6	3	we	we	PRON
aiua-5955	6	4	conducted	conduct	VERB
aiua-5955	6	5	a	a	DET
aiua-5955	6	6	randomized	randomized	ADJ
aiua-5955	6	7	,	,	PUNCT
aiua-5955	6	8	single	single	ADJ
aiua-5955	6	9	-	-	PUNCT
aiua-5955	6	10	blind	blind	ADJ
aiua-5955	6	11	trial	trial	NOUN
aiua-5955	6	12	.	.	PUNCT
aiua-5955	7	1	44	44	NUM
aiua-5955	7	2	patients	patient	NOUN
aiua-5955	7	3	diagnosed	diagnose	VERB
aiua-5955	7	4	with	with	ADP
aiua-5955	7	5	cp	cp	PROPN
aiua-5955	7	6	/	/	SYM
aiua-5955	7	7	cpps	cpps	NOUN
aiua-5955	7	8	(	(	PUNCT
aiua-5955	7	9	mean	mean	VERB
aiua-5955	7	10	age	age	NOUN
aiua-5955	7	11	41.32	41.32	NUM
aiua-5955	7	12	±	±	NUM
aiua-5955	7	13	1.686	1.686	NUM
aiua-5955	7	14	years	year	NOUN
aiua-5955	7	15	)	)	PUNCT
aiua-5955	7	16	were	be	AUX
aiua-5955	7	17	randomly	randomly	ADV
aiua-5955	7	18	assigned	assign	VERB
aiua-5955	7	19	to	to	ADP
aiua-5955	7	20	treatment	treatment	NOUN
aiua-5955	7	21	with	with	ADP
aiua-5955	7	22	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	7	23	300	300	NUM
aiua-5955	7	24	mg	mg	NOUN
aiua-5955	7	25	plus	plus	CCONJ
aiua-5955	7	26	alpha	alpha	NOUN
aiua-5955	7	27	-	-	PUNCT
aiua-5955	7	28	lipoic	lipoic	NOUN
aiua-5955	7	29	acid	acid	NOUN
aiua-5955	7	30	300	300	NUM
aiua-5955	7	31	mg	mg	NOUN
aiua-5955	7	32	(	(	PUNCT
aiua-5955	7	33	peanase	peanase	PROPN
aiua-5955	7	34	®	®	PROPN
aiua-5955	7	35	)	)	PUNCT
aiua-5955	7	36	,	,	PUNCT
aiua-5955	7	37	or	or	CCONJ
aiua-5955	7	38	serenoa	serenoa	ADJ
aiua-5955	7	39	repens	repen	NOUN
aiua-5955	7	40	at	at	ADP
aiua-5955	7	41	320	320	NUM
aiua-5955	7	42	mg	mg	NOUN
aiua-5955	7	43	.	.	PUNCT
aiua-5955	8	1	three	three	NUM
aiua-5955	8	2	questionnaires	questionnaire	NOUN
aiua-5955	8	3	(	(	PUNCT
aiua-5955	8	4	nih	nih	NOUN
aiua-5955	8	5	-	-	PUNCT
aiua-5955	8	6	cpsi	cpsi	PROPN
aiua-5955	8	7	,	,	PUNCT
aiua-5955	8	8	ipss	ipss	PROPN
aiua-5955	8	9	and	and	CCONJ
aiua-5955	8	10	iief5	iief5	PROPN
aiua-5955	8	11	)	)	PUNCT
aiua-5955	8	12	were	be	AUX
aiua-5955	8	13	administered	administer	VERB
aiua-5955	8	14	at	at	ADP
aiua-5955	8	15	baseline	baseline	NOUN
aiua-5955	8	16	and	and	CCONJ
aiua-5955	8	17	after	after	ADP
aiua-5955	8	18	12	12	NUM
aiua-5955	8	19	weeks	week	NOUN
aiua-5955	8	20	of	of	ADP
aiua-5955	8	21	treatment	treatment	NOUN
aiua-5955	8	22	in	in	ADP
aiua-5955	8	23	each	each	DET
aiua-5955	8	24	group	group	NOUN
aiua-5955	8	25	.	.	PUNCT
aiua-5955	9	1	results	result	NOUN
aiua-5955	9	2	:	:	PUNCT
aiua-5955	9	3	12	12	NUM
aiua-5955	9	4	week	week	NOUN
aiua-5955	9	5	treatment	treatment	NOUN
aiua-5955	9	6	with	with	ADP
aiua-5955	9	7	peanase	peanase	NOUN
aiua-5955	9	8	significantly	significantly	ADV
aiua-5955	9	9	improved	improve	VERB
aiua-5955	9	10	the	the	DET
aiua-5955	9	11	ipss	ipss	PROPN
aiua-5955	9	12	score	score	NOUN
aiua-5955	9	13	compared	compare	VERB
aiua-5955	9	14	to	to	ADP
aiua-5955	9	15	the	the	DET
aiua-5955	9	16	same	same	ADJ
aiua-5955	9	17	period	period	NOUN
aiua-5955	9	18	of	of	ADP
aiua-5955	9	19	treatment	treatment	NOUN
aiua-5955	9	20	with	with	ADP
aiua-5955	9	21	serenoa	serenoa	ADJ
aiua-5955	9	22	repens	repen	NOUN
aiua-5955	9	23	,	,	PUNCT
aiua-5955	9	24	and	and	CCONJ
aiua-5955	9	25	significantly	significantly	ADV
aiua-5955	9	26	reduced	reduce	VERB
aiua-5955	9	27	nih	nih	PROPN
aiua-5955	9	28	-	-	PUNCT
aiua-5955	9	29	cpsi	cpsi	PROPN
aiua-5955	9	30	score	score	NOUN
aiua-5955	9	31	.	.	PUNCT
aiua-5955	10	1	similar	similar	ADJ
aiua-5955	10	2	results	result	NOUN
aiua-5955	10	3	were	be	AUX
aiua-5955	10	4	observed	observe	VERB
aiua-5955	10	5	in	in	ADP
aiua-5955	10	6	the	the	DET
aiua-5955	10	7	different	different	ADJ
aiua-5955	10	8	nih	nih	ADJ
aiua-5955	10	9	-	-	PUNCT
aiua-5955	10	10	cpsi	cpsi	PROPN
aiua-5955	10	11	subscores	subscore	NOUN
aiua-5955	10	12	break	break	VERB
aiua-5955	10	13	down	down	ADP
aiua-5955	10	14	.	.	PUNCT
aiua-5955	11	1	however	however	ADV
aiua-5955	11	2	,	,	PUNCT
aiua-5955	11	3	the	the	DET
aiua-5955	11	4	same	same	ADJ
aiua-5955	11	5	treatment	treatment	NOUN
aiua-5955	11	6	did	do	AUX
aiua-5955	11	7	not	not	PART
aiua-5955	11	8	result	result	VERB
aiua-5955	11	9	in	in	ADP
aiua-5955	11	10	significant	significant	ADJ
aiua-5955	11	11	improvement	improvement	NOUN
aiua-5955	11	12	of	of	ADP
aiua-5955	11	13	the	the	DET
aiua-5955	11	14	iief5	iief5	PROPN
aiua-5955	11	15	score	score	NOUN
aiua-5955	11	16	.	.	PUNCT
aiua-5955	12	1	both	both	DET
aiua-5955	12	2	treatments	treatment	NOUN
aiua-5955	12	3	did	do	AUX
aiua-5955	12	4	not	not	PART
aiua-5955	12	5	produce	produce	VERB
aiua-5955	12	6	undesired	undesired	ADJ
aiua-5955	12	7	effects	effect	NOUN
aiua-5955	12	8	.	.	PUNCT
aiua-5955	13	1	conclusions	conclusion	NOUN
aiua-5955	13	2	:	:	PUNCT
aiua-5955	13	3	the	the	DET
aiua-5955	13	4	present	present	ADJ
aiua-5955	13	5	results	result	NOUN
aiua-5955	13	6	document	document	VERB
aiua-5955	13	7	the	the	DET
aiua-5955	13	8	efficacy	efficacy	NOUN
aiua-5955	13	9	of	of	ADP
aiua-5955	13	10	an	an	DET
aiua-5955	13	11	association	association	NOUN
aiua-5955	13	12	of	of	ADP
aiua-5955	13	13	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	13	14	(	(	PUNCT
aiua-5955	13	15	pea	pea	NOUN
aiua-5955	13	16	)	)	PUNCT
aiua-5955	13	17	and	and	CCONJ
aiua-5955	13	18	alpha	alpha	NOUN
aiua-5955	13	19	-	-	PUNCT
aiua-5955	13	20	lipoic	lipoic	NOUN
aiua-5955	13	21	acid	acid	NOUN
aiua-5955	13	22	(	(	PUNCT
aiua-5955	13	23	ala	ala	NOUN
aiua-5955	13	24	)	)	PUNCT
aiua-5955	13	25	administered	administer	VERB
aiua-5955	13	26	for	for	ADP
aiua-5955	13	27	12	12	NUM
aiua-5955	13	28	weeks	week	NOUN
aiua-5955	13	29	for	for	ADP
aiua-5955	13	30	treating	treat	VERB
aiua-5955	13	31	patients	patient	NOUN
aiua-5955	13	32	with	with	ADP
aiua-5955	13	33	cp	cp	PROPN
aiua-5955	13	34	/	/	SYM
aiua-5955	13	35	cpps	cpps	NOUN
aiua-5955	13	36	,	,	PUNCT
aiua-5955	13	37	compared	compare	VERB
aiua-5955	13	38	with	with	ADP
aiua-5955	13	39	serenoa	serenoa	ADJ
aiua-5955	13	40	repens	repen	NOUN
aiua-5955	13	41	monotherapy	monotherapy	NOUN
aiua-5955	13	42	.	.	PUNCT
aiua-5955	14	1	key	key	ADJ
aiua-5955	14	2	words	word	NOUN
aiua-5955	14	3	:	:	PUNCT
aiua-5955	14	4	chronic	chronic	ADJ
aiua-5955	14	5	pelvic	pelvic	ADJ
aiua-5955	14	6	pain	pain	NOUN
aiua-5955	14	7	syndrome	syndrome	NOUN
aiua-5955	14	8	;	;	PUNCT
aiua-5955	14	9	chronic	chronic	ADJ
aiua-5955	14	10	prostatitis	prostatitis	NOUN
aiua-5955	14	11	;	;	PUNCT
aiua-5955	14	12	palmitoylethanolamide	palmitoylethanolamide	ADV
aiua-5955	14	13	;	;	PUNCT
aiua-5955	14	14	serenoa	serenoa	ADJ
aiua-5955	14	15	repens	repen	NOUN
aiua-5955	14	16	;	;	PUNCT
aiua-5955	14	17	lipoic	lipoic	ADJ
aiua-5955	14	18	acid	acid	NOUN
aiua-5955	14	19	.	.	PUNCT
aiua-5955	14	20	submitted	submit	VERB
aiua-5955	14	21	14	14	NUM
aiua-5955	14	22	may	may	PROPN
aiua-5955	14	23	2016	2016	NUM
aiua-5955	14	24	;	;	PUNCT
aiua-5955	14	25	accepted	accept	VERB
aiua-5955	14	26	17	17	NUM
aiua-5955	14	27	july	july	PROPN
aiua-5955	14	28	2016	2016	NUM
aiua-5955	14	29	summary	summary	NOUN
aiua-5955	14	30	no	no	DET
aiua-5955	14	31	conflict	conflict	NOUN
aiua-5955	14	32	of	of	ADP
aiua-5955	14	33	interest	interest	NOUN
aiua-5955	14	34	declared	declare	VERB
aiua-5955	14	35	.	.	PUNCT
aiua-5955	15	1	ological	ological	ADJ
aiua-5955	15	2	methods	method	NOUN
aiua-5955	15	3	,	,	PUNCT
aiua-5955	15	4	or	or	CCONJ
aiua-5955	15	5	another	another	DET
aiua-5955	15	6	identifiable	identifiable	ADJ
aiua-5955	15	7	cause	cause	NOUN
aiua-5955	15	8	such	such	ADJ
aiua-5955	15	9	as	as	ADP
aiua-5955	15	10	malignancy	malignancy	NOUN
aiua-5955	15	11	.	.	PUNCT
aiua-5955	16	1	cp	cp	X
aiua-5955	16	2	/	/	SYM
aiua-5955	16	3	cpps	cpps	PROPN
aiua-5955	16	4	is	be	AUX
aiua-5955	16	5	a	a	DET
aiua-5955	16	6	highly	highly	ADV
aiua-5955	16	7	prevalent	prevalent	ADJ
aiua-5955	16	8	condition	condition	NOUN
aiua-5955	16	9	affecting	affect	VERB
aiua-5955	16	10	males	male	NOUN
aiua-5955	16	11	of	of	ADP
aiua-5955	16	12	a	a	DET
aiua-5955	16	13	wide	wide	ADJ
aiua-5955	16	14	age	age	NOUN
aiua-5955	16	15	range	range	NOUN
aiua-5955	16	16	,	,	PUNCT
aiua-5955	16	17	and	and	CCONJ
aiua-5955	16	18	can	can	AUX
aiua-5955	16	19	significantly	significantly	ADV
aiua-5955	16	20	impair	impair	VERB
aiua-5955	16	21	the	the	DET
aiua-5955	16	22	quality	quality	NOUN
aiua-5955	16	23	of	of	ADP
aiua-5955	16	24	life	life	NOUN
aiua-5955	16	25	(	(	PUNCT
aiua-5955	16	26	qol	qol	NOUN
aiua-5955	16	27	)	)	PUNCT
aiua-5955	16	28	and	and	CCONJ
aiua-5955	16	29	the	the	DET
aiua-5955	16	30	social	social	ADJ
aiua-5955	16	31	functioning	functioning	NOUN
aiua-5955	16	32	of	of	ADP
aiua-5955	16	33	patients	patient	NOUN
aiua-5955	16	34	.	.	PUNCT
aiua-5955	17	1	lifetime	lifetime	NOUN
aiua-5955	17	2	cp	cp	PROPN
aiua-5955	17	3	/	/	SYM
aiua-5955	17	4	cpps	cpps	NOUN
aiua-5955	17	5	prevalence	prevalence	NOUN
aiua-5955	17	6	is	be	AUX
aiua-5955	17	7	2	2	NUM
aiua-5955	17	8	%	%	NOUN
aiua-5955	17	9	to	to	PART
aiua-5955	17	10	10	10	NUM
aiua-5955	17	11	%	%	NOUN
aiua-5955	17	12	.	.	PUNCT
aiua-5955	18	1	many	many	ADJ
aiua-5955	18	2	etiologies	etiology	NOUN
aiua-5955	18	3	and	and	CCONJ
aiua-5955	18	4	mechanisms	mechanism	NOUN
aiua-5955	18	5	for	for	ADP
aiua-5955	18	6	cp	cp	NOUN
aiua-5955	18	7	/	/	SYM
aiua-5955	18	8	cpps	cpps	NOUN
aiua-5955	18	9	pathogenesis	pathogenesis	NOUN
aiua-5955	18	10	have	have	AUX
aiua-5955	18	11	been	be	AUX
aiua-5955	18	12	proposed	propose	VERB
aiua-5955	18	13	,	,	PUNCT
aiua-5955	18	14	including	include	VERB
aiua-5955	18	15	infection	infection	NOUN
aiua-5955	18	16	,	,	PUNCT
aiua-5955	18	17	detrusorsphincter	detrusorsphinct	ADJ
aiua-5955	18	18	dysfunction	dysfunction	NOUN
aiua-5955	18	19	,	,	PUNCT
aiua-5955	18	20	immunological	immunological	ADJ
aiua-5955	18	21	dysfunction	dysfunction	NOUN
aiua-5955	18	22	,	,	PUNCT
aiua-5955	18	23	interstitial	interstitial	ADJ
aiua-5955	18	24	cystitis	cystitis	NOUN
aiua-5955	18	25	,	,	PUNCT
aiua-5955	18	26	and	and	CCONJ
aiua-5955	18	27	neuropathic	neuropathic	ADJ
aiua-5955	18	28	pain	pain	NOUN
aiua-5955	18	29	.	.	PUNCT
aiua-5955	19	1	cp	cp	X
aiua-5955	19	2	/	/	SYM
aiua-5955	19	3	cpps	cpps	PROPN
aiua-5955	19	4	is	be	AUX
aiua-5955	19	5	characterized	characterize	VERB
aiua-5955	19	6	by	by	ADP
aiua-5955	19	7	a	a	DET
aiua-5955	19	8	wide	wide	ADJ
aiua-5955	19	9	spectrum	spectrum	NOUN
aiua-5955	19	10	of	of	ADP
aiua-5955	19	11	symptoms	symptom	NOUN
aiua-5955	19	12	,	,	PUNCT
aiua-5955	19	13	including	include	VERB
aiua-5955	19	14	chronic	chronic	ADJ
aiua-5955	19	15	or	or	CCONJ
aiua-5955	19	16	persistent	persistent	ADJ
aiua-5955	19	17	pain	pain	NOUN
aiua-5955	19	18	in	in	ADP
aiua-5955	19	19	the	the	DET
aiua-5955	19	20	pelvic	pelvic	ADJ
aiua-5955	19	21	region	region	NOUN
aiua-5955	19	22	,	,	PUNCT
aiua-5955	19	23	irritative	irritative	ADJ
aiua-5955	19	24	and	and	CCONJ
aiua-5955	19	25	obstructive	obstructive	ADJ
aiua-5955	19	26	voiding	void	VERB
aiua-5955	19	27	symptoms	symptom	NOUN
aiua-5955	19	28	,	,	PUNCT
aiua-5955	19	29	ejaculatory	ejaculatory	ADJ
aiua-5955	19	30	pain	pain	NOUN
aiua-5955	19	31	,	,	PUNCT
aiua-5955	19	32	sexual	sexual	ADJ
aiua-5955	19	33	dysfunction	dysfunction	NOUN
aiua-5955	19	34	,	,	PUNCT
aiua-5955	19	35	depression	depression	NOUN
aiua-5955	19	36	and	and	CCONJ
aiua-5955	19	37	psycho	psycho	NOUN
aiua-5955	19	38	-	-	PUNCT
aiua-5955	19	39	social	social	ADJ
aiua-5955	19	40	maladjustment	maladjustment	NOUN
aiua-5955	19	41	amongst	amongst	ADP
aiua-5955	19	42	others	other	NOUN
aiua-5955	19	43	.	.	PUNCT
aiua-5955	20	1	the	the	DET
aiua-5955	20	2	cp	cp	PROPN
aiua-5955	20	3	/	/	SYM
aiua-5955	20	4	cpp	cpp	NOUN
aiua-5955	20	5	mechanisms	mechanism	NOUN
aiua-5955	20	6	involve	involve	VERB
aiua-5955	20	7	ongoing	ongoing	ADJ
aiua-5955	20	8	acute	acute	ADJ
aiua-5955	20	9	pain	pain	NOUN
aiua-5955	20	10	mechanisms	mechanism	NOUN
aiua-5955	20	11	(	(	PUNCT
aiua-5955	20	12	such	such	ADJ
aiua-5955	20	13	as	as	ADP
aiua-5955	20	14	those	those	PRON
aiua-5955	20	15	associated	associate	VERB
aiua-5955	20	16	with	with	ADP
aiua-5955	20	17	inflammation	inflammation	NOUN
aiua-5955	20	18	or	or	CCONJ
aiua-5955	20	19	infection	infection	NOUN
aiua-5955	20	20	)	)	PUNCT
aiua-5955	20	21	and	and	CCONJ
aiua-5955	20	22	chronic	chronic	ADJ
aiua-5955	20	23	pain	pain	NOUN
aiua-5955	20	24	mechanisms	mechanism	NOUN
aiua-5955	20	25	(	(	PUNCT
aiua-5955	20	26	such	such	ADJ
aiua-5955	20	27	as	as	ADP
aiua-5955	20	28	central	central	ADJ
aiua-5955	20	29	sensitization	sensitization	NOUN
aiua-5955	20	30	or	or	CCONJ
aiua-5955	20	31	visceral	visceral	ADJ
aiua-5955	20	32	hyperalgesia	hyperalgesia	NOUN
aiua-5955	20	33	)	)	PUNCT
aiua-5955	20	34	(	(	PUNCT
aiua-5955	20	35	1	1	NUM
aiua-5955	20	36	)	)	PUNCT
aiua-5955	20	37	.	.	PUNCT
aiua-5955	21	1	the	the	DET
aiua-5955	21	2	efficacy	efficacy	NOUN
aiua-5955	21	3	of	of	ADP
aiua-5955	21	4	various	various	ADJ
aiua-5955	21	5	medical	medical	ADJ
aiua-5955	21	6	therapies	therapy	NOUN
aiua-5955	21	7	,	,	PUNCT
aiua-5955	21	8	such	such	ADJ
aiua-5955	21	9	as	as	ADP
aiua-5955	21	10	antibiotics	antibiotic	NOUN
aiua-5955	21	11	,	,	PUNCT
aiua-5955	21	12	alpha	alpha	NOUN
aiua-5955	21	13	-	-	PUNCT
aiua-5955	21	14	adrenergic	adrenergic	ADJ
aiua-5955	21	15	blockers	blocker	NOUN
aiua-5955	21	16	,	,	PUNCT
aiua-5955	21	17	anti	anti	ADJ
aiua-5955	21	18	-	-	ADJ
aiua-5955	21	19	inflammatory	inflammatory	ADJ
aiua-5955	21	20	agents	agent	NOUN
aiua-5955	21	21	,	,	PUNCT
aiua-5955	21	22	hormonal	hormonal	ADJ
aiua-5955	21	23	therapies	therapy	NOUN
aiua-5955	21	24	,	,	PUNCT
aiua-5955	21	25	and	and	CCONJ
aiua-5955	21	26	phytotherapies	phytotherapy	NOUN
aiua-5955	21	27	,	,	PUNCT
aiua-5955	21	28	has	have	AUX
aiua-5955	21	29	been	be	AUX
aiua-5955	21	30	evaluated	evaluate	VERB
aiua-5955	21	31	in	in	ADP
aiua-5955	21	32	clinical	clinical	ADJ
aiua-5955	21	33	studies	study	NOUN
aiua-5955	21	34	of	of	ADP
aiua-5955	21	35	cpps	cpps	NOUN
aiua-5955	21	36	.	.	PUNCT
aiua-5955	22	1	however	however	ADV
aiua-5955	22	2	,	,	PUNCT
aiua-5955	22	3	evidence	evidence	NOUN
aiua-5955	22	4	is	be	AUX
aiua-5955	22	5	lacking	lack	VERB
aiua-5955	22	6	or	or	CCONJ
aiua-5955	22	7	conflicting	conflict	VERB
aiua-5955	22	8	.	.	PUNCT
aiua-5955	23	1	phytotherapeutics	phytotherapeutic	NOUN
aiua-5955	23	2	are	be	AUX
aiua-5955	23	3	a	a	DET
aiua-5955	23	4	noteworthy	noteworthy	ADJ
aiua-5955	23	5	option	option	NOUN
aiua-5955	23	6	due	due	ADP
aiua-5955	23	7	to	to	ADP
aiua-5955	23	8	their	their	PRON
aiua-5955	23	9	generally	generally	ADV
aiua-5955	23	10	minimal	minimal	ADJ
aiua-5955	23	11	side	side	NOUN
aiua-5955	23	12	-	-	PUNCT
aiua-5955	23	13	effects	effect	NOUN
aiua-5955	23	14	;	;	PUNCT
aiua-5955	23	15	however	however	ADV
aiua-5955	23	16	,	,	PUNCT
aiua-5955	23	17	few	few	ADJ
aiua-5955	23	18	have	have	AUX
aiua-5955	23	19	been	be	AUX
aiua-5955	23	20	subjected	subject	VERB
aiua-5955	23	21	to	to	ADP
aiua-5955	23	22	scientific	scientific	ADJ
aiua-5955	23	23	scrutiny	scrutiny	NOUN
aiua-5955	23	24	and	and	CCONJ
aiua-5955	23	25	prospective	prospective	ADJ
aiua-5955	23	26	controlled	control	VERB
aiua-5955	23	27	clinical	clinical	ADJ
aiua-5955	23	28	trials	trial	NOUN
aiua-5955	23	29	.	.	PUNCT
aiua-5955	24	1	it	it	PRON
aiua-5955	24	2	has	have	AUX
aiua-5955	24	3	been	be	AUX
aiua-5955	24	4	hypothesized	hypothesize	VERB
aiua-5955	24	5	that	that	SCONJ
aiua-5955	24	6	the	the	DET
aiua-5955	24	7	etiological	etiological	ADJ
aiua-5955	24	8	determinants	determinant	NOUN
aiua-5955	24	9	of	of	ADP
aiua-5955	24	10	cp	cp	PROPN
aiua-5955	24	11	/	/	SYM
aiua-5955	24	12	cpps	cpp	NOUN
aiua-5955	24	13	are	be	AUX
aiua-5955	24	14	likely	likely	ADJ
aiua-5955	24	15	to	to	PART
aiua-5955	24	16	trigger	trigger	VERB
aiua-5955	24	17	tissue	tissue	NOUN
aiua-5955	24	18	and	and	CCONJ
aiua-5955	24	19	cellular	cellular	ADJ
aiua-5955	24	20	responses	response	NOUN
aiua-5955	24	21	that	that	PRON
aiua-5955	24	22	include	include	VERB
aiua-5955	24	23	inflammation	inflammation	NOUN
aiua-5955	24	24	and	and	CCONJ
aiua-5955	24	25	the	the	DET
aiua-5955	24	26	upregulation	upregulation	NOUN
aiua-5955	24	27	of	of	ADP
aiua-5955	24	28	cytokine	cytokine	ADJ
aiua-5955	24	29	expression	expression	NOUN
aiua-5955	24	30	and	and	CCONJ
aiua-5955	24	31	release	release	NOUN
aiua-5955	24	32	.	.	PUNCT
aiua-5955	25	1	inflammatory	inflammatory	ADJ
aiua-5955	25	2	injury	injury	NOUN
aiua-5955	25	3	may	may	AUX
aiua-5955	25	4	damage	damage	VERB
aiua-5955	25	5	tissue	tissue	NOUN
aiua-5955	25	6	components	component	NOUN
aiua-5955	25	7	such	such	ADJ
aiua-5955	25	8	as	as	ADP
aiua-5955	25	9	nerves	nerve	NOUN
aiua-5955	25	10	and	and	CCONJ
aiua-5955	25	11	blood	blood	NOUN
aiua-5955	25	12	vessels	vessel	NOUN
aiua-5955	25	13	,	,	PUNCT
aiua-5955	25	14	in	in	ADP
aiua-5955	25	15	turn	turn	NOUN
aiua-5955	25	16	causing	cause	VERB
aiua-5955	25	17	pain	pain	NOUN
aiua-5955	25	18	that	that	PRON
aiua-5955	25	19	may	may	AUX
aiua-5955	25	20	produce	produce	VERB
aiua-5955	25	21	contraction	contraction	NOUN
aiua-5955	25	22	of	of	ADP
aiua-5955	25	23	pelvic	pelvic	ADJ
aiua-5955	25	24	smooth	smooth	ADJ
aiua-5955	25	25	and	and	CCONJ
aiua-5955	25	26	skeletal	skeletal	ADJ
aiua-5955	25	27	muscles	muscle	NOUN
aiua-5955	25	28	,	,	PUNCT
aiua-5955	25	29	finally	finally	ADV
aiua-5955	25	30	leading	lead	VERB
aiua-5955	25	31	to	to	ADP
aiua-5955	25	32	lower	low	ADJ
aiua-5955	25	33	urinary	urinary	ADJ
aiua-5955	25	34	tract	tract	NOUN
aiua-5955	25	35	symptoms	symptom	NOUN
aiua-5955	25	36	,	,	PUNCT
aiua-5955	25	37	ejaculatory	ejaculatory	ADJ
aiua-5955	25	38	pain	pain	NOUN
aiua-5955	25	39	and	and	CCONJ
aiua-5955	25	40	pain	pain	NOUN
aiua-5955	25	41	in	in	ADP
aiua-5955	25	42	other	other	ADJ
aiua-5955	25	43	regions	region	NOUN
aiua-5955	25	44	,	,	PUNCT
aiua-5955	25	45	including	include	VERB
aiua-5955	25	46	the	the	DET
aiua-5955	25	47	lower	low	ADJ
aiua-5955	25	48	back	back	NOUN
aiua-5955	25	49	and	and	CCONJ
aiua-5955	25	50	abdomen	abdoman	NOUN
aiua-5955	25	51	.	.	PUNCT
aiua-5955	26	1	prolonged	prolonged	ADJ
aiua-5955	26	2	pain	pain	NOUN
aiua-5955	26	3	may	may	AUX
aiua-5955	26	4	lead	lead	VERB
aiua-5955	26	5	to	to	ADP
aiua-5955	26	6	neurogenic	neurogenic	ADJ
aiua-5955	26	7	inflammation	inflammation	NOUN
aiua-5955	26	8	and	and	CCONJ
aiua-5955	26	9	peripheral	peripheral	ADJ
aiua-5955	26	10	and	and	CCONJ
aiua-5955	26	11	central	central	ADJ
aiua-5955	26	12	sensitization	sensitization	NOUN
aiua-5955	26	13	.	.	PUNCT
aiua-5955	27	1	patients	patient	NOUN
aiua-5955	27	2	and	and	CCONJ
aiua-5955	27	3	methods	method	NOUN
aiua-5955	27	4	cp	cp	PROPN
aiua-5955	27	5	/	/	SYM
aiua-5955	27	6	cpps	cpps	PROPN
aiua-5955	27	7	is	be	AUX
aiua-5955	27	8	treated	treat	VERB
aiua-5955	27	9	by	by	ADP
aiua-5955	27	10	means	mean	NOUN
aiua-5955	27	11	of	of	ADP
aiua-5955	27	12	different	different	ADJ
aiua-5955	27	13	protocols	protocol	NOUN
aiua-5955	27	14	.	.	PUNCT
aiua-5955	28	1	we	we	PRON
aiua-5955	28	2	compared	compare	VERB
aiua-5955	28	3	serenoa	serenoa	ADJ
aiua-5955	28	4	repens	repen	NOUN
aiua-5955	28	5	in	in	ADP
aiua-5955	28	6	monotherapy	monotherapy	NOUN
aiua-5955	28	7	versus	versus	ADP
aiua-5955	28	8	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	28	9	(	(	PUNCT
aiua-5955	28	10	pea	pea	NOUN
aiua-5955	28	11	)	)	PUNCT
aiua-5955	28	12	in	in	ADP
aiua-5955	28	13	combination	combination	NOUN
aiua-5955	28	14	with	with	ADP
aiua-5955	28	15	doi	doi	NOUN
aiua-5955	28	16	:	:	PUNCT
aiua-5955	28	17	10.4081	10.4081	NUM
aiua-5955	28	18	/	/	SYM
aiua-5955	28	19	aiua.2017.1.17	aiua.2017.1.17	NOUN
aiua-5955	28	20	introduction	introduction	NOUN
aiua-5955	28	21	chronic	chronic	ADJ
aiua-5955	28	22	prostatitis	prostatitis	NOUN
aiua-5955	28	23	/	/	SYM
aiua-5955	28	24	chronic	chronic	ADJ
aiua-5955	28	25	pelvic	pelvic	ADJ
aiua-5955	28	26	pain	pain	NOUN
aiua-5955	28	27	syndrome	syndrome	NOUN
aiua-5955	28	28	(	(	PUNCT
aiua-5955	28	29	cp	cp	NOUN
aiua-5955	28	30	/	/	SYM
aiua-5955	28	31	cpps	cpps	NOUN
aiua-5955	28	32	)	)	PUNCT
aiua-5955	28	33	is	be	AUX
aiua-5955	28	34	a	a	DET
aiua-5955	28	35	complex	complex	ADJ
aiua-5955	28	36	condition	condition	NOUN
aiua-5955	28	37	,	,	PUNCT
aiua-5955	28	38	characterized	characterize	VERB
aiua-5955	28	39	by	by	ADP
aiua-5955	28	40	uncertain	uncertain	ADJ
aiua-5955	28	41	etiology	etiology	NOUN
aiua-5955	28	42	and	and	CCONJ
aiua-5955	28	43	by	by	ADP
aiua-5955	28	44	limited	limited	ADJ
aiua-5955	28	45	response	response	NOUN
aiua-5955	28	46	to	to	ADP
aiua-5955	28	47	therapy	therapy	NOUN
aiua-5955	28	48	.	.	PUNCT
aiua-5955	29	1	the	the	DET
aiua-5955	29	2	definition	definition	NOUN
aiua-5955	29	3	of	of	ADP
aiua-5955	29	4	cp	cp	PROPN
aiua-5955	29	5	/	/	SYM
aiua-5955	29	6	cpps	cpps	NOUN
aiua-5955	29	7	includes	include	VERB
aiua-5955	29	8	genitourinary	genitourinary	ADJ
aiua-5955	29	9	pain	pain	NOUN
aiua-5955	29	10	with	with	ADP
aiua-5955	29	11	or	or	CCONJ
aiua-5955	29	12	without	without	ADP
aiua-5955	29	13	voiding	void	VERB
aiua-5955	29	14	symptoms	symptom	NOUN
aiua-5955	29	15	in	in	ADP
aiua-5955	29	16	the	the	DET
aiua-5955	29	17	absence	absence	NOUN
aiua-5955	29	18	of	of	ADP
aiua-5955	29	19	uropathogenic	uropathogenic	ADJ
aiua-5955	29	20	bacteria	bacteria	NOUN
aiua-5955	29	21	,	,	PUNCT
aiua-5955	29	22	as	as	SCONJ
aiua-5955	29	23	detected	detect	VERB
aiua-5955	29	24	by	by	ADP
aiua-5955	29	25	standard	standard	ADJ
aiua-5955	29	26	microbigiammusso_stesura	microbigiammusso_stesura	PROPN
aiua-5955	29	27	seveso	seveso	VERB
aiua-5955	29	28	04/04/17	04/04/17	X
aiua-5955	29	29	09:06	09:06	NUM
aiua-5955	29	30	pagina	pagina	NOUN
aiua-5955	29	31	17	17	NUM
aiua-5955	29	32	archivio	archivio	NOUN
aiua-5955	29	33	italiano	italiano	X
aiua-5955	29	34	di	di	X
aiua-5955	29	35	urologia	urologia	PROPN
aiua-5955	29	36	e	e	PROPN
aiua-5955	29	37	andrologia	andrologia	NOUN
aiua-5955	29	38	2017	2017	NUM
aiua-5955	29	39	;	;	PUNCT
aiua-5955	29	40	89	89	NUM
aiua-5955	29	41	,	,	PUNCT
aiua-5955	29	42	1	1	NUM
aiua-5955	29	43	b.	b.	PROPN
aiua-5955	29	44	giammusso	giammusso	PROPN
aiua-5955	29	45	,	,	PUNCT
aiua-5955	29	46	r.	r.	PROPN
aiua-5955	29	47	di	di	PROPN
aiua-5955	29	48	mauro	mauro	PROPN
aiua-5955	29	49	,	,	PUNCT
aiua-5955	29	50	r.	r.	PROPN
aiua-5955	29	51	bernardini	bernardini	PROPN
aiua-5955	29	52	18	18	NUM
aiua-5955	29	53	alpha	alpha	NOUN
aiua-5955	29	54	-	-	PUNCT
aiua-5955	29	55	lipoic	lipoic	NOUN
aiua-5955	29	56	acid	acid	NOUN
aiua-5955	29	57	(	(	PUNCT
aiua-5955	29	58	ala	ala	PROPN
aiua-5955	29	59	)	)	PUNCT
aiua-5955	29	60	and	and	CCONJ
aiua-5955	29	61	evaluated	evaluate	VERB
aiua-5955	29	62	the	the	DET
aiua-5955	29	63	efficacy	efficacy	NOUN
aiua-5955	29	64	of	of	ADP
aiua-5955	29	65	these	these	DET
aiua-5955	29	66	treatments	treatment	NOUN
aiua-5955	29	67	in	in	ADP
aiua-5955	29	68	patients	patient	NOUN
aiua-5955	29	69	with	with	ADP
aiua-5955	29	70	cp	cp	NOUN
aiua-5955	29	71	/	/	SYM
aiua-5955	29	72	cpps	cpps	NOUN
aiua-5955	29	73	.	.	PUNCT
aiua-5955	30	1	we	we	PRON
aiua-5955	30	2	conducted	conduct	VERB
aiua-5955	30	3	a	a	DET
aiua-5955	30	4	randomized	randomized	ADJ
aiua-5955	30	5	,	,	PUNCT
aiua-5955	30	6	single	single	ADJ
aiua-5955	30	7	-	-	PUNCT
aiua-5955	30	8	blind	blind	ADJ
aiua-5955	30	9	trial	trial	NOUN
aiua-5955	30	10	of	of	ADP
aiua-5955	30	11	a	a	DET
aiua-5955	30	12	community	community	NOUN
aiua-5955	30	13	population	population	NOUN
aiua-5955	30	14	recruited	recruit	VERB
aiua-5955	30	15	from	from	ADP
aiua-5955	30	16	june	june	PROPN
aiua-5955	30	17	2014	2014	NUM
aiua-5955	30	18	to	to	ADP
aiua-5955	30	19	january	january	PROPN
aiua-5955	30	20	2015	2015	NUM
aiua-5955	30	21	.	.	PUNCT
aiua-5955	31	1	trial	trial	NOUN
aiua-5955	31	2	design	design	NOUN
aiua-5955	31	3	men	man	NOUN
aiua-5955	31	4	aged	age	VERB
aiua-5955	31	5	between	between	ADP
aiua-5955	31	6	22	22	NUM
aiua-5955	31	7	and	and	CCONJ
aiua-5955	31	8	61	61	NUM
aiua-5955	31	9	years	year	NOUN
aiua-5955	31	10	,	,	PUNCT
aiua-5955	31	11	attending	attend	VERB
aiua-5955	31	12	our	our	PRON
aiua-5955	31	13	outpatient	outpatient	NOUN
aiua-5955	31	14	urology	urology	NOUN
aiua-5955	31	15	clinic	clinic	NOUN
aiua-5955	31	16	were	be	AUX
aiua-5955	31	17	invited	invite	VERB
aiua-5955	31	18	to	to	PART
aiua-5955	31	19	participate	participate	VERB
aiua-5955	31	20	in	in	ADP
aiua-5955	31	21	the	the	DET
aiua-5955	31	22	study	study	NOUN
aiua-5955	31	23	.	.	PUNCT
aiua-5955	32	1	inclusion	inclusion	NOUN
aiua-5955	32	2	criteria	criterion	NOUN
aiua-5955	32	3	were	be	AUX
aiua-5955	32	4	:	:	PUNCT
aiua-5955	32	5	complaints	complaint	NOUN
aiua-5955	32	6	of	of	ADP
aiua-5955	32	7	chronic	chronic	ADJ
aiua-5955	32	8	pelvic	pelvic	ADJ
aiua-5955	32	9	pain	pain	NOUN
aiua-5955	32	10	for	for	ADP
aiua-5955	32	11	at	at	ADV
aiua-5955	32	12	least	least	ADV
aiua-5955	32	13	six	six	NUM
aiua-5955	32	14	months	month	NOUN
aiua-5955	32	15	;	;	PUNCT
aiua-5955	32	16	ipss	ipss	PROPN
aiua-5955	32	17	score	score	NOUN
aiua-5955	32	18	higher	high	ADJ
aiua-5955	32	19	than	than	ADP
aiua-5955	32	20	13	13	NUM
aiua-5955	32	21	at	at	ADP
aiua-5955	32	22	visit	visit	NOUN
aiua-5955	32	23	1	1	NUM
aiua-5955	32	24	;	;	PUNCT
aiua-5955	32	25	pain	pain	NOUN
aiua-5955	32	26	domain	domain	NOUN
aiua-5955	32	27	of	of	ADP
aiua-5955	32	28	nih	nih	PROPN
aiua-5955	32	29	-	-	PUNCT
aiua-5955	32	30	cpsi	cpsi	NOUN
aiua-5955	32	31	higher	high	ADJ
aiua-5955	32	32	than	than	ADP
aiua-5955	32	33	1	1	NUM
aiua-5955	32	34	at	at	ADP
aiua-5955	32	35	visit	visit	NOUN
aiua-5955	32	36	1	1	NUM
aiua-5955	32	37	;	;	PUNCT
aiua-5955	32	38	total	total	ADJ
aiua-5955	32	39	psa	psa	VERB
aiua-5955	32	40	lower	low	ADJ
aiua-5955	32	41	than	than	ADP
aiua-5955	32	42	4	4	NUM
aiua-5955	32	43	ng	ng	NOUN
aiua-5955	32	44	/	/	SYM
aiua-5955	32	45	ml	ml	PROPN
aiua-5955	32	46	.	.	PUNCT
aiua-5955	33	1	patients	patient	NOUN
aiua-5955	33	2	were	be	AUX
aiua-5955	33	3	included	include	VERB
aiua-5955	33	4	in	in	ADP
aiua-5955	33	5	this	this	DET
aiua-5955	33	6	study	study	NOUN
aiua-5955	33	7	if	if	SCONJ
aiua-5955	33	8	they	they	PRON
aiua-5955	33	9	exhibited	exhibit	VERB
aiua-5955	33	10	at	at	ADP
aiua-5955	33	11	a	a	DET
aiua-5955	33	12	first	first	ADJ
aiua-5955	33	13	visit	visit	NOUN
aiua-5955	33	14	signs	sign	NOUN
aiua-5955	33	15	and	and	CCONJ
aiua-5955	33	16	symptoms	symptom	NOUN
aiua-5955	33	17	of	of	ADP
aiua-5955	33	18	category	category	NOUN
aiua-5955	33	19	iii	iii	NUM
aiua-5955	33	20	cp	cp	NOUN
aiua-5955	33	21	/	/	SYM
aiua-5955	33	22	cpps	cpps	NOUN
aiua-5955	33	23	,	,	PUNCT
aiua-5955	33	24	according	accord	VERB
aiua-5955	33	25	to	to	ADP
aiua-5955	33	26	national	national	PROPN
aiua-5955	33	27	institutes	institutes	PROPN
aiua-5955	33	28	of	of	ADP
aiua-5955	33	29	health	health	PROPN
aiua-5955	33	30	(	(	PUNCT
aiua-5955	33	31	nih	nih	NOUN
aiua-5955	33	32	)	)	PUNCT
aiua-5955	33	33	criteria	criterion	NOUN
aiua-5955	33	34	(	(	PUNCT
aiua-5955	33	35	niddk	niddk	ADJ
aiua-5955	33	36	chronic	chronic	ADJ
aiua-5955	33	37	prostatitis	prostatitis	NOUN
aiua-5955	33	38	workshop	workshop	NOUN
aiua-5955	33	39	,	,	PUNCT
aiua-5955	33	40	1995	1995	NUM
aiua-5955	33	41	)	)	PUNCT
aiua-5955	33	42	.	.	PUNCT
aiua-5955	34	1	subjects	subject	NOUN
aiua-5955	34	2	younger	young	ADJ
aiua-5955	34	3	than	than	ADP
aiua-5955	34	4	22	22	NUM
aiua-5955	34	5	and	and	CCONJ
aiua-5955	34	6	older	old	ADJ
aiua-5955	34	7	than	than	ADP
aiua-5955	34	8	61	61	NUM
aiua-5955	34	9	years	year	NOUN
aiua-5955	34	10	,	,	PUNCT
aiua-5955	34	11	affected	affect	VERB
aiua-5955	34	12	by	by	ADP
aiua-5955	34	13	major	major	ADJ
aiua-5955	34	14	comorbidities	comorbiditie	NOUN
aiua-5955	34	15	,	,	PUNCT
aiua-5955	34	16	with	with	ADP
aiua-5955	34	17	known	know	VERB
aiua-5955	34	18	anatomical	anatomical	ADJ
aiua-5955	34	19	abnormalities	abnormality	NOUN
aiua-5955	34	20	of	of	ADP
aiua-5955	34	21	the	the	DET
aiua-5955	34	22	urinary	urinary	ADJ
aiua-5955	34	23	tract	tract	NOUN
aiua-5955	34	24	or	or	CCONJ
aiua-5955	34	25	with	with	ADP
aiua-5955	34	26	evidence	evidence	NOUN
aiua-5955	34	27	of	of	ADP
aiua-5955	34	28	other	other	ADJ
aiua-5955	34	29	urological	urological	ADJ
aiua-5955	34	30	diseases	disease	NOUN
aiua-5955	34	31	,	,	PUNCT
aiua-5955	34	32	and	and	CCONJ
aiua-5955	34	33	with	with	ADP
aiua-5955	34	34	residual	residual	ADJ
aiua-5955	34	35	urine	urine	NOUN
aiua-5955	34	36	volume	volume	NOUN
aiua-5955	34	37	>	>	X
aiua-5955	34	38	50	50	NUM
aiua-5955	34	39	ml	ml	NOUN
aiua-5955	34	40	resulting	result	VERB
aiua-5955	34	41	from	from	ADP
aiua-5955	34	42	bladder	bladder	NOUN
aiua-5955	34	43	outlet	outlet	NOUN
aiua-5955	34	44	obstruction	obstruction	NOUN
aiua-5955	34	45	were	be	AUX
aiua-5955	34	46	excluded	exclude	VERB
aiua-5955	34	47	.	.	PUNCT
aiua-5955	35	1	males	male	NOUN
aiua-5955	35	2	with	with	ADP
aiua-5955	35	3	a	a	DET
aiua-5955	35	4	reported	report	VERB
aiua-5955	35	5	allergy	allergy	NOUN
aiua-5955	35	6	to	to	ADP
aiua-5955	35	7	the	the	DET
aiua-5955	35	8	drugs	drug	NOUN
aiua-5955	35	9	administered	administer	VERB
aiua-5955	35	10	during	during	ADP
aiua-5955	35	11	the	the	DET
aiua-5955	35	12	trial	trial	NOUN
aiua-5955	35	13	,	,	PUNCT
aiua-5955	35	14	who	who	PRON
aiua-5955	35	15	had	have	AUX
aiua-5955	35	16	recently	recently	ADV
aiua-5955	35	17	(	(	PUNCT
aiua-5955	35	18	<	<	X
aiua-5955	35	19	4	4	NUM
aiua-5955	35	20	weeks	week	NOUN
aiua-5955	35	21	)	)	PUNCT
aiua-5955	35	22	undergone	undergone	ADJ
aiua-5955	35	23	oral	oral	ADJ
aiua-5955	35	24	or	or	CCONJ
aiua-5955	35	25	parenteral	parenteral	ADJ
aiua-5955	35	26	treatment	treatment	NOUN
aiua-5955	35	27	or	or	CCONJ
aiua-5955	35	28	who	who	PRON
aiua-5955	35	29	were	be	AUX
aiua-5955	35	30	currently	currently	ADV
aiua-5955	35	31	using	use	VERB
aiua-5955	35	32	prophylactic	prophylactic	ADJ
aiua-5955	35	33	antibiotic	antibiotic	ADJ
aiua-5955	35	34	drugs	drug	NOUN
aiua-5955	35	35	and/or	and/or	CCONJ
aiua-5955	35	36	finasteride	finasteride	ADJ
aiua-5955	35	37	were	be	AUX
aiua-5955	35	38	also	also	ADV
aiua-5955	35	39	excluded	exclude	VERB
aiua-5955	35	40	.	.	PUNCT
aiua-5955	36	1	all	all	DET
aiua-5955	36	2	patients	patient	NOUN
aiua-5955	36	3	positive	positive	ADJ
aiua-5955	36	4	to	to	AUX
aiua-5955	36	5	tests	test	NOUN
aiua-5955	36	6	for	for	ADP
aiua-5955	36	7	chlamydia	chlamydia	NOUN
aiua-5955	36	8	trachomatis	trachomatis	ADJ
aiua-5955	36	9	(	(	PUNCT
aiua-5955	36	10	ct	ct	PROPN
aiua-5955	36	11	)	)	PUNCT
aiua-5955	36	12	,	,	PUNCT
aiua-5955	36	13	ureaplasma	ureaplasma	NOUN
aiua-5955	36	14	urealyticum	urealyticum	NOUN
aiua-5955	36	15	,	,	PUNCT
aiua-5955	36	16	neisseria	neisseria	PROPN
aiua-5955	36	17	gonorrhoeae	gonorrhoeae	PROPN
aiua-5955	36	18	,	,	PUNCT
aiua-5955	36	19	herpes	herpe	NOUN
aiua-5955	36	20	viruses	virus	NOUN
aiua-5955	36	21	(	(	PUNCT
aiua-5955	36	22	hsv	hsv	NOUN
aiua-5955	36	23	1/2	1/2	NUM
aiua-5955	36	24	)	)	PUNCT
aiua-5955	36	25	and	and	CCONJ
aiua-5955	36	26	human	human	ADJ
aiua-5955	36	27	papillomavirus	papillomavirus	NOUN
aiua-5955	36	28	(	(	PUNCT
aiua-5955	36	29	hpv	hpv	NOUN
aiua-5955	36	30	)	)	PUNCT
aiua-5955	36	31	were	be	AUX
aiua-5955	36	32	also	also	ADV
aiua-5955	36	33	excluded	exclude	VERB
aiua-5955	36	34	.	.	PUNCT
aiua-5955	37	1	the	the	DET
aiua-5955	37	2	severity	severity	NOUN
aiua-5955	37	3	of	of	ADP
aiua-5955	37	4	the	the	DET
aiua-5955	37	5	chronic	chronic	ADJ
aiua-5955	37	6	prostatitis	prostatitis	NOUN
aiua-5955	37	7	symptoms	symptom	NOUN
aiua-5955	37	8	was	be	AUX
aiua-5955	37	9	scored	score	VERB
aiua-5955	37	10	by	by	ADP
aiua-5955	37	11	means	mean	NOUN
aiua-5955	37	12	of	of	ADP
aiua-5955	37	13	an	an	DET
aiua-5955	37	14	italian	italian	ADJ
aiua-5955	37	15	validated	validate	VERB
aiua-5955	37	16	version	version	NOUN
aiua-5955	37	17	of	of	ADP
aiua-5955	37	18	the	the	DET
aiua-5955	37	19	nih	nih	PROPN
aiua-5955	37	20	chronic	chronic	PROPN
aiua-5955	37	21	prostatitis	prostatitis	NOUN
aiua-5955	37	22	symptom	symptom	NOUN
aiua-5955	37	23	index	index	NOUN
aiua-5955	37	24	(	(	PUNCT
aiua-5955	37	25	nih	nih	NOUN
aiua-5955	37	26	-	-	PUNCT
aiua-5955	37	27	cpsi	cpsi	NOUN
aiua-5955	37	28	)	)	PUNCT
aiua-5955	37	29	,	,	PUNCT
aiua-5955	37	30	addressing	address	VERB
aiua-5955	37	31	pain	pain	NOUN
aiua-5955	37	32	and	and	CCONJ
aiua-5955	37	33	voiding	void	VERB
aiua-5955	37	34	symptoms	symptom	NOUN
aiua-5955	37	35	,	,	PUNCT
aiua-5955	37	36	and	and	CCONJ
aiua-5955	37	37	the	the	DET
aiua-5955	37	38	impact	impact	NOUN
aiua-5955	37	39	of	of	ADP
aiua-5955	37	40	the	the	DET
aiua-5955	37	41	disease	disease	NOUN
aiua-5955	37	42	on	on	ADP
aiua-5955	37	43	patients	patient	NOUN
aiua-5955	37	44	'	'	PART
aiua-5955	37	45	quality	quality	NOUN
aiua-5955	37	46	of	of	ADP
aiua-5955	37	47	life	life	NOUN
aiua-5955	37	48	(	(	PUNCT
aiua-5955	37	49	qol	qol	NOUN
aiua-5955	37	50	)	)	PUNCT
aiua-5955	37	51	.	.	PUNCT
aiua-5955	38	1	the	the	DET
aiua-5955	38	2	international	international	ADJ
aiua-5955	38	3	index	index	NOUN
aiua-5955	38	4	of	of	ADP
aiua-5955	38	5	erectile	erectile	NOUN
aiua-5955	38	6	function	function	NOUN
aiua-5955	38	7	(	(	PUNCT
aiua-5955	38	8	iief	iief	ADJ
aiua-5955	38	9	)	)	PUNCT
aiua-5955	38	10	questionnaire	questionnaire	NOUN
aiua-5955	38	11	was	be	AUX
aiua-5955	38	12	adopted	adopt	VERB
aiua-5955	38	13	to	to	PART
aiua-5955	38	14	assess	assess	VERB
aiua-5955	38	15	the	the	DET
aiua-5955	38	16	erectile	erectile	ADJ
aiua-5955	38	17	function	function	NOUN
aiua-5955	38	18	of	of	ADP
aiua-5955	38	19	patients	patient	NOUN
aiua-5955	38	20	.	.	PUNCT
aiua-5955	39	1	mild	mild	ADJ
aiua-5955	39	2	to	to	ADP
aiua-5955	39	3	severe	severe	ADJ
aiua-5955	39	4	erectile	erectile	NOUN
aiua-5955	39	5	dysfunction	dysfunction	NOUN
aiua-5955	39	6	(	(	PUNCT
aiua-5955	39	7	ed	ed	NOUN
aiua-5955	39	8	)	)	PUNCT
aiua-5955	39	9	was	be	AUX
aiua-5955	39	10	defined	define	VERB
aiua-5955	39	11	as	as	ADP
aiua-5955	39	12	the	the	DET
aiua-5955	39	13	sum	sum	NOUN
aiua-5955	39	14	of	of	ADP
aiua-5955	39	15	the	the	DET
aiua-5955	39	16	scores	score	NOUN
aiua-5955	39	17	for	for	ADP
aiua-5955	39	18	iief	iief	ADJ
aiua-5955	39	19	questions	question	NOUN
aiua-5955	39	20	1	1	NUM
aiua-5955	39	21	-	-	SYM
aiua-5955	39	22	5	5	NUM
aiua-5955	39	23	and	and	CCONJ
aiua-5955	39	24	15	15	NUM
aiua-5955	39	25	,	,	PUNCT
aiua-5955	39	26	which	which	PRON
aiua-5955	39	27	in	in	ADP
aiua-5955	39	28	total	total	NOUN
aiua-5955	39	29	were	be	AUX
aiua-5955	39	30	inferior	inferior	ADJ
aiua-5955	39	31	to	to	ADP
aiua-5955	39	32	26	26	NUM
aiua-5955	39	33	.	.	PUNCT
aiua-5955	40	1	the	the	DET
aiua-5955	40	2	ipss	ipss	PROPN
aiua-5955	40	3	is	be	AUX
aiua-5955	40	4	a	a	DET
aiua-5955	40	5	validated	validate	VERB
aiua-5955	40	6	,	,	PUNCT
aiua-5955	40	7	seven	seven	NUM
aiua-5955	40	8	-	-	PUNCT
aiua-5955	40	9	item	item	NOUN
aiua-5955	40	10	questionnaire	questionnaire	NOUN
aiua-5955	40	11	evaluating	evaluate	VERB
aiua-5955	40	12	luts	luts	PROPN
aiua-5955	40	13	occurring	occur	VERB
aiua-5955	40	14	during	during	ADP
aiua-5955	40	15	the	the	DET
aiua-5955	40	16	preceding	precede	VERB
aiua-5955	40	17	month	month	NOUN
aiua-5955	40	18	,	,	PUNCT
aiua-5955	40	19	with	with	ADP
aiua-5955	40	20	lower	low	ADJ
aiua-5955	40	21	scores	score	NOUN
aiua-5955	40	22	indicating	indicate	VERB
aiua-5955	40	23	less	less	ADV
aiua-5955	40	24	severe	severe	ADJ
aiua-5955	40	25	luts	lut	NOUN
aiua-5955	40	26	.	.	PUNCT
aiua-5955	41	1	forty	forty	NUM
aiua-5955	41	2	-	-	PUNCT
aiua-5955	41	3	four	four	NUM
aiua-5955	41	4	patients	patient	NOUN
aiua-5955	41	5	diagnosed	diagnose	VERB
aiua-5955	41	6	with	with	ADP
aiua-5955	41	7	cpps	cpp	NOUN
aiua-5955	41	8	were	be	AUX
aiua-5955	41	9	randomly	randomly	ADV
aiua-5955	41	10	assigned	assign	VERB
aiua-5955	41	11	to	to	ADP
aiua-5955	41	12	treatment	treatment	NOUN
aiua-5955	41	13	with	with	ADP
aiua-5955	41	14	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	41	15	300	300	NUM
aiua-5955	41	16	mg	mg	NOUN
aiua-5955	41	17	plus	plus	CCONJ
aiua-5955	41	18	alpha	alpha	NOUN
aiua-5955	41	19	-	-	PUNCT
aiua-5955	41	20	lipoic	lipoic	NOUN
aiua-5955	41	21	acid	acid	NOUN
aiua-5955	41	22	300	300	NUM
aiua-5955	41	23	mg	mg	NOUN
aiua-5955	41	24	(	(	PUNCT
aiua-5955	41	25	peanase	peanase	PROPN
aiua-5955	41	26	®	®	PROPN
aiua-5955	41	27	)	)	PUNCT
aiua-5955	41	28	,	,	PUNCT
aiua-5955	41	29	two	two	NUM
aiua-5955	41	30	capsules	capsule	NOUN
aiua-5955	41	31	every	every	DET
aiua-5955	41	32	24h	24h	NOUN
aiua-5955	41	33	(	(	PUNCT
aiua-5955	41	34	group	group	NOUN
aiua-5955	41	35	a	a	NOUN
aiua-5955	41	36	)	)	PUNCT
aiua-5955	41	37	,	,	PUNCT
aiua-5955	41	38	or	or	CCONJ
aiua-5955	41	39	serenoa	serenoa	ADJ
aiua-5955	41	40	repens	repen	NOUN
aiua-5955	41	41	at	at	ADP
aiua-5955	41	42	320	320	NUM
aiua-5955	41	43	mg	mg	NOUN
aiua-5955	41	44	,	,	PUNCT
aiua-5955	41	45	one	one	NUM
aiua-5955	41	46	capsule	capsule	NOUN
aiua-5955	41	47	every	every	DET
aiua-5955	41	48	24h	24h	X
aiua-5955	41	49	(	(	PUNCT
aiua-5955	41	50	group	group	NOUN
aiua-5955	41	51	b	b	NOUN
aiua-5955	41	52	)	)	PUNCT
aiua-5955	41	53	.	.	PUNCT
aiua-5955	42	1	nih	nih	PROPN
aiua-5955	42	2	-	-	PUNCT
aiua-5955	42	3	cpsi	cpsi	PROPN
aiua-5955	42	4	,	,	PUNCT
aiua-5955	42	5	iief	iief	ADJ
aiua-5955	42	6	,	,	PUNCT
aiua-5955	42	7	and	and	CCONJ
aiua-5955	42	8	ipss	ipss	PROPN
aiua-5955	42	9	questionnaires	questionnaire	NOUN
aiua-5955	42	10	were	be	AUX
aiua-5955	42	11	completed	complete	VERB
aiua-5955	42	12	by	by	ADP
aiua-5955	42	13	each	each	DET
aiua-5955	42	14	patient	patient	NOUN
aiua-5955	42	15	prior	prior	ADV
aiua-5955	42	16	to	to	ADP
aiua-5955	42	17	and	and	CCONJ
aiua-5955	42	18	12	12	NUM
aiua-5955	42	19	weeks	week	NOUN
aiua-5955	42	20	after	after	ADP
aiua-5955	42	21	the	the	DET
aiua-5955	42	22	treatment	treatment	NOUN
aiua-5955	42	23	.	.	PUNCT
aiua-5955	43	1	mean	mean	VERB
aiua-5955	43	2	values	value	NOUN
aiua-5955	43	3	of	of	ADP
aiua-5955	43	4	total	total	ADJ
aiua-5955	43	5	scores	score	NOUN
aiua-5955	43	6	before	before	ADV
aiua-5955	43	7	and	and	CCONJ
aiua-5955	43	8	following	follow	VERB
aiua-5955	43	9	the	the	DET
aiua-5955	43	10	treatment	treatment	NOUN
aiua-5955	43	11	were	be	AUX
aiua-5955	43	12	compared	compare	VERB
aiua-5955	43	13	.	.	PUNCT
aiua-5955	44	1	at	at	ADP
aiua-5955	44	2	time	time	NOUN
aiua-5955	44	3	-	-	PUNCT
aiua-5955	44	4	point	point	NOUN
aiua-5955	44	5	v2	v2	NOUN
aiua-5955	44	6	(	(	PUNCT
aiua-5955	44	7	visit	visit	NOUN
aiua-5955	44	8	two	two	NUM
aiua-5955	44	9	)	)	PUNCT
aiua-5955	44	10	,	,	PUNCT
aiua-5955	44	11	after	after	ADP
aiua-5955	44	12	complete	complete	ADJ
aiua-5955	44	13	clinical	clinical	ADJ
aiua-5955	44	14	and	and	CCONJ
aiua-5955	44	15	microbiological	microbiological	ADJ
aiua-5955	44	16	assessments	assessment	NOUN
aiua-5955	44	17	,	,	PUNCT
aiua-5955	44	18	patients	patient	NOUN
aiua-5955	44	19	received	receive	VERB
aiua-5955	44	20	a	a	DET
aiua-5955	44	21	full	full	ADJ
aiua-5955	44	22	course	course	NOUN
aiua-5955	44	23	of	of	ADP
aiua-5955	44	24	pharmacological	pharmacological	NOUN
aiua-5955	44	25	therapy	therapy	NOUN
aiua-5955	44	26	.	.	PUNCT
aiua-5955	45	1	microbiological	microbiological	ADJ
aiua-5955	45	2	eradication	eradication	NOUN
aiua-5955	45	3	of	of	ADP
aiua-5955	45	4	pathogens	pathogen	NOUN
aiua-5955	45	5	was	be	AUX
aiua-5955	45	6	assessed	assess	VERB
aiua-5955	45	7	before	before	ADP
aiua-5955	45	8	enrolment	enrolment	NOUN
aiua-5955	45	9	.	.	PUNCT
aiua-5955	46	1	at	at	ADP
aiua-5955	46	2	time	time	NOUN
aiua-5955	46	3	-	-	PUNCT
aiua-5955	46	4	point	point	NOUN
aiua-5955	46	5	v3	v3	PROPN
aiua-5955	46	6	(	(	PUNCT
aiua-5955	46	7	visit	visit	VERB
aiua-5955	46	8	three	three	NUM
aiua-5955	46	9	)	)	PUNCT
aiua-5955	46	10	,	,	PUNCT
aiua-5955	46	11	performed	perform	VERB
aiua-5955	46	12	12	12	NUM
aiua-5955	46	13	weeks	week	NOUN
aiua-5955	46	14	after	after	ADP
aiua-5955	46	15	the	the	DET
aiua-5955	46	16	start	start	NOUN
aiua-5955	46	17	of	of	ADP
aiua-5955	46	18	therapy	therapy	NOUN
aiua-5955	46	19	,	,	PUNCT
aiua-5955	46	20	symptoms	symptom	NOUN
aiua-5955	46	21	were	be	AUX
aiua-5955	46	22	assessed	assess	VERB
aiua-5955	46	23	again	again	ADV
aiua-5955	46	24	with	with	ADP
aiua-5955	46	25	questionnaires	questionnaire	NOUN
aiua-5955	46	26	.	.	PUNCT
aiua-5955	47	1	data	datum	NOUN
aiua-5955	47	2	are	be	AUX
aiua-5955	47	3	presented	present	VERB
aiua-5955	47	4	as	as	SCONJ
aiua-5955	47	5	means	mean	VERB
aiua-5955	47	6	±	±	NUM
aiua-5955	47	7	standard	standard	PROPN
aiua-5955	47	8	error	error	NOUN
aiua-5955	47	9	.	.	PUNCT
aiua-5955	48	1	changes	change	NOUN
aiua-5955	48	2	from	from	ADP
aiua-5955	48	3	baseline	baseline	NOUN
aiua-5955	48	4	within	within	ADP
aiua-5955	48	5	each	each	DET
aiua-5955	48	6	group	group	NOUN
aiua-5955	48	7	were	be	AUX
aiua-5955	48	8	assessed	assess	VERB
aiua-5955	48	9	through	through	ADP
aiua-5955	48	10	one	one	NUM
aiua-5955	48	11	-	-	PUNCT
aiua-5955	48	12	way	way	NOUN
aiua-5955	48	13	analysis	analysis	NOUN
aiua-5955	48	14	of	of	ADP
aiua-5955	48	15	variance	variance	NOUN
aiua-5955	48	16	(	(	PUNCT
aiua-5955	48	17	one	one	NUM
aiua-5955	48	18	-	-	PUNCT
aiua-5955	48	19	way	way	NOUN
aiua-5955	48	20	anova	anova	PROPN
aiua-5955	48	21	)	)	PUNCT
aiua-5955	48	22	,	,	PUNCT
aiua-5955	48	23	followed	follow	VERB
aiua-5955	48	24	by	by	ADP
aiua-5955	48	25	a	a	DET
aiua-5955	48	26	bonferroni	bonferroni	NOUN
aiua-5955	48	27	test	test	NOUN
aiua-5955	48	28	(	(	PUNCT
aiua-5955	48	29	bonferroni	bonferroni	NOUN
aiua-5955	48	30	's	's	PART
aiua-5955	48	31	multiple	multiple	ADJ
aiua-5955	48	32	comparison	comparison	NOUN
aiua-5955	48	33	test	test	NOUN
aiua-5955	48	34	)	)	PUNCT
aiua-5955	48	35	.	.	PUNCT
aiua-5955	49	1	statistical	statistical	ADJ
aiua-5955	49	2	significance	significance	NOUN
aiua-5955	49	3	was	be	AUX
aiua-5955	49	4	assessed	assess	VERB
aiua-5955	49	5	at	at	ADP
aiua-5955	49	6	a	a	DET
aiua-5955	49	7	p	p	NOUN
aiua-5955	49	8	value	value	NOUN
aiua-5955	49	9	<	<	X
aiua-5955	49	10	0.05	0.05	NUM
aiua-5955	49	11	.	.	PUNCT
aiua-5955	50	1	the	the	DET
aiua-5955	50	2	full	full	ADJ
aiua-5955	50	3	analysis	analysis	NOUN
aiua-5955	50	4	set	set	VERB
aiua-5955	50	5	included	include	VERB
aiua-5955	50	6	patients	patient	NOUN
aiua-5955	50	7	who	who	PRON
aiua-5955	50	8	received	receive	VERB
aiua-5955	50	9	84	84	NUM
aiua-5955	50	10	doses	dose	NOUN
aiua-5955	50	11	of	of	ADP
aiua-5955	50	12	the	the	DET
aiua-5955	50	13	study	study	NOUN
aiua-5955	50	14	drugs	drug	NOUN
aiua-5955	50	15	.	.	PUNCT
aiua-5955	51	1	it	it	PRON
aiua-5955	51	2	was	be	AUX
aiua-5955	51	3	estimated	estimate	VERB
aiua-5955	51	4	that	that	SCONJ
aiua-5955	51	5	22	22	NUM
aiua-5955	51	6	patients	patient	NOUN
aiua-5955	51	7	per	per	ADP
aiua-5955	51	8	treatment	treatment	NOUN
aiua-5955	51	9	group	group	NOUN
aiua-5955	51	10	were	be	AUX
aiua-5955	51	11	required	require	VERB
aiua-5955	51	12	to	to	PART
aiua-5955	51	13	demonstrate	demonstrate	VERB
aiua-5955	51	14	efficacy	efficacy	NOUN
aiua-5955	51	15	in	in	ADP
aiua-5955	51	16	terms	term	NOUN
aiua-5955	51	17	of	of	ADP
aiua-5955	51	18	symptoms	symptom	NOUN
aiua-5955	51	19	score	score	VERB
aiua-5955	51	20	changes	change	NOUN
aiua-5955	51	21	from	from	ADP
aiua-5955	51	22	baseline	baseline	NOUN
aiua-5955	51	23	.	.	PUNCT
aiua-5955	52	1	the	the	DET
aiua-5955	52	2	safety	safety	NOUN
aiua-5955	52	3	analysis	analysis	NOUN
aiua-5955	52	4	consisted	consist	VERB
aiua-5955	52	5	of	of	ADP
aiua-5955	52	6	all	all	DET
aiua-5955	52	7	randomised	randomised	ADJ
aiua-5955	52	8	subjects	subject	NOUN
aiua-5955	52	9	who	who	PRON
aiua-5955	52	10	took	take	VERB
aiua-5955	52	11	one	one	NUM
aiua-5955	52	12	dose	dose	NOUN
aiua-5955	52	13	or	or	CCONJ
aiua-5955	52	14	more	more	ADJ
aiua-5955	52	15	of	of	ADP
aiua-5955	52	16	study	study	NOUN
aiua-5955	52	17	medication	medication	NOUN
aiua-5955	52	18	.	.	PUNCT
aiua-5955	53	1	results	result	NOUN
aiua-5955	53	2	in	in	ADP
aiua-5955	53	3	this	this	DET
aiua-5955	53	4	study	study	NOUN
aiua-5955	53	5	44	44	NUM
aiua-5955	53	6	patients	patient	NOUN
aiua-5955	53	7	were	be	AUX
aiua-5955	53	8	enrolled	enrol	VERB
aiua-5955	53	9	and	and	CCONJ
aiua-5955	53	10	randomised	randomise	VERB
aiua-5955	53	11	into	into	ADP
aiua-5955	53	12	two	two	NUM
aiua-5955	53	13	groups	group	NOUN
aiua-5955	53	14	(	(	PUNCT
aiua-5955	53	15	mean	mean	VERB
aiua-5955	53	16	age	age	NOUN
aiua-5955	53	17	41.32	41.32	NUM
aiua-5955	53	18	±	±	NUM
aiua-5955	53	19	1.686	1.686	NUM
aiua-5955	53	20	years	year	NOUN
aiua-5955	53	21	)	)	PUNCT
aiua-5955	53	22	.	.	PUNCT
aiua-5955	54	1	among	among	ADP
aiua-5955	54	2	them	they	PRON
aiua-5955	54	3	,	,	PUNCT
aiua-5955	54	4	22	22	NUM
aiua-5955	54	5	received	receive	VERB
aiua-5955	54	6	peanase	peanase	NOUN
aiua-5955	54	7	®	®	NOUN
aiua-5955	54	8	(	(	PUNCT
aiua-5955	54	9	palmitoylethanolamide	palmitoylethanolamide	ADJ
aiua-5955	54	10	plus	plus	CCONJ
aiua-5955	54	11	alpha	alpha	NOUN
aiua-5955	54	12	-	-	PUNCT
aiua-5955	54	13	lipoic	lipoic	NOUN
aiua-5955	54	14	acid	acid	NOUN
aiua-5955	54	15	)	)	PUNCT
aiua-5955	54	16	,	,	PUNCT
aiua-5955	54	17	group	group	NOUN
aiua-5955	54	18	a	a	NOUN
aiua-5955	54	19	,	,	PUNCT
aiua-5955	54	20	and	and	CCONJ
aiua-5955	54	21	22	22	NUM
aiua-5955	54	22	received	receive	VERB
aiua-5955	54	23	serenoa	serenoa	ADJ
aiua-5955	54	24	repens	repen	NOUN
aiua-5955	54	25	,	,	PUNCT
aiua-5955	54	26	group	group	NOUN
aiua-5955	54	27	b.	b.	PROPN
aiua-5955	55	1	the	the	DET
aiua-5955	55	2	treatment	treatment	NOUN
aiua-5955	55	3	arms	arm	NOUN
aiua-5955	55	4	were	be	AUX
aiua-5955	55	5	comparable	comparable	ADJ
aiua-5955	55	6	for	for	ADP
aiua-5955	55	7	all	all	DET
aiua-5955	55	8	variables	variable	NOUN
aiua-5955	55	9	at	at	ADP
aiua-5955	55	10	the	the	DET
aiua-5955	55	11	enrollment	enrollment	NOUN
aiua-5955	55	12	and	and	CCONJ
aiua-5955	55	13	randomisation	randomisation	NOUN
aiua-5955	55	14	visits	visit	NOUN
aiua-5955	55	15	.	.	PUNCT
aiua-5955	56	1	three	three	NUM
aiua-5955	56	2	questionnaires	questionnaire	NOUN
aiua-5955	56	3	(	(	PUNCT
aiua-5955	56	4	nih	nih	NOUN
aiua-5955	56	5	-	-	PUNCT
aiua-5955	56	6	cpsi	cpsi	PROPN
aiua-5955	56	7	,	,	PUNCT
aiua-5955	56	8	ipss	ipss	PROPN
aiua-5955	56	9	and	and	CCONJ
aiua-5955	56	10	iief5	iief5	PROPN
aiua-5955	56	11	scores	score	NOUN
aiua-5955	56	12	)	)	PUNCT
aiua-5955	56	13	were	be	AUX
aiua-5955	56	14	administered	administer	VERB
aiua-5955	56	15	at	at	ADP
aiua-5955	56	16	baseline	baseline	NOUN
aiua-5955	56	17	and	and	CCONJ
aiua-5955	56	18	after	after	ADP
aiua-5955	56	19	12	12	NUM
aiua-5955	56	20	weeks	week	NOUN
aiua-5955	56	21	of	of	ADP
aiua-5955	56	22	treatment	treatment	NOUN
aiua-5955	56	23	in	in	ADP
aiua-5955	56	24	each	each	DET
aiua-5955	56	25	group	group	NOUN
aiua-5955	56	26	.	.	PUNCT
aiua-5955	57	1	data	datum	NOUN
aiua-5955	57	2	indicate	indicate	VERB
aiua-5955	57	3	that	that	SCONJ
aiua-5955	57	4	12	12	NUM
aiua-5955	57	5	week	week	NOUN
aiua-5955	57	6	treatment	treatment	NOUN
aiua-5955	57	7	with	with	ADP
aiua-5955	57	8	peanase	peanase	NOUN
aiua-5955	57	9	significantly	significantly	ADV
aiua-5955	57	10	improved	improve	VERB
aiua-5955	57	11	the	the	DET
aiua-5955	57	12	ipss	ipss	PROPN
aiua-5955	57	13	score	score	NOUN
aiua-5955	57	14	compared	compare	VERB
aiua-5955	57	15	to	to	ADP
aiua-5955	57	16	the	the	DET
aiua-5955	57	17	same	same	ADJ
aiua-5955	57	18	period	period	NOUN
aiua-5955	57	19	of	of	ADP
aiua-5955	57	20	treatment	treatment	NOUN
aiua-5955	57	21	with	with	ADP
aiua-5955	57	22	serenoa	serenoa	ADJ
aiua-5955	57	23	repens	repen	NOUN
aiua-5955	57	24	(	(	PUNCT
aiua-5955	57	25	figure	figure	NOUN
aiua-5955	57	26	1	1	NUM
aiua-5955	57	27	)	)	PUNCT
aiua-5955	57	28	.	.	PUNCT
aiua-5955	58	1	however	however	ADV
aiua-5955	58	2	,	,	PUNCT
aiua-5955	58	3	the	the	DET
aiua-5955	58	4	same	same	ADJ
aiua-5955	58	5	treatment	treatment	NOUN
aiua-5955	58	6	did	do	AUX
aiua-5955	58	7	not	not	PART
aiua-5955	58	8	result	result	VERB
aiua-5955	58	9	in	in	ADP
aiua-5955	58	10	significant	significant	ADJ
aiua-5955	58	11	improvement	improvement	NOUN
aiua-5955	58	12	of	of	ADP
aiua-5955	58	13	the	the	DET
aiua-5955	58	14	second	second	ADJ
aiua-5955	58	15	score	score	NOUN
aiua-5955	58	16	analysed	analyse	VERB
aiua-5955	58	17	,	,	PUNCT
aiua-5955	58	18	the	the	DET
aiua-5955	58	19	iief5	iief5	PROPN
aiua-5955	58	20	(	(	PUNCT
aiua-5955	58	21	figire	figire	PROPN
aiua-5955	58	22	2	2	NUM
aiua-5955	58	23	)	)	PUNCT
aiua-5955	58	24	.	.	PUNCT
aiua-5955	59	1	finally	finally	ADV
aiua-5955	59	2	,	,	PUNCT
aiua-5955	59	3	the	the	DET
aiua-5955	59	4	12	12	NUM
aiua-5955	59	5	-	-	PUNCT
aiua-5955	59	6	week	week	NOUN
aiua-5955	59	7	treatment	treatment	NOUN
aiua-5955	59	8	with	with	ADP
aiua-5955	59	9	peanase	peanase	NOUN
aiua-5955	59	10	was	be	AUX
aiua-5955	59	11	able	able	ADJ
aiua-5955	59	12	to	to	PART
aiua-5955	59	13	significantly	significantly	ADV
aiua-5955	59	14	reduce	reduce	VERB
aiua-5955	59	15	nih	nih	NOUN
aiua-5955	59	16	-	-	PUNCT
aiua-5955	59	17	cpsi	cpsi	NOUN
aiua-5955	59	18	score	score	NOUN
aiua-5955	59	19	.	.	PUNCT
aiua-5955	60	1	similar	similar	ADJ
aiua-5955	60	2	results	result	NOUN
aiua-5955	60	3	were	be	AUX
aiua-5955	60	4	observed	observe	VERB
aiua-5955	60	5	in	in	ADP
aiua-5955	60	6	the	the	DET
aiua-5955	60	7	different	different	ADJ
aiua-5955	60	8	nih	nih	ADJ
aiua-5955	60	9	-	-	PUNCT
aiua-5955	60	10	cpsi	cpsi	PROPN
aiua-5955	60	11	subscores	subscore	NOUN
aiua-5955	60	12	break	break	VERB
aiua-5955	60	13	down	down	ADP
aiua-5955	60	14	.	.	PUNCT
aiua-5955	61	1	on	on	ADP
aiua-5955	61	2	the	the	DET
aiua-5955	61	3	other	other	ADJ
aiua-5955	61	4	hand	hand	NOUN
aiua-5955	61	5	,	,	PUNCT
aiua-5955	61	6	statistical	statistical	ADJ
aiua-5955	61	7	of	of	ADP
aiua-5955	61	8	data	datum	NOUN
aiua-5955	61	9	from	from	ADP
aiua-5955	61	10	patients	patient	NOUN
aiua-5955	61	11	treated	treat	VERB
aiua-5955	61	12	with	with	ADP
aiua-5955	61	13	serenoa	serenoa	ADJ
aiua-5955	61	14	repens	repen	NOUN
aiua-5955	61	15	did	do	AUX
aiua-5955	61	16	not	not	PART
aiua-5955	61	17	result	result	VERB
aiua-5955	61	18	in	in	ADP
aiua-5955	61	19	significant	significant	ADJ
aiua-5955	61	20	differences	difference	NOUN
aiua-5955	61	21	between	between	ADP
aiua-5955	61	22	treated	treat	VERB
aiua-5955	61	23	and	and	CCONJ
aiua-5955	61	24	untreated	untreated	ADJ
aiua-5955	61	25	patients	patient	NOUN
aiua-5955	61	26	(	(	PUNCT
aiua-5955	61	27	figure	figure	NOUN
aiua-5955	61	28	3	3	NUM
aiua-5955	61	29	)	)	PUNCT
aiua-5955	61	30	.	.	PUNCT
aiua-5955	62	1	both	both	DET
aiua-5955	62	2	treatments	treatment	NOUN
aiua-5955	62	3	were	be	AUX
aiua-5955	62	4	well	well	ADV
aiua-5955	62	5	tolerated	tolerate	VERB
aiua-5955	62	6	in	in	ADP
aiua-5955	62	7	all	all	DET
aiua-5955	62	8	the	the	DET
aiua-5955	62	9	patients	patient	NOUN
aiua-5955	62	10	examined	examine	VERB
aiua-5955	62	11	,	,	PUNCT
aiua-5955	62	12	and	and	CCONJ
aiua-5955	62	13	no	no	DET
aiua-5955	62	14	significant	significant	ADJ
aiua-5955	62	15	drug	drug	NOUN
aiua-5955	62	16	-	-	PUNCT
aiua-5955	62	17	related	relate	VERB
aiua-5955	62	18	side	side	NOUN
aiua-5955	62	19	effects	effect	NOUN
aiua-5955	62	20	were	be	AUX
aiua-5955	62	21	noticed	notice	VERB
aiua-5955	62	22	.	.	PUNCT
aiua-5955	63	1	figure	figure	NOUN
aiua-5955	63	2	1	1	NUM
aiua-5955	63	3	.	.	PUNCT
aiua-5955	64	1	comparative	comparative	ADJ
aiua-5955	64	2	effects	effect	NOUN
aiua-5955	64	3	of	of	ADP
aiua-5955	64	4	12	12	NUM
aiua-5955	64	5	-	-	PUNCT
aiua-5955	64	6	week	week	NOUN
aiua-5955	64	7	treatments	treatment	NOUN
aiua-5955	64	8	with	with	ADP
aiua-5955	64	9	either	either	CCONJ
aiua-5955	64	10	the	the	DET
aiua-5955	64	11	combination	combination	NOUN
aiua-5955	64	12	á	á	NOUN
aiua-5955	64	13	-	-	PUNCT
aiua-5955	64	14	lipoic	lipoic	ADJ
aiua-5955	64	15	acid	acid	NOUN
aiua-5955	64	16	-	-	PUNCT
aiua-5955	64	17	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	64	18	or	or	CCONJ
aiua-5955	64	19	the	the	DET
aiua-5955	64	20	extract	extract	NOUN
aiua-5955	64	21	from	from	ADP
aiua-5955	64	22	s.	s.	PROPN
aiua-5955	64	23	repens	repen	NOUN
aiua-5955	64	24	on	on	ADP
aiua-5955	64	25	the	the	DET
aiua-5955	64	26	ipss	ipss	PROPN
aiua-5955	64	27	score	score	NOUN
aiua-5955	64	28	for	for	ADP
aiua-5955	64	29	evaluation	evaluation	NOUN
aiua-5955	64	30	of	of	ADP
aiua-5955	64	31	urinary	urinary	ADJ
aiua-5955	64	32	symptoms	symptom	NOUN
aiua-5955	64	33	in	in	ADP
aiua-5955	64	34	patients	patient	NOUN
aiua-5955	64	35	with	with	ADP
aiua-5955	64	36	chronic	chronic	ADJ
aiua-5955	64	37	prostatitis	prostatitis	NOUN
aiua-5955	64	38	.	.	PUNCT
aiua-5955	65	1	vertical	vertical	ADJ
aiua-5955	65	2	bars	bar	NOUN
aiua-5955	65	3	are	be	AUX
aiua-5955	65	4	means	mean	VERB
aiua-5955	65	5	±	±	NOUN
aiua-5955	65	6	se	se	X
aiua-5955	65	7	;	;	PUNCT
aiua-5955	65	8	*	*	PUNCT
aiua-5955	65	9	p	p	X
aiua-5955	65	10	<	<	X
aiua-5955	65	11	0.05	0.05	NUM
aiua-5955	65	12	vs.	vs.	ADP
aiua-5955	65	13	s.	s.	PROPN
aiua-5955	65	14	repens	repen	NOUN
aiua-5955	65	15	(	(	PUNCT
aiua-5955	65	16	one	one	NUM
aiua-5955	65	17	way	way	NOUN
aiua-5955	65	18	analysis	analysis	NOUN
aiua-5955	65	19	of	of	ADP
aiua-5955	65	20	variance	variance	NOUN
aiua-5955	65	21	,	,	PUNCT
aiua-5955	65	22	followed	follow	VERB
aiua-5955	65	23	by	by	ADP
aiua-5955	65	24	the	the	DET
aiua-5955	65	25	bonferroni	bonferroni	NOUN
aiua-5955	65	26	’s	’s	PART
aiua-5955	65	27	multiple	multiple	ADJ
aiua-5955	65	28	comparison	comparison	NOUN
aiua-5955	65	29	test	test	NOUN
aiua-5955	65	30	)	)	PUNCT
aiua-5955	65	31	.	.	PUNCT
aiua-5955	66	1	giammusso_stesura	giammusso_stesura	NOUN
aiua-5955	66	2	seveso	seveso	AUX
aiua-5955	66	3	04/04/17	04/04/17	PROPN
aiua-5955	66	4	09:06	09:06	NUM
aiua-5955	66	5	pagina	pagina	NOUN
aiua-5955	66	6	18	18	NUM
aiua-5955	66	7	discussion	discussion	NOUN
aiua-5955	66	8	the	the	DET
aiua-5955	66	9	most	most	ADV
aiua-5955	66	10	recent	recent	ADJ
aiua-5955	66	11	nih	nih	PROPN
aiua-5955	66	12	classification	classification	NOUN
aiua-5955	66	13	of	of	ADP
aiua-5955	66	14	prostatitis	prostatitis	NOUN
aiua-5955	66	15	adopted	adopt	VERB
aiua-5955	66	16	in	in	ADP
aiua-5955	66	17	1995	1995	NUM
aiua-5955	66	18	includes	include	VERB
aiua-5955	66	19	several	several	ADJ
aiua-5955	66	20	clinical	clinical	ADJ
aiua-5955	66	21	entities	entity	NOUN
aiua-5955	66	22	,	,	PUNCT
aiua-5955	66	23	such	such	ADJ
aiua-5955	66	24	as	as	ADP
aiua-5955	66	25	acute	acute	ADJ
aiua-5955	66	26	and	and	CCONJ
aiua-5955	66	27	chronic	chronic	ADJ
aiua-5955	66	28	bacterial	bacterial	ADJ
aiua-5955	66	29	infections	infection	NOUN
aiua-5955	66	30	,	,	PUNCT
aiua-5955	66	31	cpps	cpp	NOUN
aiua-5955	66	32	,	,	PUNCT
aiua-5955	66	33	and	and	CCONJ
aiua-5955	66	34	asymptomatic	asymptomatic	ADJ
aiua-5955	66	35	inflammation	inflammation	NOUN
aiua-5955	66	36	of	of	ADP
aiua-5955	66	37	the	the	DET
aiua-5955	66	38	prostate	prostate	NOUN
aiua-5955	66	39	.	.	PUNCT
aiua-5955	67	1	the	the	DET
aiua-5955	67	2	most	most	ADV
aiua-5955	67	3	common	common	ADJ
aiua-5955	67	4	type	type	NOUN
aiua-5955	67	5	of	of	ADP
aiua-5955	67	6	prostatitis	prostatitis	NOUN
aiua-5955	67	7	is	be	AUX
aiua-5955	67	8	category	category	NOUN
aiua-5955	67	9	iii	iii	NOUN
aiua-5955	67	10	,	,	PUNCT
aiua-5955	67	11	also	also	ADV
aiua-5955	67	12	known	know	VERB
aiua-5955	67	13	as	as	ADP
aiua-5955	67	14	cp	cp	NOUN
aiua-5955	67	15	/	/	SYM
aiua-5955	67	16	cpps	cpps	NOUN
aiua-5955	67	17	.	.	PUNCT
aiua-5955	68	1	the	the	DET
aiua-5955	68	2	current	current	ADJ
aiua-5955	68	3	nih	nih	PROPN
aiua-5955	68	4	definition	definition	NOUN
aiua-5955	68	5	of	of	ADP
aiua-5955	68	6	cp	cp	PROPN
aiua-5955	68	7	/	/	SYM
aiua-5955	68	8	cpps	cpps	NOUN
aiua-5955	68	9	includes	include	VERB
aiua-5955	68	10	genitourinary	genitourinary	ADJ
aiua-5955	68	11	pain	pain	NOUN
aiua-5955	68	12	with	with	ADP
aiua-5955	68	13	or	or	CCONJ
aiua-5955	68	14	without	without	ADP
aiua-5955	68	15	voiding	void	VERB
aiua-5955	68	16	symptoms	symptom	NOUN
aiua-5955	68	17	in	in	ADP
aiua-5955	68	18	the	the	DET
aiua-5955	68	19	absence	absence	NOUN
aiua-5955	68	20	of	of	ADP
aiua-5955	68	21	uropathogenic	uropathogenic	ADJ
aiua-5955	68	22	bacteria	bacteria	NOUN
aiua-5955	68	23	,	,	PUNCT
aiua-5955	68	24	as	as	SCONJ
aiua-5955	68	25	detected	detect	VERB
aiua-5955	68	26	by	by	ADP
aiua-5955	68	27	standard	standard	ADJ
aiua-5955	68	28	microbiological	microbiological	ADJ
aiua-5955	68	29	methods	method	NOUN
aiua-5955	68	30	,	,	PUNCT
aiua-5955	68	31	or	or	CCONJ
aiua-5955	68	32	another	another	DET
aiua-5955	68	33	identifiable	identifiable	ADJ
aiua-5955	68	34	cause	cause	NOUN
aiua-5955	68	35	such	such	ADJ
aiua-5955	68	36	as	as	ADP
aiua-5955	68	37	malignancy	malignancy	NOUN
aiua-5955	68	38	.	.	PUNCT
aiua-5955	69	1	the	the	DET
aiua-5955	69	2	efficacy	efficacy	NOUN
aiua-5955	69	3	of	of	ADP
aiua-5955	69	4	various	various	ADJ
aiua-5955	69	5	medical	medical	ADJ
aiua-5955	69	6	therapies	therapy	NOUN
aiua-5955	69	7	,	,	PUNCT
aiua-5955	69	8	such	such	ADJ
aiua-5955	69	9	as	as	ADP
aiua-5955	69	10	antibiotics	antibiotic	NOUN
aiua-5955	69	11	,	,	PUNCT
aiua-5955	69	12	alpha	alpha	NOUN
aiua-5955	69	13	-	-	PUNCT
aiua-5955	69	14	adrenergic	adrenergic	ADJ
aiua-5955	69	15	blockers	blocker	NOUN
aiua-5955	69	16	,	,	PUNCT
aiua-5955	69	17	anti	anti	ADJ
aiua-5955	69	18	-	-	ADJ
aiua-5955	69	19	inflammatory	inflammatory	ADJ
aiua-5955	69	20	agents	agent	NOUN
aiua-5955	69	21	,	,	PUNCT
aiua-5955	69	22	hormonal	hormonal	ADJ
aiua-5955	69	23	therapies	therapy	NOUN
aiua-5955	69	24	,	,	PUNCT
aiua-5955	69	25	and	and	CCONJ
aiua-5955	69	26	phytotherapies	phytotherapy	NOUN
aiua-5955	69	27	,	,	PUNCT
aiua-5955	69	28	has	have	AUX
aiua-5955	69	29	been	be	AUX
aiua-5955	69	30	evaluated	evaluate	VERB
aiua-5955	69	31	clinically	clinically	ADV
aiua-5955	69	32	and	and	CCONJ
aiua-5955	69	33	is	be	AUX
aiua-5955	69	34	however	however	ADV
aiua-5955	69	35	a	a	DET
aiua-5955	69	36	matter	matter	NOUN
aiua-5955	69	37	of	of	ADP
aiua-5955	69	38	debate	debate	NOUN
aiua-5955	69	39	.	.	PUNCT
aiua-5955	70	1	in	in	ADP
aiua-5955	70	2	this	this	DET
aiua-5955	70	3	short	short	ADJ
aiua-5955	70	4	study	study	NOUN
aiua-5955	70	5	we	we	PRON
aiua-5955	70	6	demonstrate	demonstrate	VERB
aiua-5955	70	7	that	that	SCONJ
aiua-5955	70	8	the	the	DET
aiua-5955	70	9	combination	combination	NOUN
aiua-5955	70	10	of	of	ADP
aiua-5955	70	11	alpha	alpha	NOUN
aiua-5955	70	12	-	-	PUNCT
aiua-5955	70	13	lipoic	lipoic	NOUN
aiua-5955	70	14	acid	acid	NOUN
aiua-5955	70	15	with	with	ADP
aiua-5955	70	16	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	70	17	improves	improve	VERB
aiua-5955	70	18	significantly	significantly	ADV
aiua-5955	70	19	parameters	parameter	NOUN
aiua-5955	70	20	related	relate	VERB
aiua-5955	70	21	to	to	ADP
aiua-5955	70	22	prostate	prostate	NOUN
aiua-5955	70	23	function	function	NOUN
aiua-5955	70	24	in	in	ADP
aiua-5955	70	25	course	course	NOUN
aiua-5955	70	26	of	of	ADP
aiua-5955	70	27	inflammatory	inflammatory	ADJ
aiua-5955	70	28	processes	process	NOUN
aiua-5955	70	29	.	.	PUNCT
aiua-5955	71	1	alpha	alpha	NOUN
aiua-5955	71	2	-	-	PUNCT
aiua-5955	71	3	lipoic	lipoic	NOUN
aiua-5955	71	4	acid	acid	NOUN
aiua-5955	71	5	(	(	PUNCT
aiua-5955	71	6	ala	ala	PROPN
aiua-5955	71	7	)	)	PUNCT
aiua-5955	71	8	,	,	PUNCT
aiua-5955	71	9	or	or	CCONJ
aiua-5955	71	10	1,2	1,2	NUM
aiua-5955	71	11	-	-	PUNCT
aiua-5955	71	12	dithiolane-3	dithiolane-3	NUM
aiua-5955	71	13	-	-	PUNCT
aiua-5955	71	14	pentanoic	pentanoic	ADJ
aiua-5955	71	15	acid	acid	NOUN
aiua-5955	71	16	,	,	PUNCT
aiua-5955	71	17	is	be	AUX
aiua-5955	71	18	a	a	DET
aiua-5955	71	19	natural	natural	ADV
aiua-5955	71	20	-	-	PUNCT
aiua-5955	71	21	occurring	occur	VERB
aiua-5955	71	22	co	co	NOUN
aiua-5955	71	23	-	-	NOUN
aiua-5955	71	24	factor	factor	NOUN
aiua-5955	71	25	for	for	ADP
aiua-5955	71	26	vital	vital	ADJ
aiua-5955	71	27	metabolic	metabolic	NOUN
aiua-5955	71	28	multienzyme	multienzyme	NOUN
aiua-5955	71	29	complexes	complex	NOUN
aiua-5955	71	30	,	,	PUNCT
aiua-5955	71	31	including	include	VERB
aiua-5955	71	32	pyruvate	pyruvate	NOUN
aiua-5955	71	33	dehydrogenase	dehydrogenase	NOUN
aiua-5955	71	34	and	and	CCONJ
aiua-5955	71	35	glycine	glycine	NOUN
aiua-5955	71	36	decarboxylase	decarboxylase	NOUN
aiua-5955	71	37	.	.	PUNCT
aiua-5955	72	1	ala	ala	PROPN
aiua-5955	72	2	is	be	AUX
aiua-5955	72	3	absorbed	absorb	VERB
aiua-5955	72	4	from	from	ADP
aiua-5955	72	5	the	the	DET
aiua-5955	72	6	diet	diet	NOUN
aiua-5955	72	7	,	,	PUNCT
aiua-5955	72	8	and	and	CCONJ
aiua-5955	72	9	it	it	PRON
aiua-5955	72	10	is	be	AUX
aiua-5955	72	11	readily	readily	ADV
aiua-5955	72	12	converted	convert	VERB
aiua-5955	72	13	to	to	ADP
aiua-5955	72	14	its	its	PRON
aiua-5955	72	15	reduced	reduced	ADJ
aiua-5955	72	16	form	form	NOUN
aiua-5955	72	17	,	,	PUNCT
aiua-5955	72	18	dihydrolipoic	dihydrolipoic	ADJ
aiua-5955	72	19	acid	acid	NOUN
aiua-5955	72	20	,	,	PUNCT
aiua-5955	72	21	in	in	ADP
aiua-5955	72	22	mammalian	mammalian	ADJ
aiua-5955	72	23	cells	cell	NOUN
aiua-5955	72	24	.	.	PUNCT
aiua-5955	73	1	ala	ala	PROPN
aiua-5955	73	2	acts	act	VERB
aiua-5955	73	3	as	as	ADP
aiua-5955	73	4	a	a	DET
aiua-5955	73	5	redox	redox	ADJ
aiua-5955	73	6	regulator	regulator	NOUN
aiua-5955	73	7	of	of	ADP
aiua-5955	73	8	thiolcointaining	thiolcointaine	VERB
aiua-5955	73	9	proteins	protein	NOUN
aiua-5955	73	10	and	and	CCONJ
aiua-5955	73	11	is	be	AUX
aiua-5955	73	12	effective	effective	ADJ
aiua-5955	73	13	in	in	ADP
aiua-5955	73	14	the	the	DET
aiua-5955	73	15	treatment	treatment	NOUN
aiua-5955	73	16	of	of	ADP
aiua-5955	73	17	several	several	ADJ
aiua-5955	73	18	pathologic	pathologic	ADJ
aiua-5955	73	19	conditions	condition	NOUN
aiua-5955	73	20	including	include	VERB
aiua-5955	73	21	diabetes	diabetes	NOUN
aiua-5955	73	22	,	,	PUNCT
aiua-5955	73	23	neurodegeneration	neurodegeneration	NOUN
aiua-5955	73	24	,	,	PUNCT
aiua-5955	73	25	radiation	radiation	NOUN
aiua-5955	73	26	injury	injury	NOUN
aiua-5955	73	27	,	,	PUNCT
aiua-5955	73	28	and	and	CCONJ
aiua-5955	73	29	malignancy	malignancy	NOUN
aiua-5955	73	30	(	(	PUNCT
aiua-5955	73	31	2	2	NUM
aiua-5955	73	32	)	)	PUNCT
aiua-5955	73	33	.	.	PUNCT
aiua-5955	74	1	growing	grow	VERB
aiua-5955	74	2	evidence	evidence	NOUN
aiua-5955	74	3	shows	show	VERB
aiua-5955	74	4	that	that	SCONJ
aiua-5955	74	5	orally	orally	ADV
aiua-5955	74	6	supplied	supply	VERB
aiua-5955	74	7	ala	ala	NOUN
aiua-5955	74	8	may	may	AUX
aiua-5955	74	9	not	not	PART
aiua-5955	74	10	be	be	AUX
aiua-5955	74	11	used	use	VERB
aiua-5955	74	12	as	as	ADP
aiua-5955	74	13	a	a	DET
aiua-5955	74	14	metabolic	metabolic	NOUN
aiua-5955	74	15	cofactor	cofactor	NOUN
aiua-5955	74	16	,	,	PUNCT
aiua-5955	74	17	but	but	CCONJ
aiua-5955	74	18	instead	instead	ADV
aiua-5955	74	19	elicits	elicit	VERB
aiua-5955	74	20	a	a	DET
aiua-5955	74	21	unique	unique	ADJ
aiua-5955	74	22	set	set	NOUN
aiua-5955	74	23	of	of	ADP
aiua-5955	74	24	biochemical	biochemical	ADJ
aiua-5955	74	25	activities	activity	NOUN
aiua-5955	74	26	with	with	ADP
aiua-5955	74	27	potential	potential	ADJ
aiua-5955	74	28	pharmacotherapeutic	pharmacotherapeutic	ADJ
aiua-5955	74	29	value	value	NOUN
aiua-5955	74	30	against	against	ADP
aiua-5955	74	31	a	a	DET
aiua-5955	74	32	host	host	NOUN
aiua-5955	74	33	of	of	ADP
aiua-5955	74	34	pathophysiologic	pathophysiologic	ADJ
aiua-5955	74	35	insults	insult	NOUN
aiua-5955	74	36	.	.	PUNCT
aiua-5955	75	1	ala	ala	PROPN
aiua-5955	75	2	has	have	AUX
aiua-5955	75	3	been	be	AUX
aiua-5955	75	4	described	describe	VERB
aiua-5955	75	5	as	as	ADP
aiua-5955	75	6	a	a	DET
aiua-5955	75	7	potent	potent	ADJ
aiua-5955	75	8	biological	biological	ADJ
aiua-5955	75	9	antioxidant	antioxidant	NOUN
aiua-5955	75	10	,	,	PUNCT
aiua-5955	75	11	and	and	CCONJ
aiua-5955	75	12	has	have	AUX
aiua-5955	75	13	been	be	AUX
aiua-5955	75	14	implicated	implicate	VERB
aiua-5955	75	15	as	as	ADP
aiua-5955	75	16	a	a	DET
aiua-5955	75	17	modulator	modulator	NOUN
aiua-5955	75	18	of	of	ADP
aiua-5955	75	19	various	various	ADJ
aiua-5955	75	20	inflammatory	inflammatory	ADJ
aiua-5955	75	21	signalling	signal	VERB
aiua-5955	75	22	pathways	pathway	NOUN
aiua-5955	75	23	(	(	PUNCT
aiua-5955	75	24	3	3	NUM
aiua-5955	75	25	-	-	SYM
aiua-5955	75	26	4	4	NUM
aiua-5955	75	27	)	)	PUNCT
aiua-5955	75	28	.	.	PUNCT
aiua-5955	76	1	this	this	DET
aiua-5955	76	2	impressive	impressive	ADJ
aiua-5955	76	3	array	array	NOUN
aiua-5955	76	4	of	of	ADP
aiua-5955	76	5	cellular	cellular	ADJ
aiua-5955	76	6	and	and	CCONJ
aiua-5955	76	7	molecular	molecular	ADJ
aiua-5955	76	8	functions	function	NOUN
aiua-5955	76	9	has	have	AUX
aiua-5955	76	10	gained	gain	VERB
aiua-5955	76	11	considerable	considerable	ADJ
aiua-5955	76	12	interest	interest	NOUN
aiua-5955	76	13	among	among	ADP
aiua-5955	76	14	the	the	DET
aiua-5955	76	15	public	public	NOUN
aiua-5955	76	16	and	and	CCONJ
aiua-5955	76	17	the	the	DET
aiua-5955	76	18	research	research	NOUN
aiua-5955	76	19	community	community	NOUN
aiua-5955	76	20	for	for	ADP
aiua-5955	76	21	the	the	DET
aiua-5955	76	22	use	use	NOUN
aiua-5955	76	23	of	of	ADP
aiua-5955	76	24	ala	ala	PROPN
aiua-5955	76	25	both	both	PRON
aiua-5955	76	26	as	as	ADP
aiua-5955	76	27	a	a	DET
aiua-5955	76	28	nutritive	nutritive	ADJ
aiua-5955	76	29	supplement	supplement	NOUN
aiua-5955	76	30	and	and	CCONJ
aiua-5955	76	31	as	as	ADP
aiua-5955	76	32	a	a	DET
aiua-5955	76	33	pharmacotherapy	pharmacotherapy	NOUN
aiua-5955	76	34	.	.	PUNCT
aiua-5955	77	1	the	the	DET
aiua-5955	77	2	chemical	chemical	NOUN
aiua-5955	77	3	reactivity	reactivity	NOUN
aiua-5955	77	4	of	of	ADP
aiua-5955	77	5	ala	ala	PROPN
aiua-5955	77	6	is	be	AUX
aiua-5955	77	7	mainly	mainly	ADV
aiua-5955	77	8	conferred	confer	VERB
aiua-5955	77	9	by	by	ADP
aiua-5955	77	10	its	its	PRON
aiua-5955	77	11	dithiolane	dithiolane	ADJ
aiua-5955	77	12	ring	ring	NOUN
aiua-5955	77	13	.	.	PUNCT
aiua-5955	78	1	the	the	DET
aiua-5955	78	2	oxidized	oxidize	VERB
aiua-5955	78	3	(	(	PUNCT
aiua-5955	78	4	ala	ala	NOUN
aiua-5955	78	5	)	)	PUNCT
aiua-5955	78	6	and	and	CCONJ
aiua-5955	78	7	reduced	reduce	VERB
aiua-5955	78	8	(	(	PUNCT
aiua-5955	78	9	dhla	dhla	ADJ
aiua-5955	78	10	)	)	PUNCT
aiua-5955	78	11	forms	form	NOUN
aiua-5955	78	12	create	create	VERB
aiua-5955	78	13	a	a	DET
aiua-5955	78	14	potent	potent	ADJ
aiua-5955	78	15	redox	redox	ADJ
aiua-5955	78	16	couple	couple	NOUN
aiua-5955	78	17	that	that	PRON
aiua-5955	78	18	has	have	VERB
aiua-5955	78	19	a	a	DET
aiua-5955	78	20	standard	standard	ADJ
aiua-5955	78	21	reduction	reduction	NOUN
aiua-5955	78	22	potential	potential	NOUN
aiua-5955	78	23	of	of	ADP
aiua-5955	78	24	-0.32	-0.32	NUM
aiua-5955	78	25	v.	v.	ADP
aiua-5955	78	26	this	this	PRON
aiua-5955	78	27	makes	make	VERB
aiua-5955	78	28	dhla	dhla	ADJ
aiua-5955	78	29	one	one	NUM
aiua-5955	78	30	of	of	ADP
aiua-5955	78	31	the	the	DET
aiua-5955	78	32	most	most	ADV
aiua-5955	78	33	potent	potent	ADJ
aiua-5955	78	34	naturally	naturally	ADV
aiua-5955	78	35	occurring	occur	VERB
aiua-5955	78	36	antioxidants	antioxidant	NOUN
aiua-5955	78	37	(	(	PUNCT
aiua-5955	78	38	5	5	NUM
aiua-5955	78	39	)	)	PUNCT
aiua-5955	78	40	.	.	PUNCT
aiua-5955	79	1	in	in	ADP
aiua-5955	79	2	fact	fact	NOUN
aiua-5955	79	3	,	,	PUNCT
aiua-5955	79	4	there	there	PRON
aiua-5955	79	5	is	be	VERB
aiua-5955	79	6	evidence	evidence	NOUN
aiua-5955	79	7	that	that	SCONJ
aiua-5955	79	8	both	both	CCONJ
aiua-5955	79	9	ala	ala	PROPN
aiua-5955	79	10	and	and	CCONJ
aiua-5955	79	11	dhla	dhla	NOUN
aiua-5955	79	12	are	be	AUX
aiua-5955	79	13	capable	capable	ADJ
aiua-5955	79	14	of	of	ADP
aiua-5955	79	15	scavenging	scavenge	VERB
aiua-5955	79	16	a	a	DET
aiua-5955	79	17	variety	variety	NOUN
aiua-5955	79	18	of	of	ADP
aiua-5955	79	19	reactive	reactive	ADJ
aiua-5955	79	20	oxygen	oxygen	NOUN
aiua-5955	79	21	species	specie	NOUN
aiua-5955	79	22	.	.	PUNCT
aiua-5955	80	1	in	in	ADP
aiua-5955	80	2	addition	addition	NOUN
aiua-5955	80	3	to	to	ADP
aiua-5955	80	4	being	be	AUX
aiua-5955	80	5	direct	direct	ADJ
aiua-5955	80	6	reactive	reactive	ADJ
aiua-5955	80	7	oxygen	oxygen	NOUN
aiua-5955	80	8	species	specie	NOUN
aiua-5955	80	9	scavengers	scavenger	NOUN
aiua-5955	80	10	,	,	PUNCT
aiua-5955	80	11	both	both	CCONJ
aiua-5955	80	12	ala	ala	PROPN
aiua-5955	80	13	and	and	CCONJ
aiua-5955	80	14	dhla	dhla	ADJ
aiua-5955	80	15	chelate	chelate	NOUN
aiua-5955	80	16	redox	redox	NOUN
aiua-5955	80	17	-	-	PUNCT
aiua-5955	80	18	active	active	ADJ
aiua-5955	80	19	metals	metal	NOUN
aiua-5955	80	20	in	in	ADP
aiua-5955	80	21	vitro	vitro	X
aiua-5955	80	22	and	and	CCONJ
aiua-5955	80	23	in	in	ADP
aiua-5955	80	24	vivo	vivo	NOUN
aiua-5955	80	25	.	.	PUNCT
aiua-5955	81	1	the	the	DET
aiua-5955	81	2	oxidized	oxidize	VERB
aiua-5955	81	3	and	and	CCONJ
aiua-5955	81	4	reduced	reduce	VERB
aiua-5955	81	5	forms	form	NOUN
aiua-5955	81	6	bind	bind	VERB
aiua-5955	81	7	a	a	DET
aiua-5955	81	8	number	number	NOUN
aiua-5955	81	9	of	of	ADP
aiua-5955	81	10	metal	metal	NOUN
aiua-5955	81	11	ions	ion	NOUN
aiua-5955	81	12	,	,	PUNCT
aiua-5955	81	13	but	but	CCONJ
aiua-5955	81	14	with	with	ADP
aiua-5955	81	15	different	different	ADJ
aiua-5955	81	16	properties	property	NOUN
aiua-5955	81	17	depending	depend	VERB
aiua-5955	81	18	on	on	ADP
aiua-5955	81	19	the	the	DET
aiua-5955	81	20	metal	metal	NOUN
aiua-5955	81	21	chelated	chelate	VERB
aiua-5955	81	22	.	.	PUNCT
aiua-5955	82	1	these	these	DET
aiua-5955	82	2	results	result	NOUN
aiua-5955	82	3	imply	imply	VERB
aiua-5955	82	4	,	,	PUNCT
aiua-5955	82	5	but	but	CCONJ
aiua-5955	82	6	do	do	AUX
aiua-5955	82	7	not	not	PART
aiua-5955	82	8	yet	yet	ADV
aiua-5955	82	9	prove	prove	VERB
aiua-5955	82	10	,	,	PUNCT
aiua-5955	82	11	that	that	SCONJ
aiua-5955	82	12	ala	ala	PROPN
aiua-5955	82	13	supplementation	supplementation	NOUN
aiua-5955	82	14	may	may	AUX
aiua-5955	82	15	modulate	modulate	VERB
aiua-5955	82	16	the	the	DET
aiua-5955	82	17	labile	labile	ADJ
aiua-5955	82	18	pool	pool	NOUN
aiua-5955	82	19	of	of	ADP
aiua-5955	82	20	redox	redox	ADJ
aiua-5955	82	21	active	active	ADJ
aiua-5955	82	22	transition	transition	NOUN
aiua-5955	82	23	metals	metal	NOUN
aiua-5955	82	24	,	,	PUNCT
aiua-5955	82	25	without	without	ADP
aiua-5955	82	26	causing	cause	VERB
aiua-5955	82	27	metal	metal	NOUN
aiua-5955	82	28	depletion	depletion	NOUN
aiua-5955	82	29	.	.	PUNCT
aiua-5955	83	1	there	there	PRON
aiua-5955	83	2	is	be	VERB
aiua-5955	83	3	growing	grow	VERB
aiua-5955	83	4	evidence	evidence	NOUN
aiua-5955	83	5	that	that	SCONJ
aiua-5955	83	6	ala	ala	PROPN
aiua-5955	83	7	may	may	AUX
aiua-5955	83	8	act	act	VERB
aiua-5955	83	9	indirectly	indirectly	ADV
aiua-5955	83	10	to	to	PART
aiua-5955	83	11	maintain	maintain	VERB
aiua-5955	83	12	cellular	cellular	ADJ
aiua-5955	83	13	antioxidant	antioxidant	ADJ
aiua-5955	83	14	status	status	NOUN
aiua-5955	83	15	by	by	ADP
aiua-5955	83	16	either	either	CCONJ
aiua-5955	83	17	inducing	induce	VERB
aiua-5955	83	18	the	the	DET
aiua-5955	83	19	uptake	uptake	NOUN
aiua-5955	83	20	or	or	CCONJ
aiua-5955	83	21	enhancing	enhance	VERB
aiua-5955	83	22	the	the	DET
aiua-5955	83	23	synthesis	synthesis	NOUN
aiua-5955	83	24	of	of	ADP
aiua-5955	83	25	endogenous	endogenous	ADJ
aiua-5955	83	26	low	low	ADJ
aiua-5955	83	27	molecular	molecular	ADJ
aiua-5955	83	28	weight	weight	NOUN
aiua-5955	83	29	antioxidants	antioxidant	NOUN
aiua-5955	83	30	or	or	CCONJ
aiua-5955	83	31	antioxidant	antioxidant	ADJ
aiua-5955	83	32	enzymes	enzyme	NOUN
aiua-5955	83	33	.	.	PUNCT
aiua-5955	84	1	for	for	ADP
aiua-5955	84	2	instance	instance	NOUN
aiua-5955	84	3	,	,	PUNCT
aiua-5955	84	4	reports	report	NOUN
aiua-5955	84	5	show	show	VERB
aiua-5955	84	6	that	that	SCONJ
aiua-5955	84	7	ala	ala	PROPN
aiua-5955	84	8	increases	increase	VERB
aiua-5955	84	9	intracellular	intracellular	ADJ
aiua-5955	84	10	ascorbate	ascorbate	NOUN
aiua-5955	84	11	levels	level	NOUN
aiua-5955	84	12	.	.	PUNCT
aiua-5955	85	1	in	in	ADP
aiua-5955	85	2	concert	concert	NOUN
aiua-5955	85	3	with	with	ADP
aiua-5955	85	4	improving	improve	VERB
aiua-5955	85	5	ascorbate	ascorbate	NOUN
aiua-5955	85	6	status	status	NOUN
aiua-5955	85	7	,	,	PUNCT
aiua-5955	85	8	la	la	PRON
aiua-5955	85	9	markedly	markedly	ADV
aiua-5955	85	10	increases	increase	VERB
aiua-5955	85	11	intracellular	intracellular	ADJ
aiua-5955	85	12	glutathione	glutathione	NOUN
aiua-5955	85	13	(	(	PUNCT
aiua-5955	85	14	gsh	gsh	PROPN
aiua-5955	85	15	)	)	PUNCT
aiua-5955	85	16	,	,	PUNCT
aiua-5955	85	17	an	an	DET
aiua-5955	85	18	abundant	abundant	ADJ
aiua-5955	85	19	natural	natural	ADJ
aiua-5955	85	20	thiol	thiol	ADJ
aiua-5955	85	21	antioxidant	antioxidant	NOUN
aiua-5955	85	22	and	and	CCONJ
aiua-5955	85	23	co	co	NOUN
aiua-5955	85	24	-	-	NOUN
aiua-5955	85	25	substrate	substrate	NOUN
aiua-5955	85	26	for	for	ADP
aiua-5955	85	27	detoxification	detoxification	NOUN
aiua-5955	85	28	enzymes	enzyme	NOUN
aiua-5955	85	29	,	,	PUNCT
aiua-5955	85	30	in	in	ADP
aiua-5955	85	31	a	a	DET
aiua-5955	85	32	variety	variety	NOUN
aiua-5955	85	33	of	of	ADP
aiua-5955	85	34	cell	cell	NOUN
aiua-5955	85	35	types	type	NOUN
aiua-5955	85	36	and	and	CCONJ
aiua-5955	85	37	tissues	tissue	NOUN
aiua-5955	85	38	(	(	PUNCT
aiua-5955	85	39	6	6	NUM
aiua-5955	85	40	-	-	SYM
aiua-5955	85	41	7	7	NUM
aiua-5955	85	42	)	)	PUNCT
aiua-5955	85	43	.	.	PUNCT
aiua-5955	86	1	several	several	ADJ
aiua-5955	86	2	clinical	clinical	ADJ
aiua-5955	86	3	trials	trial	NOUN
aiua-5955	86	4	have	have	AUX
aiua-5955	86	5	been	be	AUX
aiua-5955	86	6	conducted	conduct	VERB
aiua-5955	86	7	to	to	PART
aiua-5955	86	8	measure	measure	VERB
aiua-5955	86	9	the	the	DET
aiua-5955	86	10	efficacy	efficacy	NOUN
aiua-5955	86	11	of	of	ADP
aiua-5955	86	12	racemic	racemic	ADJ
aiua-5955	86	13	ala	ala	NOUN
aiua-5955	86	14	in	in	ADP
aiua-5955	86	15	decreasing	decrease	VERB
aiua-5955	86	16	symptoms	symptom	NOUN
aiua-5955	86	17	of	of	ADP
aiua-5955	86	18	diabetic	diabetic	ADJ
aiua-5955	86	19	polyneuropathies	polyneuropathie	NOUN
aiua-5955	86	20	;	;	PUNCT
aiua-5955	86	21	these	these	PRON
aiua-5955	86	22	are	be	AUX
aiua-5955	86	23	the	the	DET
aiua-5955	86	24	“	"	PUNCT
aiua-5955	86	25	alpha	alpha	NOUN
aiua-5955	86	26	-	-	PUNCT
aiua-5955	86	27	lipoic	lipoic	ADJ
aiua-5955	86	28	acid	acid	NOUN
aiua-5955	86	29	19archivio	19archivio	NUM
aiua-5955	86	30	italiano	italiano	PROPN
aiua-5955	86	31	di	di	X
aiua-5955	86	32	urologia	urologia	PROPN
aiua-5955	86	33	e	e	PROPN
aiua-5955	86	34	andrologia	andrologia	NOUN
aiua-5955	86	35	2017	2017	NUM
aiua-5955	86	36	;	;	PUNCT
aiua-5955	86	37	89	89	NUM
aiua-5955	86	38	,	,	PUNCT
aiua-5955	86	39	1	1	NUM
aiua-5955	86	40	palmitoylethanolamide	palmitoylethanolamide	ADJ
aiua-5955	86	41	-	-	PUNCT
aiua-5955	86	42	alphalipoic	alphalipoic	NOUN
aiua-5955	86	43	acid	acid	NOUN
aiua-5955	86	44	in	in	ADP
aiua-5955	86	45	cp	cp	PROPN
aiua-5955	86	46	/	/	SYM
aiua-5955	86	47	cpp	cpp	ADJ
aiua-5955	86	48	figure	figure	NOUN
aiua-5955	86	49	2	2	NUM
aiua-5955	86	50	.	.	PUNCT
aiua-5955	86	51	comparative	comparative	ADJ
aiua-5955	86	52	effects	effect	NOUN
aiua-5955	86	53	of	of	ADP
aiua-5955	86	54	12	12	NUM
aiua-5955	86	55	-	-	PUNCT
aiua-5955	86	56	week	week	NOUN
aiua-5955	86	57	treatments	treatment	NOUN
aiua-5955	86	58	with	with	ADP
aiua-5955	86	59	either	either	CCONJ
aiua-5955	86	60	the	the	DET
aiua-5955	86	61	combination	combination	NOUN
aiua-5955	86	62	á	á	NOUN
aiua-5955	86	63	-	-	PUNCT
aiua-5955	86	64	lipoic	lipoic	ADJ
aiua-5955	86	65	acid	acid	NOUN
aiua-5955	86	66	-	-	PUNCT
aiua-5955	86	67	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	86	68	or	or	CCONJ
aiua-5955	86	69	the	the	DET
aiua-5955	86	70	extract	extract	NOUN
aiua-5955	86	71	from	from	ADP
aiua-5955	86	72	s.	s.	PROPN
aiua-5955	86	73	repens	repen	NOUN
aiua-5955	86	74	on	on	ADP
aiua-5955	86	75	the	the	DET
aiua-5955	86	76	iief5	iief5	PROPN
aiua-5955	86	77	score	score	NOUN
aiua-5955	86	78	for	for	ADP
aiua-5955	86	79	evaluation	evaluation	NOUN
aiua-5955	86	80	of	of	ADP
aiua-5955	86	81	erectile	erectile	ADJ
aiua-5955	86	82	function	function	NOUN
aiua-5955	86	83	in	in	ADP
aiua-5955	86	84	patients	patient	NOUN
aiua-5955	86	85	with	with	ADP
aiua-5955	86	86	chronic	chronic	ADJ
aiua-5955	86	87	prostatitis	prostatitis	NOUN
aiua-5955	86	88	.	.	PUNCT
aiua-5955	87	1	vertical	vertical	ADJ
aiua-5955	87	2	bars	bar	NOUN
aiua-5955	87	3	are	be	AUX
aiua-5955	87	4	means	mean	VERB
aiua-5955	87	5	±	±	PROPN
aiua-5955	87	6	se	se	X
aiua-5955	87	7	;	;	PUNCT
aiua-5955	87	8	significance	significance	NOUN
aiua-5955	87	9	was	be	AUX
aiua-5955	87	10	set	set	VERB
aiua-5955	87	11	for	for	ADP
aiua-5955	87	12	a	a	DET
aiua-5955	87	13	*	*	X
aiua-5955	87	14	p	p	X
aiua-5955	87	15	<	<	X
aiua-5955	87	16	0.05	0.05	NUM
aiua-5955	87	17	(	(	PUNCT
aiua-5955	87	18	one	one	NUM
aiua-5955	87	19	way	way	NOUN
aiua-5955	87	20	analysis	analysis	NOUN
aiua-5955	87	21	of	of	ADP
aiua-5955	87	22	variance	variance	NOUN
aiua-5955	87	23	,	,	PUNCT
aiua-5955	87	24	followed	follow	VERB
aiua-5955	87	25	by	by	ADP
aiua-5955	87	26	the	the	DET
aiua-5955	87	27	bonferroni	bonferroni	NOUN
aiua-5955	87	28	’s	’s	PART
aiua-5955	87	29	multiple	multiple	ADJ
aiua-5955	87	30	comparison	comparison	NOUN
aiua-5955	87	31	test	test	NOUN
aiua-5955	87	32	)	)	PUNCT
aiua-5955	87	33	.	.	PUNCT
aiua-5955	88	1	figure	figure	VERB
aiua-5955	88	2	3	3	NUM
aiua-5955	88	3	.	.	PUNCT
aiua-5955	88	4	comparative	comparative	ADJ
aiua-5955	88	5	effects	effect	NOUN
aiua-5955	88	6	of	of	ADP
aiua-5955	88	7	12	12	NUM
aiua-5955	88	8	-	-	PUNCT
aiua-5955	88	9	week	week	NOUN
aiua-5955	88	10	treatments	treatment	NOUN
aiua-5955	88	11	with	with	ADP
aiua-5955	88	12	either	either	CCONJ
aiua-5955	88	13	the	the	DET
aiua-5955	88	14	combination	combination	NOUN
aiua-5955	88	15	á	á	NOUN
aiua-5955	88	16	-	-	PUNCT
aiua-5955	88	17	lipoic	lipoic	ADJ
aiua-5955	88	18	acid	acid	NOUN
aiua-5955	88	19	-	-	PUNCT
aiua-5955	88	20	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	88	21	or	or	CCONJ
aiua-5955	88	22	the	the	DET
aiua-5955	88	23	extract	extract	NOUN
aiua-5955	88	24	from	from	ADP
aiua-5955	88	25	s.	s.	PROPN
aiua-5955	88	26	repens	repen	NOUN
aiua-5955	88	27	on	on	ADP
aiua-5955	88	28	the	the	DET
aiua-5955	88	29	nih	nih	PROPN
aiua-5955	88	30	-	-	PUNCT
aiua-5955	88	31	cpsi	cpsi	NOUN
aiua-5955	88	32	score	score	NOUN
aiua-5955	88	33	for	for	ADP
aiua-5955	88	34	evaluation	evaluation	NOUN
aiua-5955	88	35	of	of	ADP
aiua-5955	88	36	pain	pain	NOUN
aiua-5955	88	37	,	,	PUNCT
aiua-5955	88	38	urinary	urinary	ADJ
aiua-5955	88	39	discomfort	discomfort	NOUN
aiua-5955	88	40	and	and	CCONJ
aiua-5955	88	41	relative	relative	ADJ
aiua-5955	88	42	quality	quality	NOUN
aiua-5955	88	43	of	of	ADP
aiua-5955	88	44	life	life	NOUN
aiua-5955	88	45	in	in	ADP
aiua-5955	88	46	patients	patient	NOUN
aiua-5955	88	47	with	with	ADP
aiua-5955	88	48	chronic	chronic	ADJ
aiua-5955	88	49	prostatitis	prostatitis	NOUN
aiua-5955	88	50	.	.	PUNCT
aiua-5955	89	1	vertical	vertical	ADJ
aiua-5955	89	2	bars	bar	NOUN
aiua-5955	89	3	are	be	AUX
aiua-5955	89	4	means	mean	VERB
aiua-5955	89	5	±	±	NOUN
aiua-5955	89	6	se	se	X
aiua-5955	89	7	;	;	PUNCT
aiua-5955	89	8	*	*	PUNCT
aiua-5955	89	9	p	p	X
aiua-5955	89	10	<	<	X
aiua-5955	89	11	0.05	0.05	NUM
aiua-5955	89	12	vs.	vs.	ADP
aiua-5955	89	13	time	time	NOUN
aiua-5955	89	14	zero	zero	NUM
aiua-5955	89	15	of	of	ADP
aiua-5955	89	16	the	the	DET
aiua-5955	89	17	combination	combination	NOUN
aiua-5955	89	18	(	(	PUNCT
aiua-5955	89	19	one	one	NUM
aiua-5955	89	20	way	way	NOUN
aiua-5955	89	21	analysis	analysis	NOUN
aiua-5955	89	22	of	of	ADP
aiua-5955	89	23	variance	variance	NOUN
aiua-5955	89	24	,	,	PUNCT
aiua-5955	89	25	followed	follow	VERB
aiua-5955	89	26	by	by	ADP
aiua-5955	89	27	the	the	DET
aiua-5955	89	28	bonferroni	bonferroni	NOUN
aiua-5955	89	29	’s	’s	PART
aiua-5955	89	30	multiple	multiple	ADJ
aiua-5955	89	31	comparison	comparison	NOUN
aiua-5955	89	32	test	test	NOUN
aiua-5955	89	33	)	)	PUNCT
aiua-5955	89	34	.	.	PUNCT
aiua-5955	90	1	giammusso_stesura	giammusso_stesura	NOUN
aiua-5955	90	2	seveso	seveso	PROPN
aiua-5955	90	3	04/04/17	04/04/17	PROPN
aiua-5955	90	4	09:06	09:06	NUM
aiua-5955	90	5	pagina	pagina	NOUN
aiua-5955	90	6	19	19	NUM
aiua-5955	90	7	archivio	archivio	NOUN
aiua-5955	90	8	italiano	italiano	X
aiua-5955	90	9	di	di	X
aiua-5955	90	10	urologia	urologia	PROPN
aiua-5955	90	11	e	e	PROPN
aiua-5955	90	12	andrologia	andrologia	NOUN
aiua-5955	90	13	2017	2017	NUM
aiua-5955	90	14	;	;	PUNCT
aiua-5955	90	15	89	89	NUM
aiua-5955	90	16	,	,	PUNCT
aiua-5955	90	17	1	1	NUM
aiua-5955	90	18	b.	b.	PROPN
aiua-5955	90	19	giammusso	giammusso	PROPN
aiua-5955	90	20	,	,	PUNCT
aiua-5955	90	21	r.	r.	PROPN
aiua-5955	90	22	di	di	PROPN
aiua-5955	90	23	mauro	mauro	PROPN
aiua-5955	90	24	,	,	PUNCT
aiua-5955	90	25	r.	r.	PROPN
aiua-5955	90	26	bernardini	bernardini	PROPN
aiua-5955	90	27	20	20	NUM
aiua-5955	90	28	in	in	ADP
aiua-5955	90	29	diabetic	diabetic	ADJ
aiua-5955	90	30	neuropathy	neuropathy	ADJ
aiua-5955	90	31	”	"	PUNCT
aiua-5955	90	32	(	(	PUNCT
aiua-5955	90	33	aladin	aladin	NOUN
aiua-5955	90	34	)	)	PUNCT
aiua-5955	90	35	trials	trial	NOUN
aiua-5955	90	36	and	and	CCONJ
aiua-5955	90	37	the	the	DET
aiua-5955	90	38	“	"	PUNCT
aiua-5955	90	39	symptoms	symptom	NOUN
aiua-5955	90	40	of	of	ADP
aiua-5955	90	41	diabetic	diabetic	ADJ
aiua-5955	90	42	polyneuropathy	polyneuropathy	NOUN
aiua-5955	90	43	”	"	PUNCT
aiua-5955	90	44	(	(	PUNCT
aiua-5955	90	45	sydney	sydney	NOUN
aiua-5955	90	46	)	)	PUNCT
aiua-5955	90	47	trials	trial	NOUN
aiua-5955	90	48	.	.	PUNCT
aiua-5955	91	1	ala	ala	PROPN
aiua-5955	91	2	was	be	AUX
aiua-5955	91	3	given	give	VERB
aiua-5955	91	4	orally	orally	ADV
aiua-5955	91	5	,	,	PUNCT
aiua-5955	91	6	intravenously	intravenously	ADV
aiua-5955	91	7	,	,	PUNCT
aiua-5955	91	8	or	or	CCONJ
aiua-5955	91	9	i.v	i.v	PROPN
aiua-5955	91	10	.	.	PUNCT
aiua-5955	92	1	with	with	ADP
aiua-5955	92	2	oral	oral	ADJ
aiua-5955	92	3	follow	follow	NOUN
aiua-5955	92	4	-	-	PUNCT
aiua-5955	92	5	up	up	NOUN
aiua-5955	92	6	.	.	PUNCT
aiua-5955	93	1	however	however	ADV
aiua-5955	93	2	,	,	PUNCT
aiua-5955	93	3	some	some	DET
aiua-5955	93	4	additional	additional	ADJ
aiua-5955	93	5	studies	study	NOUN
aiua-5955	93	6	have	have	AUX
aiua-5955	93	7	found	find	VERB
aiua-5955	93	8	that	that	PRON
aiua-5955	93	9	oral	oral	ADJ
aiua-5955	93	10	ala	ala	NOUN
aiua-5955	93	11	is	be	AUX
aiua-5955	93	12	very	very	ADV
aiua-5955	93	13	effective	effective	ADJ
aiua-5955	93	14	.	.	PUNCT
aiua-5955	94	1	for	for	ADP
aiua-5955	94	2	example	example	NOUN
aiua-5955	94	3	,	,	PUNCT
aiua-5955	94	4	the	the	DET
aiua-5955	94	5	oral	oral	ADJ
aiua-5955	94	6	pilot	pilot	NOUN
aiua-5955	94	7	(	(	PUNCT
aiua-5955	94	8	orpil	orpil	ADJ
aiua-5955	94	9	)	)	PUNCT
aiua-5955	94	10	study	study	NOUN
aiua-5955	94	11	showed	show	VERB
aiua-5955	94	12	a	a	DET
aiua-5955	94	13	reduction	reduction	NOUN
aiua-5955	94	14	in	in	ADP
aiua-5955	94	15	diabetic	diabetic	ADJ
aiua-5955	94	16	polyneuropathic	polyneuropathic	ADJ
aiua-5955	94	17	symptoms	symptom	NOUN
aiua-5955	94	18	after	after	ADP
aiua-5955	94	19	three	three	NUM
aiua-5955	94	20	weeks	week	NOUN
aiua-5955	94	21	with	with	ADP
aiua-5955	94	22	600	600	NUM
aiua-5955	94	23	mg	mg	PROPN
aiua-5955	94	24	ala	ala	PROPN
aiua-5955	94	25	t.i.d	t.i.d	PROPN
aiua-5955	94	26	.	.	PUNCT
aiua-5955	95	1	(	(	PUNCT
aiua-5955	95	2	8)	8)	NUM
aiua-5955	95	3	while	while	SCONJ
aiua-5955	95	4	the	the	DET
aiua-5955	95	5	first	first	ADJ
aiua-5955	95	6	sydney	sydney	PROPN
aiua-5955	95	7	trial	trial	NOUN
aiua-5955	95	8	used	use	VERB
aiua-5955	95	9	i.v	i.v	PROPN
aiua-5955	95	10	.	.	PUNCT
aiua-5955	96	1	la	la	PROPN
aiua-5955	96	2	(	(	PUNCT
aiua-5955	96	3	9	9	NUM
aiua-5955	96	4	)	)	PUNCT
aiua-5955	96	5	,	,	PUNCT
aiua-5955	96	6	the	the	DET
aiua-5955	96	7	sydney	sydney	PROPN
aiua-5955	96	8	ii	ii	PROPN
aiua-5955	96	9	study	study	PROPN
aiua-5955	96	10	used	use	VERB
aiua-5955	96	11	oral	oral	NOUN
aiua-5955	96	12	la	la	NOUN
aiua-5955	96	13	at	at	ADP
aiua-5955	96	14	600	600	NUM
aiua-5955	96	15	,	,	PUNCT
aiua-5955	96	16	1200	1200	NUM
aiua-5955	96	17	,	,	PUNCT
aiua-5955	96	18	or	or	CCONJ
aiua-5955	96	19	1800	1800	NUM
aiua-5955	96	20	mg	mg	PROPN
aiua-5955	96	21	q.d	q.d	PROPN
aiua-5955	96	22	.	.	PROPN
aiua-5955	96	23	for	for	ADP
aiua-5955	96	24	5	5	NUM
aiua-5955	96	25	weeks	week	NOUN
aiua-5955	96	26	(	(	PUNCT
aiua-5955	96	27	10	10	NUM
aiua-5955	96	28	)	)	PUNCT
aiua-5955	96	29	;	;	PUNCT
aiua-5955	96	30	consequently	consequently	ADV
aiua-5955	96	31	,	,	PUNCT
aiua-5955	96	32	both	both	DET
aiua-5955	96	33	studies	study	NOUN
aiua-5955	96	34	showed	show	VERB
aiua-5955	96	35	significant	significant	ADJ
aiua-5955	96	36	improvements	improvement	NOUN
aiua-5955	96	37	in	in	ADP
aiua-5955	96	38	neuropathic	neuropathic	ADJ
aiua-5955	96	39	endpoints	endpoint	NOUN
aiua-5955	96	40	.	.	PUNCT
aiua-5955	97	1	ala	ala	PROPN
aiua-5955	97	2	has	have	AUX
aiua-5955	97	3	also	also	ADV
aiua-5955	97	4	been	be	AUX
aiua-5955	97	5	studied	study	VERB
aiua-5955	97	6	for	for	ADP
aiua-5955	97	7	its	its	PRON
aiua-5955	97	8	antioxidant	antioxidant	ADJ
aiua-5955	97	9	properties	property	NOUN
aiua-5955	97	10	in	in	ADP
aiua-5955	97	11	cytokine	cytokine	NOUN
aiua-5955	97	12	-	-	PUNCT
aiua-5955	97	13	induced	induced	ADJ
aiua-5955	97	14	inflammation	inflammation	NOUN
aiua-5955	97	15	;	;	PUNCT
aiua-5955	97	16	it	it	PRON
aiua-5955	97	17	is	be	AUX
aiua-5955	97	18	also	also	ADV
aiua-5955	97	19	widely	widely	ADV
aiua-5955	97	20	known	know	VERB
aiua-5955	97	21	as	as	ADP
aiua-5955	97	22	an	an	DET
aiua-5955	97	23	inhibitor	inhibitor	NOUN
aiua-5955	97	24	of	of	ADP
aiua-5955	97	25	nf	nf	NOUN
aiua-5955	97	26	-	-	PUNCT
aiua-5955	97	27	kappab	kappab	NOUN
aiua-5955	97	28	(	(	PUNCT
aiua-5955	97	29	11	11	NUM
aiua-5955	97	30	)	)	PUNCT
aiua-5955	97	31	.	.	PUNCT
aiua-5955	98	1	results	result	NOUN
aiua-5955	98	2	show	show	VERB
aiua-5955	98	3	that	that	SCONJ
aiua-5955	98	4	ala	ala	PROPN
aiua-5955	98	5	lowers	lower	VERB
aiua-5955	98	6	expression	expression	NOUN
aiua-5955	98	7	of	of	ADP
aiua-5955	98	8	vascular	vascular	ADJ
aiua-5955	98	9	cell	cell	NOUN
aiua-5955	98	10	adhesion	adhesion	NOUN
aiua-5955	98	11	molecule-1	molecule-1	PROPN
aiua-5955	98	12	(	(	PUNCT
aiua-5955	98	13	vcam-1	vcam-1	NOUN
aiua-5955	98	14	)	)	PUNCT
aiua-5955	98	15	and	and	CCONJ
aiua-5955	98	16	endothelial	endothelial	ADJ
aiua-5955	98	17	adhesion	adhesion	NOUN
aiua-5955	98	18	of	of	ADP
aiua-5955	98	19	human	human	ADJ
aiua-5955	98	20	monocytes	monocyte	NOUN
aiua-5955	98	21	,	,	PUNCT
aiua-5955	98	22	and	and	CCONJ
aiua-5955	98	23	inhibits	inhibit	VERB
aiua-5955	98	24	nf	nf	ADJ
aiua-5955	98	25	-	-	PUNCT
aiua-5955	98	26	kappab	kappab	NOUN
aiua-5955	98	27	-	-	PUNCT
aiua-5955	98	28	dependent	dependent	ADJ
aiua-5955	98	29	expression	expression	NOUN
aiua-5955	98	30	of	of	ADP
aiua-5955	98	31	metalloproteinase-9	metalloproteinase-9	NUM
aiua-5955	98	32	in	in	ADP
aiua-5955	98	33	vitro	vitro	X
aiua-5955	98	34	(	(	PUNCT
aiua-5955	98	35	12	12	NUM
aiua-5955	98	36	-	-	SYM
aiua-5955	98	37	13	13	NUM
aiua-5955	98	38	)	)	PUNCT
aiua-5955	98	39	.	.	PUNCT
aiua-5955	99	1	similarly	similarly	ADV
aiua-5955	99	2	,	,	PUNCT
aiua-5955	99	3	ala	ala	PROPN
aiua-5955	99	4	(	(	PUNCT
aiua-5955	99	5	25100	25100	NUM
aiua-5955	99	6	ìg	ìg	NOUN
aiua-5955	99	7	/	/	SYM
aiua-5955	99	8	ml	ml	NOUN
aiua-5955	99	9	=	=	SYM
aiua-5955	99	10	122	122	NUM
aiua-5955	99	11	-	-	SYM
aiua-5955	99	12	486	486	NUM
aiua-5955	99	13	ìm	ìm	NOUN
aiua-5955	99	14	)	)	PUNCT
aiua-5955	99	15	prevents	prevent	VERB
aiua-5955	99	16	the	the	DET
aiua-5955	99	17	upregulation	upregulation	NOUN
aiua-5955	99	18	of	of	ADP
aiua-5955	99	19	intercellular	intercellular	ADJ
aiua-5955	99	20	adhesion	adhesion	NOUN
aiua-5955	99	21	molecule-1	molecule-1	PROPN
aiua-5955	99	22	(	(	PUNCT
aiua-5955	99	23	icam-1	icam-1	NOUN
aiua-5955	99	24	)	)	PUNCT
aiua-5955	99	25	and	and	CCONJ
aiua-5955	99	26	vascular	vascular	ADJ
aiua-5955	99	27	cell	cell	NOUN
aiua-5955	99	28	adhesion	adhesion	NOUN
aiua-5955	99	29	molecule-1	molecule-1	PROPN
aiua-5955	99	30	(	(	PUNCT
aiua-5955	99	31	vcam-1	vcam-1	NOUN
aiua-5955	99	32	)	)	PUNCT
aiua-5955	99	33	in	in	ADP
aiua-5955	99	34	spinal	spinal	ADJ
aiua-5955	99	35	cords	cord	NOUN
aiua-5955	99	36	and	and	CCONJ
aiua-5955	99	37	in	in	ADP
aiua-5955	99	38	tnf	tnf	PROPN
aiua-5955	99	39	-	-	PUNCT
aiua-5955	99	40	alpha	alpha	NOUN
aiua-5955	99	41	stimulated	stimulate	VERB
aiua-5955	99	42	cultured	cultured	ADJ
aiua-5955	99	43	brain	brain	NOUN
aiua-5955	99	44	endothelial	endothelial	NOUN
aiua-5955	99	45	cells	cell	NOUN
aiua-5955	99	46	(	(	PUNCT
aiua-5955	99	47	14	14	NUM
aiua-5955	99	48	)	)	PUNCT
aiua-5955	99	49	.	.	PUNCT
aiua-5955	100	1	to	to	ADP
aiua-5955	100	2	date	date	NOUN
aiua-5955	100	3	,	,	PUNCT
aiua-5955	100	4	the	the	DET
aiua-5955	100	5	anti	anti	ADJ
aiua-5955	100	6	-	-	ADJ
aiua-5955	100	7	inflammatory	inflammatory	ADJ
aiua-5955	100	8	properties	property	NOUN
aiua-5955	100	9	of	of	ADP
aiua-5955	100	10	ala	ala	PROPN
aiua-5955	100	11	have	have	AUX
aiua-5955	100	12	rarely	rarely	ADV
aiua-5955	100	13	been	be	AUX
aiua-5955	100	14	investigated	investigate	VERB
aiua-5955	100	15	in	in	ADP
aiua-5955	100	16	humans	human	NOUN
aiua-5955	100	17	.	.	PUNCT
aiua-5955	101	1	the	the	DET
aiua-5955	101	2	island	island	NOUN
aiua-5955	101	3	trial	trial	NOUN
aiua-5955	101	4	showed	show	VERB
aiua-5955	101	5	a	a	DET
aiua-5955	101	6	15	15	NUM
aiua-5955	101	7	%	%	NOUN
aiua-5955	101	8	significant	significant	ADJ
aiua-5955	101	9	decrease	decrease	NOUN
aiua-5955	101	10	in	in	ADP
aiua-5955	101	11	serum	serum	NOUN
aiua-5955	101	12	interleukin-6	interleukin-6	NUM
aiua-5955	101	13	levels	level	NOUN
aiua-5955	101	14	following	follow	VERB
aiua-5955	101	15	4	4	NUM
aiua-5955	101	16	weeks	week	NOUN
aiua-5955	101	17	of	of	ADP
aiua-5955	101	18	supplementation	supplementation	NOUN
aiua-5955	101	19	with	with	ADP
aiua-5955	101	20	ala	ala	PROPN
aiua-5955	101	21	(	(	PUNCT
aiua-5955	101	22	300	300	NUM
aiua-5955	101	23	mg	mg	NOUN
aiua-5955	101	24	/	/	SYM
aiua-5955	101	25	day	day	NOUN
aiua-5955	101	26	)	)	PUNCT
aiua-5955	101	27	(	(	PUNCT
aiua-5955	101	28	15	15	NUM
aiua-5955	101	29	)	)	PUNCT
aiua-5955	101	30	.	.	PUNCT
aiua-5955	102	1	although	although	SCONJ
aiua-5955	102	2	some	some	DET
aiua-5955	102	3	important	important	ADJ
aiua-5955	102	4	aspects	aspect	NOUN
aiua-5955	102	5	of	of	ADP
aiua-5955	102	6	ala	ala	PROPN
aiua-5955	102	7	’s	’s	PART
aiua-5955	102	8	mechanism	mechanism	NOUN
aiua-5955	102	9	of	of	ADP
aiua-5955	102	10	action	action	NOUN
aiua-5955	102	11	in	in	ADP
aiua-5955	102	12	vivo	vivo	NOUN
aiua-5955	102	13	are	be	AUX
aiua-5955	102	14	yet	yet	ADV
aiua-5955	102	15	to	to	PART
aiua-5955	102	16	be	be	AUX
aiua-5955	102	17	uncovered	uncover	VERB
aiua-5955	102	18	,	,	PUNCT
aiua-5955	102	19	it	it	PRON
aiua-5955	102	20	is	be	AUX
aiua-5955	102	21	apparent	apparent	ADJ
aiua-5955	102	22	that	that	SCONJ
aiua-5955	102	23	oral	oral	ADJ
aiua-5955	102	24	ala	ala	PROPN
aiua-5955	102	25	supplements	supplement	NOUN
aiua-5955	102	26	are	be	AUX
aiua-5955	102	27	clinically	clinically	ADV
aiua-5955	102	28	effective	effective	ADJ
aiua-5955	102	29	in	in	ADP
aiua-5955	102	30	mitigating	mitigate	VERB
aiua-5955	102	31	chronic	chronic	ADJ
aiua-5955	102	32	inflammatory	inflammatory	ADJ
aiua-5955	102	33	conditions	condition	NOUN
aiua-5955	102	34	,	,	PUNCT
aiua-5955	102	35	as	as	ADV
aiua-5955	102	36	well	well	ADV
aiua-5955	102	37	as	as	ADP
aiua-5955	102	38	improving	improve	VERB
aiua-5955	102	39	or	or	CCONJ
aiua-5955	102	40	maintaining	maintain	VERB
aiua-5955	102	41	antioxidant	antioxidant	ADJ
aiua-5955	102	42	/	/	SYM
aiua-5955	102	43	detoxification	detoxification	NOUN
aiua-5955	102	44	defenses	defense	NOUN
aiua-5955	102	45	that	that	PRON
aiua-5955	102	46	otherwise	otherwise	ADV
aiua-5955	102	47	decline	decline	VERB
aiua-5955	102	48	with	with	ADP
aiua-5955	102	49	age	age	NOUN
aiua-5955	102	50	.	.	PUNCT
aiua-5955	103	1	among	among	ADP
aiua-5955	103	2	molecules	molecule	NOUN
aiua-5955	103	3	able	able	ADJ
aiua-5955	103	4	to	to	PART
aiua-5955	103	5	modify	modify	VERB
aiua-5955	103	6	the	the	DET
aiua-5955	103	7	course	course	NOUN
aiua-5955	103	8	of	of	ADP
aiua-5955	103	9	chronic	chronic	ADJ
aiua-5955	103	10	pain	pain	NOUN
aiua-5955	103	11	in	in	ADP
aiua-5955	103	12	adults	adult	NOUN
aiua-5955	103	13	,	,	PUNCT
aiua-5955	103	14	palmitoylethanolamide	palmitoylethanolamide	ADJ
aiua-5955	103	15	(	(	PUNCT
aiua-5955	103	16	pea	pea	NOUN
aiua-5955	103	17	)	)	PUNCT
aiua-5955	103	18	seems	seem	VERB
aiua-5955	103	19	to	to	PART
aiua-5955	103	20	deserve	deserve	VERB
aiua-5955	103	21	interest	interest	NOUN
aiua-5955	103	22	.	.	PUNCT
aiua-5955	104	1	pea	pea	NOUN
aiua-5955	104	2	is	be	AUX
aiua-5955	104	3	an	an	DET
aiua-5955	104	4	endogenous	endogenous	ADJ
aiua-5955	104	5	nacylethanolamine	nacylethanolamine	NOUN
aiua-5955	104	6	produced	produce	VERB
aiua-5955	104	7	on	on	ADP
aiua-5955	104	8	demand	demand	NOUN
aiua-5955	104	9	to	to	PART
aiua-5955	104	10	promote	promote	VERB
aiua-5955	104	11	the	the	DET
aiua-5955	104	12	resolution	resolution	NOUN
aiua-5955	104	13	of	of	ADP
aiua-5955	104	14	neuroinflammation	neuroinflammation	NOUN
aiua-5955	104	15	and	and	CCONJ
aiua-5955	104	16	pain	pain	NOUN
aiua-5955	104	17	(	(	PUNCT
aiua-5955	104	18	16	16	NUM
aiua-5955	104	19	)	)	PUNCT
aiua-5955	104	20	.	.	PUNCT
aiua-5955	105	1	pea	pea	NOUN
aiua-5955	105	2	administration	administration	PROPN
aiua-5955	105	3	seems	seem	VERB
aiua-5955	105	4	able	able	ADJ
aiua-5955	105	5	to	to	PART
aiua-5955	105	6	control	control	VERB
aiua-5955	105	7	reactivity	reactivity	NOUN
aiua-5955	105	8	of	of	ADP
aiua-5955	105	9	tissue	tissue	NOUN
aiua-5955	105	10	peripheral	peripheral	ADJ
aiua-5955	105	11	mast	mast	NOUN
aiua-5955	105	12	cells	cell	NOUN
aiua-5955	105	13	located	locate	VERB
aiua-5955	105	14	in	in	ADP
aiua-5955	105	15	close	close	ADJ
aiua-5955	105	16	proximity	proximity	NOUN
aiua-5955	105	17	to	to	ADP
aiua-5955	105	18	nerve	nerve	NOUN
aiua-5955	105	19	terminals	terminal	NOUN
aiua-5955	105	20	and	and	CCONJ
aiua-5955	105	21	within	within	ADP
aiua-5955	105	22	the	the	DET
aiua-5955	105	23	endoneural	endoneural	ADJ
aiua-5955	105	24	microenvironment	microenvironment	NOUN
aiua-5955	105	25	,	,	PUNCT
aiua-5955	105	26	thereby	thereby	ADV
aiua-5955	105	27	normalizing	normalize	VERB
aiua-5955	105	28	the	the	DET
aiua-5955	105	29	sensitivity	sensitivity	NOUN
aiua-5955	105	30	and	and	CCONJ
aiua-5955	105	31	function	function	NOUN
aiua-5955	105	32	of	of	ADP
aiua-5955	105	33	primary	primary	ADJ
aiua-5955	105	34	somatosensory	somatosensory	NOUN
aiua-5955	105	35	peripheral	peripheral	ADJ
aiua-5955	105	36	neurons	neuron	NOUN
aiua-5955	105	37	(	(	PUNCT
aiua-5955	105	38	17	17	NUM
aiua-5955	105	39	)	)	PUNCT
aiua-5955	105	40	.	.	PUNCT
aiua-5955	106	1	furthermore	furthermore	ADV
aiua-5955	106	2	,	,	PUNCT
aiua-5955	106	3	pea	pea	NOUN
aiua-5955	106	4	act	act	VERB
aiua-5955	106	5	on	on	ADP
aiua-5955	106	6	spinal	spinal	NOUN
aiua-5955	106	7	/	/	SYM
aiua-5955	106	8	supraspinal	supraspinal	ADJ
aiua-5955	106	9	nonneuronal	nonneuronal	ADJ
aiua-5955	106	10	cells	cell	NOUN
aiua-5955	106	11	(	(	PUNCT
aiua-5955	106	12	microglia	microglia	ADJ
aiua-5955	106	13	,	,	PUNCT
aiua-5955	106	14	resident	resident	NOUN
aiua-5955	106	15	or	or	CCONJ
aiua-5955	106	16	infiltrating	infiltrating	ADJ
aiua-5955	106	17	mast	mast	NOUN
aiua-5955	106	18	cells	cell	NOUN
aiua-5955	106	19	,	,	PUNCT
aiua-5955	106	20	astrocytes	astrocyte	NOUN
aiua-5955	106	21	)	)	PUNCT
aiua-5955	106	22	to	to	PART
aiua-5955	106	23	counteract	counteract	VERB
aiua-5955	106	24	neuroinflammation	neuroinflammation	NOUN
aiua-5955	106	25	and	and	CCONJ
aiua-5955	106	26	normalize	normalize	VERB
aiua-5955	106	27	the	the	DET
aiua-5955	106	28	activity	activity	NOUN
aiua-5955	106	29	of	of	ADP
aiua-5955	106	30	secondand	secondand	NOUN
aiua-5955	106	31	third	third	ADJ
aiua-5955	106	32	-	-	PUNCT
aiua-5955	106	33	order	order	NOUN
aiua-5955	106	34	somatosensory	somatosensory	NOUN
aiua-5955	106	35	neurons	neuron	NOUN
aiua-5955	106	36	(	(	PUNCT
aiua-5955	106	37	18	18	NUM
aiua-5955	106	38	,	,	PUNCT
aiua-5955	106	39	19	19	NUM
aiua-5955	106	40	)	)	PUNCT
aiua-5955	106	41	.	.	PUNCT
aiua-5955	107	1	clinical	clinical	ADJ
aiua-5955	107	2	studies	study	NOUN
aiua-5955	107	3	demonstrate	demonstrate	VERB
aiua-5955	107	4	the	the	DET
aiua-5955	107	5	efficacy	efficacy	NOUN
aiua-5955	107	6	of	of	ADP
aiua-5955	107	7	pea	pea	NOUN
aiua-5955	107	8	in	in	ADP
aiua-5955	107	9	reducing	reduce	VERB
aiua-5955	107	10	chronic	chronic	ADJ
aiua-5955	107	11	and	and	CCONJ
aiua-5955	107	12	neuropathic	neuropathic	ADJ
aiua-5955	107	13	pain	pain	NOUN
aiua-5955	107	14	associated	associate	VERB
aiua-5955	107	15	with	with	ADP
aiua-5955	107	16	various	various	ADJ
aiua-5955	107	17	pathological	pathological	ADJ
aiua-5955	107	18	conditions	condition	NOUN
aiua-5955	107	19	.	.	PUNCT
aiua-5955	108	1	a	a	DET
aiua-5955	108	2	remarkable	remarkable	ADJ
aiua-5955	108	3	pharmacological	pharmacological	ADJ
aiua-5955	108	4	feature	feature	NOUN
aiua-5955	108	5	of	of	ADP
aiua-5955	108	6	pea	pea	NOUN
aiua-5955	108	7	is	be	AUX
aiua-5955	108	8	that	that	SCONJ
aiua-5955	108	9	its	its	PRON
aiua-5955	108	10	addition	addition	NOUN
aiua-5955	108	11	to	to	ADP
aiua-5955	108	12	ongoing	ongoing	ADJ
aiua-5955	108	13	standard	standard	ADJ
aiua-5955	108	14	therapies	therapy	NOUN
aiua-5955	108	15	for	for	ADP
aiua-5955	108	16	chronic	chronic	ADJ
aiua-5955	108	17	or	or	CCONJ
aiua-5955	108	18	neuropathic	neuropathic	ADJ
aiua-5955	108	19	pain	pain	NOUN
aiua-5955	108	20	in	in	ADP
aiua-5955	108	21	patients	patient	NOUN
aiua-5955	108	22	with	with	ADP
aiua-5955	108	23	unsatisfactory	unsatisfactory	ADJ
aiua-5955	108	24	management	management	NOUN
aiua-5955	108	25	of	of	ADP
aiua-5955	108	26	pain	pain	NOUN
aiua-5955	108	27	relief	relief	NOUN
aiua-5955	108	28	allows	allow	VERB
aiua-5955	108	29	a	a	DET
aiua-5955	108	30	significant	significant	ADJ
aiua-5955	108	31	reduction	reduction	NOUN
aiua-5955	108	32	of	of	ADP
aiua-5955	108	33	non	non	ADJ
aiua-5955	108	34	-	-	ADJ
aiua-5955	108	35	steroidal	steroidal	ADJ
aiua-5955	108	36	antiinflammatory	antiinflammatory	NOUN
aiua-5955	108	37	drug	drug	NOUN
aiua-5955	108	38	use	use	NOUN
aiua-5955	108	39	(	(	PUNCT
aiua-5955	108	40	20	20	NUM
aiua-5955	108	41	)	)	PUNCT
aiua-5955	108	42	.	.	PUNCT
aiua-5955	109	1	in	in	ADP
aiua-5955	109	2	the	the	DET
aiua-5955	109	3	present	present	ADJ
aiua-5955	109	4	study	study	NOUN
aiua-5955	109	5	,	,	PUNCT
aiua-5955	109	6	a	a	DET
aiua-5955	109	7	significant	significant	ADJ
aiua-5955	109	8	reduction	reduction	NOUN
aiua-5955	109	9	of	of	ADP
aiua-5955	109	10	the	the	DET
aiua-5955	109	11	total	total	ADJ
aiua-5955	109	12	nih	nih	PROPN
aiua-5955	109	13	-	-	PUNCT
aiua-5955	109	14	cpsi	cpsi	NOUN
aiua-5955	109	15	score	score	NOUN
aiua-5955	109	16	was	be	AUX
aiua-5955	109	17	achieved	achieve	VERB
aiua-5955	109	18	in	in	ADP
aiua-5955	109	19	the	the	DET
aiua-5955	109	20	group	group	NOUN
aiua-5955	109	21	of	of	ADP
aiua-5955	109	22	patients	patient	NOUN
aiua-5955	109	23	subjected	subject	VERB
aiua-5955	109	24	to	to	ADP
aiua-5955	109	25	combination	combination	NOUN
aiua-5955	109	26	therapy	therapy	NOUN
aiua-5955	109	27	(	(	PUNCT
aiua-5955	109	28	ala	ala	NOUN
aiua-5955	109	29	plus	plus	CCONJ
aiua-5955	109	30	pea	pea	NOUN
aiua-5955	109	31	)	)	PUNCT
aiua-5955	109	32	for	for	ADP
aiua-5955	109	33	a	a	DET
aiua-5955	109	34	period	period	NOUN
aiua-5955	109	35	of	of	ADP
aiua-5955	109	36	12	12	NUM
aiua-5955	109	37	weeks	week	NOUN
aiua-5955	109	38	.	.	PUNCT
aiua-5955	110	1	notably	notably	ADV
aiua-5955	110	2	,	,	PUNCT
aiua-5955	110	3	this	this	DET
aiua-5955	110	4	improvement	improvement	NOUN
aiua-5955	110	5	in	in	ADP
aiua-5955	110	6	nihcpsi	nihcpsi	NOUN
aiua-5955	110	7	score	score	NOUN
aiua-5955	110	8	was	be	AUX
aiua-5955	110	9	not	not	PART
aiua-5955	110	10	seen	see	VERB
aiua-5955	110	11	in	in	ADP
aiua-5955	110	12	the	the	DET
aiua-5955	110	13	group	group	NOUN
aiua-5955	110	14	of	of	ADP
aiua-5955	110	15	patients	patient	NOUN
aiua-5955	110	16	treated	treat	VERB
aiua-5955	110	17	with	with	ADP
aiua-5955	110	18	serenoa	serenoa	ADJ
aiua-5955	110	19	repens	repen	NOUN
aiua-5955	110	20	.	.	PUNCT
aiua-5955	111	1	the	the	DET
aiua-5955	111	2	same	same	ADJ
aiua-5955	111	3	observation	observation	NOUN
aiua-5955	111	4	comes	come	VERB
aiua-5955	111	5	from	from	ADP
aiua-5955	111	6	the	the	DET
aiua-5955	111	7	evaluation	evaluation	NOUN
aiua-5955	111	8	of	of	ADP
aiua-5955	111	9	iief	iief	ADJ
aiua-5955	111	10	score	score	NOUN
aiua-5955	111	11	in	in	ADP
aiua-5955	111	12	both	both	DET
aiua-5955	111	13	arms	arm	NOUN
aiua-5955	111	14	.	.	PUNCT
aiua-5955	112	1	patient	patient	PROPN
aiua-5955	112	2	treated	treat	VERB
aiua-5955	112	3	with	with	ADP
aiua-5955	112	4	ala	ala	PROPN
aiua-5955	112	5	plus	plus	CCONJ
aiua-5955	112	6	pea	pea	NOUN
aiua-5955	112	7	showed	show	VERB
aiua-5955	112	8	a	a	DET
aiua-5955	112	9	significant	significant	ADJ
aiua-5955	112	10	improvement	improvement	NOUN
aiua-5955	112	11	in	in	ADP
aiua-5955	112	12	erectile	erectile	ADJ
aiua-5955	112	13	function	function	NOUN
aiua-5955	112	14	,	,	PUNCT
aiua-5955	112	15	not	not	PART
aiua-5955	112	16	seen	see	VERB
aiua-5955	112	17	in	in	ADP
aiua-5955	112	18	the	the	DET
aiua-5955	112	19	arm	arm	NOUN
aiua-5955	112	20	treated	treat	VERB
aiua-5955	112	21	with	with	ADP
aiua-5955	112	22	serenoa	serenoa	ADJ
aiua-5955	112	23	repens	repen	NOUN
aiua-5955	112	24	.	.	PUNCT
aiua-5955	113	1	this	this	DET
aiua-5955	113	2	study	study	NOUN
aiua-5955	113	3	clearly	clearly	ADV
aiua-5955	113	4	has	have	VERB
aiua-5955	113	5	limitations	limitation	NOUN
aiua-5955	113	6	.	.	PUNCT
aiua-5955	114	1	the	the	DET
aiua-5955	114	2	small	small	ADJ
aiua-5955	114	3	number	number	NOUN
aiua-5955	114	4	of	of	ADP
aiua-5955	114	5	subjects	subject	NOUN
aiua-5955	114	6	may	may	AUX
aiua-5955	114	7	not	not	PART
aiua-5955	114	8	be	be	AUX
aiua-5955	114	9	representative	representative	ADJ
aiua-5955	114	10	of	of	ADP
aiua-5955	114	11	the	the	DET
aiua-5955	114	12	general	general	ADJ
aiua-5955	114	13	population	population	NOUN
aiua-5955	114	14	with	with	ADP
aiua-5955	114	15	cp	cp	PROPN
aiua-5955	114	16	/	/	SYM
aiua-5955	114	17	cpps	cpps	NOUN
aiua-5955	114	18	.	.	PUNCT
aiua-5955	115	1	the	the	DET
aiua-5955	115	2	absence	absence	NOUN
aiua-5955	115	3	of	of	ADP
aiua-5955	115	4	a	a	DET
aiua-5955	115	5	placebo	placebo	NOUN
aiua-5955	115	6	arm	arm	NOUN
aiua-5955	115	7	may	may	AUX
aiua-5955	115	8	be	be	AUX
aiua-5955	115	9	considered	consider	VERB
aiua-5955	115	10	a	a	DET
aiua-5955	115	11	limitation	limitation	NOUN
aiua-5955	115	12	in	in	ADP
aiua-5955	115	13	terms	term	NOUN
aiua-5955	115	14	of	of	ADP
aiua-5955	115	15	efficacy	efficacy	NOUN
aiua-5955	115	16	evaluation	evaluation	NOUN
aiua-5955	115	17	of	of	ADP
aiua-5955	115	18	administered	administer	VERB
aiua-5955	115	19	treatments	treatment	NOUN
aiua-5955	115	20	,	,	PUNCT
aiua-5955	115	21	anyway	anyway	ADV
aiua-5955	115	22	our	our	PRON
aiua-5955	115	23	aim	aim	NOUN
aiua-5955	115	24	was	be	AUX
aiua-5955	115	25	a	a	DET
aiua-5955	115	26	direct	direct	ADJ
aiua-5955	115	27	comparison	comparison	NOUN
aiua-5955	115	28	between	between	ADP
aiua-5955	115	29	a	a	DET
aiua-5955	115	30	new	new	ADJ
aiua-5955	115	31	therapeutic	therapeutic	ADJ
aiua-5955	115	32	option	option	NOUN
aiua-5955	115	33	for	for	ADP
aiua-5955	115	34	cp	cp	NOUN
aiua-5955	115	35	/	/	SYM
aiua-5955	115	36	cpps	cpps	NOUN
aiua-5955	115	37	and	and	CCONJ
aiua-5955	115	38	a	a	DET
aiua-5955	115	39	traditional	traditional	ADJ
aiua-5955	115	40	treatment	treatment	NOUN
aiua-5955	115	41	strategy	strategy	NOUN
aiua-5955	115	42	,	,	PUNCT
aiua-5955	115	43	rather	rather	ADV
aiua-5955	115	44	than	than	ADP
aiua-5955	115	45	an	an	DET
aiua-5955	115	46	absolute	absolute	ADJ
aiua-5955	115	47	measurement	measurement	NOUN
aiua-5955	115	48	of	of	ADP
aiua-5955	115	49	efficacy	efficacy	NOUN
aiua-5955	115	50	.	.	PUNCT
aiua-5955	116	1	furthermore	furthermore	ADV
aiua-5955	116	2	,	,	PUNCT
aiua-5955	116	3	a	a	DET
aiua-5955	116	4	significant	significant	ADJ
aiua-5955	116	5	psychological	psychological	ADJ
aiua-5955	116	6	component	component	NOUN
aiua-5955	116	7	is	be	AUX
aiua-5955	116	8	well	well	ADV
aiua-5955	116	9	described	describe	VERB
aiua-5955	116	10	in	in	ADP
aiua-5955	116	11	patients	patient	NOUN
aiua-5955	116	12	with	with	ADP
aiua-5955	116	13	cp	cp	PROPN
aiua-5955	116	14	/	/	SYM
aiua-5955	116	15	cpps	cpps	NOUN
aiua-5955	116	16	symptoms	symptom	NOUN
aiua-5955	116	17	,	,	PUNCT
aiua-5955	116	18	and	and	CCONJ
aiua-5955	116	19	a	a	DET
aiua-5955	116	20	comparable	comparable	ADJ
aiua-5955	116	21	placebo	placebo	NOUN
aiua-5955	116	22	effect	effect	NOUN
aiua-5955	116	23	can	can	AUX
aiua-5955	116	24	be	be	AUX
aiua-5955	116	25	assumed	assume	VERB
aiua-5955	116	26	in	in	ADP
aiua-5955	116	27	all	all	DET
aiua-5955	116	28	patients	patient	NOUN
aiua-5955	116	29	taking	take	VERB
aiua-5955	116	30	drugs	drug	NOUN
aiua-5955	116	31	to	to	PART
aiua-5955	116	32	treat	treat	VERB
aiua-5955	116	33	this	this	DET
aiua-5955	116	34	kind	kind	NOUN
aiua-5955	116	35	of	of	ADP
aiua-5955	116	36	symptoms	symptom	NOUN
aiua-5955	116	37	.	.	PUNCT
aiua-5955	117	1	more	more	ADV
aiua-5955	117	2	extensive	extensive	ADJ
aiua-5955	117	3	studies	study	NOUN
aiua-5955	117	4	to	to	PART
aiua-5955	117	5	assess	assess	VERB
aiua-5955	117	6	these	these	DET
aiua-5955	117	7	parameters	parameter	NOUN
aiua-5955	117	8	will	will	AUX
aiua-5955	117	9	enhance	enhance	VERB
aiua-5955	117	10	our	our	PRON
aiua-5955	117	11	understanding	understanding	NOUN
aiua-5955	117	12	of	of	ADP
aiua-5955	117	13	the	the	DET
aiua-5955	117	14	mechanism	mechanism	NOUN
aiua-5955	117	15	of	of	ADP
aiua-5955	117	16	action	action	NOUN
aiua-5955	117	17	of	of	ADP
aiua-5955	117	18	ala	ala	PROPN
aiua-5955	117	19	plus	plus	CCONJ
aiua-5955	117	20	pea	pea	NOUN
aiua-5955	117	21	in	in	ADP
aiua-5955	117	22	patients	patient	NOUN
aiua-5955	117	23	with	with	ADP
aiua-5955	117	24	cp	cp	NOUN
aiua-5955	117	25	/	/	SYM
aiua-5955	117	26	cpps	cpps	NOUN
aiua-5955	117	27	.	.	PUNCT
aiua-5955	118	1	in	in	ADP
aiua-5955	118	2	conclusion	conclusion	NOUN
aiua-5955	118	3	,	,	PUNCT
aiua-5955	118	4	given	give	VERB
aiua-5955	118	5	the	the	DET
aiua-5955	118	6	aforementioned	aforementioned	ADJ
aiua-5955	118	7	limitations	limitation	NOUN
aiua-5955	118	8	,	,	PUNCT
aiua-5955	118	9	the	the	DET
aiua-5955	118	10	present	present	ADJ
aiua-5955	118	11	results	result	NOUN
aiua-5955	118	12	document	document	VERB
aiua-5955	118	13	the	the	DET
aiua-5955	118	14	efficacy	efficacy	NOUN
aiua-5955	118	15	of	of	ADP
aiua-5955	118	16	an	an	DET
aiua-5955	118	17	association	association	NOUN
aiua-5955	118	18	of	of	ADP
aiua-5955	118	19	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	118	20	(	(	PUNCT
aiua-5955	118	21	pea	pea	NOUN
aiua-5955	118	22	)	)	PUNCT
aiua-5955	118	23	and	and	CCONJ
aiua-5955	118	24	alpha	alpha	NOUN
aiua-5955	118	25	-	-	PUNCT
aiua-5955	118	26	lipoic	lipoic	NOUN
aiua-5955	118	27	acid	acid	NOUN
aiua-5955	118	28	(	(	PUNCT
aiua-5955	118	29	ala	ala	NOUN
aiua-5955	118	30	)	)	PUNCT
aiua-5955	118	31	administered	administer	VERB
aiua-5955	118	32	for	for	ADP
aiua-5955	118	33	12	12	NUM
aiua-5955	118	34	weeks	week	NOUN
aiua-5955	118	35	for	for	ADP
aiua-5955	118	36	treating	treat	VERB
aiua-5955	118	37	patients	patient	NOUN
aiua-5955	118	38	with	with	ADP
aiua-5955	118	39	cp	cp	PROPN
aiua-5955	118	40	/	/	SYM
aiua-5955	118	41	cpps	cpps	NOUN
aiua-5955	118	42	,	,	PUNCT
aiua-5955	118	43	compared	compare	VERB
aiua-5955	118	44	with	with	ADP
aiua-5955	118	45	serenoa	serenoa	ADJ
aiua-5955	118	46	repens	repen	NOUN
aiua-5955	118	47	monotherapy	monotherapy	NOUN
aiua-5955	118	48	.	.	PUNCT
aiua-5955	119	1	the	the	DET
aiua-5955	119	2	treatment	treatment	NOUN
aiua-5955	119	3	did	do	AUX
aiua-5955	119	4	not	not	PART
aiua-5955	119	5	produce	produce	VERB
aiua-5955	119	6	undesired	undesired	ADJ
aiua-5955	119	7	effects	effect	NOUN
aiua-5955	119	8	.	.	PUNCT
aiua-5955	120	1	however	however	ADV
aiua-5955	120	2	,	,	PUNCT
aiua-5955	120	3	additional	additional	ADJ
aiua-5955	120	4	long	long	ADJ
aiua-5955	120	5	term	term	NOUN
aiua-5955	120	6	and	and	CCONJ
aiua-5955	120	7	thorough	thorough	ADJ
aiua-5955	120	8	clinical	clinical	ADJ
aiua-5955	120	9	studies	study	NOUN
aiua-5955	120	10	are	be	AUX
aiua-5955	120	11	needed	need	VERB
aiua-5955	120	12	to	to	PART
aiua-5955	120	13	better	well	ADV
aiua-5955	120	14	explain	explain	VERB
aiua-5955	120	15	the	the	DET
aiua-5955	120	16	mechanisms	mechanism	NOUN
aiua-5955	120	17	of	of	ADP
aiua-5955	120	18	its	its	PRON
aiua-5955	120	19	neuroprotective	neuroprotective	ADJ
aiua-5955	120	20	effects	effect	NOUN
aiua-5955	120	21	and	and	CCONJ
aiua-5955	120	22	to	to	PART
aiua-5955	120	23	further	far	ADV
aiua-5955	120	24	investigate	investigate	VERB
aiua-5955	120	25	the	the	DET
aiua-5955	120	26	efficacy	efficacy	NOUN
aiua-5955	120	27	of	of	ADP
aiua-5955	120	28	its	its	PRON
aiua-5955	120	29	supplementation	supplementation	NOUN
aiua-5955	120	30	.	.	PUNCT
aiua-5955	121	1	references	reference	NOUN
aiua-5955	121	2	1	1	NUM
aiua-5955	121	3	.	.	PUNCT
aiua-5955	122	1	magri	magri	VERB
aiua-5955	122	2	v	v	NOUN
aiua-5955	122	3	,	,	PUNCT
aiua-5955	122	4	marras	marras	PROPN
aiua-5955	122	5	e	e	NOUN
aiua-5955	122	6	,	,	PUNCT
aiua-5955	122	7	restelli	restelli	VERB
aiua-5955	122	8	a	a	PRON
aiua-5955	122	9	,	,	PUNCT
aiua-5955	122	10	et	et	PROPN
aiua-5955	122	11	al	al	PROPN
aiua-5955	122	12	.	.	PUNCT
aiua-5955	122	13	multimodal	multimodal	NOUN
aiua-5955	122	14	therapy	therapy	NOUN
aiua-5955	122	15	for	for	ADP
aiua-5955	122	16	category	category	NOUN
aiua-5955	122	17	iii	iii	NUM
aiua-5955	122	18	chronic	chronic	ADJ
aiua-5955	122	19	prostatitis	prostatitis	NOUN
aiua-5955	122	20	/	/	SYM
aiua-5955	122	21	chronic	chronic	ADJ
aiua-5955	122	22	pelvic	pelvic	ADJ
aiua-5955	122	23	pain	pain	NOUN
aiua-5955	122	24	syndrome	syndrome	NOUN
aiua-5955	122	25	in	in	ADP
aiua-5955	122	26	upoints	upoint	NOUN
aiua-5955	122	27	phenotyped	phenotype	VERB
aiua-5955	122	28	patients	patient	NOUN
aiua-5955	122	29	.	.	PUNCT
aiua-5955	123	1	exper	exper	PROPN
aiua-5955	123	2	ther	ther	PROPN
aiua-5955	123	3	med	med	PROPN
aiua-5955	123	4	.	.	PROPN
aiua-5955	124	1	2015	2015	NUM
aiua-5955	124	2	;	;	PUNCT
aiua-5955	124	3	9:658	9:658	NUM
aiua-5955	124	4	-	-	SYM
aiua-5955	124	5	666	666	NUM
aiua-5955	124	6	.	.	NOUN
aiua-5955	125	1	2	2	NUM
aiua-5955	125	2	.	.	X
aiua-5955	125	3	sunghyup	sunghyup	PROPN
aiua-5955	125	4	c	c	PROPN
aiua-5955	125	5	,	,	PUNCT
aiua-5955	125	6	kweonsik	kweonsik	PROPN
aiua-5955	125	7	m	m	PROPN
aiua-5955	125	8	,	,	PUNCT
aiua-5955	125	9	ikjoon	ikjoon	ADV
aiua-5955	125	10	c	c	X
aiua-5955	125	11	,	,	PUNCT
aiua-5955	125	12	et	et	PROPN
aiua-5955	125	13	al	al	PROPN
aiua-5955	125	14	.	.	PUNCT
aiua-5955	126	1	effects	effect	NOUN
aiua-5955	126	2	of	of	ADP
aiua-5955	126	3	alpha	alpha	NOUN
aiua-5955	126	4	-	-	PUNCT
aiua-5955	126	5	lipoic	lipoic	NOUN
aiua-5955	126	6	acid	acid	NOUN
aiua-5955	126	7	on	on	ADP
aiua-5955	126	8	the	the	DET
aiua-5955	126	9	antioxidant	antioxidant	ADJ
aiua-5955	126	10	system	system	NOUN
aiua-5955	126	11	in	in	ADP
aiua-5955	126	12	prostate	prostate	NOUN
aiua-5955	126	13	cancer	cancer	NOUN
aiua-5955	126	14	cells	cell	NOUN
aiua-5955	126	15	.	.	PUNCT
aiua-5955	127	1	korean	korean	PROPN
aiua-5955	127	2	j	j	PROPN
aiua-5955	127	3	urol	urol	PROPN
aiua-5955	127	4	.	.	PUNCT
aiua-5955	127	5	2009	2009	NUM
aiua-5955	127	6	;	;	PUNCT
aiua-5955	127	7	50:72	50:72	NUM
aiua-5955	127	8	-	-	SYM
aiua-5955	127	9	80	80	NUM
aiua-5955	127	10	.	.	PUNCT
aiua-5955	128	1	3	3	X
aiua-5955	128	2	.	.	X
aiua-5955	128	3	shay	shay	PROPN
aiua-5955	128	4	kp	kp	PROPN
aiua-5955	128	5	,	,	PUNCT
aiua-5955	128	6	moreau	moreau	PROPN
aiua-5955	128	7	,	,	PUNCT
aiua-5955	128	8	rf	rf	PROPN
aiua-5955	128	9	,	,	PUNCT
aiua-5955	128	10	hagen	hagen	PROPN
aiua-5955	128	11	tm	tm	PROPN
aiua-5955	128	12	,	,	PUNCT
aiua-5955	128	13	et	et	PROPN
aiua-5955	128	14	al	al	PROPN
aiua-5955	128	15	.	.	PUNCT
aiua-5955	128	16	alpha	alpha	NOUN
aiua-5955	128	17	-	-	PUNCT
aiua-5955	128	18	lipoic	lipoic	NOUN
aiua-5955	128	19	acid	acid	NOUN
aiua-5955	128	20	as	as	ADP
aiua-5955	128	21	a	a	DET
aiua-5955	128	22	dietary	dietary	ADJ
aiua-5955	128	23	supplement	supplement	NOUN
aiua-5955	128	24	:	:	PUNCT
aiua-5955	128	25	molecular	molecular	ADJ
aiua-5955	128	26	mechanisms	mechanism	NOUN
aiua-5955	128	27	and	and	CCONJ
aiua-5955	128	28	therapeutic	therapeutic	ADJ
aiua-5955	128	29	potential	potential	NOUN
aiua-5955	128	30	.	.	PUNCT
aiua-5955	129	1	biochim	biochim	PROPN
aiua-5955	129	2	biophys	biophy	NOUN
aiua-5955	129	3	acta	acta	PROPN
aiua-5955	129	4	.	.	PUNCT
aiua-5955	130	1	2009	2009	NUM
aiua-5955	130	2	;	;	PUNCT
aiua-5955	130	3	1790:1149	1790:1149	NUM
aiua-5955	130	4	-	-	SYM
aiua-5955	130	5	1160	1160	NUM
aiua-5955	130	6	.	.	PUNCT
aiua-5955	131	1	4	4	X
aiua-5955	131	2	.	.	X
aiua-5955	131	3	smith	smith	PROPN
aiua-5955	131	4	ar	ar	PROPN
aiua-5955	131	5	,	,	PUNCT
aiua-5955	131	6	shenvi	shenvi	PROPN
aiua-5955	131	7	sv	sv	PROPN
aiua-5955	131	8	,	,	PUNCT
aiua-5955	131	9	widlansky	widlansky	PROPN
aiua-5955	131	10	m	m	PROPN
aiua-5955	131	11	,	,	PUNCT
aiua-5955	131	12	et	et	PROPN
aiua-5955	131	13	al	al	PROPN
aiua-5955	131	14	.	.	PUNCT
aiua-5955	131	15	lipoic	lipoic	ADJ
aiua-5955	131	16	acid	acid	NOUN
aiua-5955	131	17	as	as	ADP
aiua-5955	131	18	a	a	DET
aiua-5955	131	19	potential	potential	ADJ
aiua-5955	131	20	therapy	therapy	NOUN
aiua-5955	131	21	for	for	ADP
aiua-5955	131	22	chronic	chronic	ADJ
aiua-5955	131	23	diseases	disease	NOUN
aiua-5955	131	24	associated	associate	VERB
aiua-5955	131	25	with	with	ADP
aiua-5955	131	26	oxidative	oxidative	ADJ
aiua-5955	131	27	stress	stress	NOUN
aiua-5955	131	28	.	.	PUNCT
aiua-5955	132	1	curr	curr	PROPN
aiua-5955	132	2	med	med	PROPN
aiua-5955	132	3	chem	chem	NOUN
aiua-5955	132	4	.	.	PUNCT
aiua-5955	133	1	2004	2004	NUM
aiua-5955	133	2	;	;	PUNCT
aiua-5955	133	3	11:113546	11:113546	NUM
aiua-5955	133	4	.	.	NOUN
aiua-5955	133	5	5	5	NUM
aiua-5955	133	6	.	.	X
aiua-5955	133	7	scott	scott	PROPN
aiua-5955	133	8	bc	bc	PROPN
aiua-5955	133	9	,	,	PUNCT
aiua-5955	133	10	aruoma	aruoma	PROPN
aiua-5955	133	11	oi	oi	PROPN
aiua-5955	133	12	,	,	PUNCT
aiua-5955	133	13	evans	evans	PROPN
aiua-5955	133	14	pj	pj	PROPN
aiua-5955	133	15	,	,	PUNCT
aiua-5955	133	16	et	et	PROPN
aiua-5955	133	17	al	al	PROPN
aiua-5955	133	18	.	.	PUNCT
aiua-5955	134	1	lipoic	lipoic	PROPN
aiua-5955	134	2	and	and	CCONJ
aiua-5955	134	3	dihydrolipoic	dihydrolipoic	ADJ
aiua-5955	134	4	acids	acid	NOUN
aiua-5955	134	5	as	as	ADP
aiua-5955	134	6	antioxidants	antioxidant	NOUN
aiua-5955	134	7	.	.	PUNCT
aiua-5955	135	1	a	a	DET
aiua-5955	135	2	critical	critical	ADJ
aiua-5955	135	3	evaluation	evaluation	NOUN
aiua-5955	135	4	.	.	PUNCT
aiua-5955	136	1	free	free	ADJ
aiua-5955	136	2	radic	radic	ADJ
aiua-5955	136	3	res	re	NOUN
aiua-5955	136	4	.	.	PROPN
aiua-5955	136	5	1994	1994	NUM
aiua-5955	136	6	;	;	PUNCT
aiua-5955	136	7	20:119	20:119	NUM
aiua-5955	136	8	-	-	SYM
aiua-5955	136	9	33	33	NUM
aiua-5955	136	10	.	.	NOUN
aiua-5955	137	1	6	6	NUM
aiua-5955	137	2	.	.	X
aiua-5955	137	3	bast	bast	NOUN
aiua-5955	137	4	a	a	PRON
aiua-5955	137	5	,	,	PUNCT
aiua-5955	137	6	haenen	haenen	PROPN
aiua-5955	137	7	gr	gr	PROPN
aiua-5955	137	8	.	.	PROPN
aiua-5955	137	9	interplay	interplay	NOUN
aiua-5955	137	10	between	between	ADP
aiua-5955	137	11	lipoic	lipoic	ADJ
aiua-5955	137	12	acid	acid	NOUN
aiua-5955	137	13	and	and	CCONJ
aiua-5955	137	14	glutathione	glutathione	NOUN
aiua-5955	137	15	in	in	ADP
aiua-5955	137	16	the	the	DET
aiua-5955	137	17	protection	protection	NOUN
aiua-5955	137	18	against	against	ADP
aiua-5955	137	19	microsomal	microsomal	ADJ
aiua-5955	137	20	lipid	lipid	NOUN
aiua-5955	137	21	peroxidation	peroxidation	NOUN
aiua-5955	137	22	.	.	PUNCT
aiua-5955	138	1	biochim	biochim	PROPN
aiua-5955	138	2	biophys	biophy	NOUN
aiua-5955	138	3	acta	acta	PROPN
aiua-5955	138	4	.	.	PUNCT
aiua-5955	139	1	1988	1988	NUM
aiua-5955	139	2	;	;	PUNCT
aiua-5955	139	3	963:558	963:558	NUM
aiua-5955	139	4	-	-	SYM
aiua-5955	139	5	61	61	NUM
aiua-5955	139	6	.	.	PUNCT
aiua-5955	140	1	7	7	X
aiua-5955	140	2	.	.	X
aiua-5955	140	3	busse	busse	PROPN
aiua-5955	140	4	e	e	PROPN
aiua-5955	140	5	,	,	PUNCT
aiua-5955	140	6	zimmer	zimmer	PROPN
aiua-5955	140	7	g	g	PROPN
aiua-5955	140	8	,	,	PUNCT
aiua-5955	140	9	schopohl	schopohl	NOUN
aiua-5955	140	10	b	b	NUM
aiua-5955	140	11	,	,	PUNCT
aiua-5955	140	12	et	et	PROPN
aiua-5955	140	13	al	al	PROPN
aiua-5955	140	14	.	.	PROPN
aiua-5955	140	15	influence	influence	NOUN
aiua-5955	140	16	of	of	ADP
aiua-5955	140	17	alpha	alpha	NOUN
aiua-5955	140	18	-	-	PUNCT
aiua-5955	140	19	lipoic	lipoic	NOUN
aiua-5955	140	20	acid	acid	NOUN
aiua-5955	140	21	on	on	ADP
aiua-5955	140	22	intracellular	intracellular	ADJ
aiua-5955	140	23	glutathione	glutathione	NOUN
aiua-5955	140	24	in	in	ADP
aiua-5955	140	25	vitro	vitro	X
aiua-5955	140	26	and	and	CCONJ
aiua-5955	140	27	in	in	ADP
aiua-5955	140	28	vivo	vivo	NOUN
aiua-5955	140	29	.	.	PUNCT
aiua-5955	141	1	arzneimittelforschung	arzneimittelforschung	PROPN
aiua-5955	141	2	.	.	PUNCT
aiua-5955	141	3	1992	1992	NUM
aiua-5955	141	4	;	;	PUNCT
aiua-5955	141	5	42:829	42:829	NUM
aiua-5955	141	6	-	-	SYM
aiua-5955	141	7	31	31	NUM
aiua-5955	141	8	.	.	NOUN
aiua-5955	142	1	8	8	NUM
aiua-5955	142	2	.	.	PUNCT
aiua-5955	142	3	ruhnau	ruhnau	PROPN
aiua-5955	142	4	kj	kj	PROPN
aiua-5955	142	5	,	,	PUNCT
aiua-5955	142	6	meissner	meissner	PROPN
aiua-5955	142	7	hp	hp	PROPN
aiua-5955	142	8	,	,	PUNCT
aiua-5955	142	9	finn	finn	PROPN
aiua-5955	142	10	jr	jr	PROPN
aiua-5955	142	11	,	,	PUNCT
aiua-5955	142	12	et	et	PROPN
aiua-5955	142	13	al	al	PROPN
aiua-5955	142	14	.	.	PUNCT
aiua-5955	142	15	effects	effect	NOUN
aiua-5955	142	16	of	of	ADP
aiua-5955	142	17	3	3	NUM
aiua-5955	142	18	-	-	PUNCT
aiua-5955	142	19	week	week	NOUN
aiua-5955	142	20	oral	oral	ADJ
aiua-5955	142	21	treatment	treatment	NOUN
aiua-5955	142	22	with	with	ADP
aiua-5955	142	23	the	the	DET
aiua-5955	142	24	antioxidant	antioxidant	ADJ
aiua-5955	142	25	thioctic	thioctic	ADJ
aiua-5955	142	26	acid	acid	NOUN
aiua-5955	142	27	(	(	PUNCT
aiua-5955	142	28	alpha	alpha	NOUN
aiua-5955	142	29	-	-	PUNCT
aiua-5955	142	30	lipoic	lipoic	ADJ
aiua-5955	142	31	acid	acid	NOUN
aiua-5955	142	32	)	)	PUNCT
aiua-5955	142	33	in	in	ADP
aiua-5955	142	34	symptomatic	symptomatic	ADJ
aiua-5955	142	35	diabetic	diabetic	ADJ
aiua-5955	142	36	polyneuropathy	polyneuropathy	NOUN
aiua-5955	142	37	.	.	PUNCT
aiua-5955	143	1	diabet	diabet	PROPN
aiua-5955	143	2	med	med	PROPN
aiua-5955	143	3	.	.	PUNCT
aiua-5955	143	4	1999	1999	NUM
aiua-5955	143	5	;	;	PUNCT
aiua-5955	143	6	16:1040	16:1040	NUM
aiua-5955	143	7	-	-	SYM
aiua-5955	143	8	3	3	NUM
aiua-5955	143	9	.	.	NOUN
aiua-5955	143	10	9	9	NUM
aiua-5955	143	11	.	.	X
aiua-5955	143	12	ametov	ametov	PROPN
aiua-5955	143	13	as	as	ADP
aiua-5955	143	14	,	,	PUNCT
aiua-5955	143	15	barinov	barinov	PROPN
aiua-5955	143	16	a	a	PRON
aiua-5955	143	17	,	,	PUNCT
aiua-5955	143	18	dyck	dyck	PROPN
aiua-5955	143	19	pj	pj	PROPN
aiua-5955	143	20	,	,	PUNCT
aiua-5955	143	21	et	et	PROPN
aiua-5955	143	22	al	al	PROPN
aiua-5955	143	23	.	.	PUNCT
aiua-5955	144	1	the	the	DET
aiua-5955	144	2	sensory	sensory	ADJ
aiua-5955	144	3	symptoms	symptom	NOUN
aiua-5955	144	4	of	of	ADP
aiua-5955	144	5	diabetic	diabetic	ADJ
aiua-5955	144	6	polyneuropathy	polyneuropathy	NOUN
aiua-5955	144	7	are	be	AUX
aiua-5955	144	8	improved	improve	VERB
aiua-5955	144	9	with	with	ADP
aiua-5955	144	10	alpha	alpha	NOUN
aiua-5955	144	11	-	-	PUNCT
aiua-5955	144	12	lipoic	lipoic	NOUN
aiua-5955	144	13	acid	acid	NOUN
aiua-5955	144	14	:	:	PUNCT
aiua-5955	144	15	the	the	DET
aiua-5955	144	16	sydney	sydney	PROPN
aiua-5955	144	17	trial	trial	NOUN
aiua-5955	144	18	.	.	PUNCT
aiua-5955	145	1	diabetes	diabetes	NOUN
aiua-5955	145	2	care	care	NOUN
aiua-5955	145	3	.	.	PUNCT
aiua-5955	146	1	2003	2003	NUM
aiua-5955	146	2	;	;	PUNCT
aiua-5955	146	3	26:770	26:770	NUM
aiua-5955	146	4	-	-	SYM
aiua-5955	146	5	6	6	NUM
aiua-5955	146	6	.	.	PUNCT
aiua-5955	147	1	giammusso_stesura	giammusso_stesura	NOUN
aiua-5955	147	2	seveso	seveso	PROPN
aiua-5955	147	3	04/04/17	04/04/17	PROPN
aiua-5955	147	4	09:06	09:06	NUM
aiua-5955	147	5	pagina	pagina	NOUN
aiua-5955	147	6	20	20	NUM
aiua-5955	147	7	10	10	NUM
aiua-5955	147	8	.	.	PUNCT
aiua-5955	148	1	ziegler	ziegler	PROPN
aiua-5955	148	2	d	d	PROPN
aiua-5955	148	3	,	,	PUNCT
aiua-5955	148	4	ametov	ametov	PROPN
aiua-5955	148	5	a	a	X
aiua-5955	148	6	,	,	PUNCT
aiua-5955	148	7	barinov	barinov	PROPN
aiua-5955	148	8	a	a	PRON
aiua-5955	148	9	,	,	PUNCT
aiua-5955	148	10	et	et	PROPN
aiua-5955	148	11	al	al	PROPN
aiua-5955	148	12	.	.	PROPN
aiua-5955	148	13	oral	oral	ADJ
aiua-5955	148	14	treatment	treatment	NOUN
aiua-5955	148	15	with	with	ADP
aiua-5955	148	16	alpha	alpha	NOUN
aiua-5955	148	17	-	-	PUNCT
aiua-5955	148	18	lipoic	lipoic	ADJ
aiua-5955	148	19	acid	acid	NOUN
aiua-5955	148	20	improves	improve	VERB
aiua-5955	148	21	symptomatic	symptomatic	ADJ
aiua-5955	148	22	diabetic	diabetic	ADJ
aiua-5955	148	23	polyneuropathy	polyneuropathy	NOUN
aiua-5955	148	24	:	:	PUNCT
aiua-5955	148	25	the	the	DET
aiua-5955	148	26	sydney	sydney	NOUN
aiua-5955	148	27	2	2	NUM
aiua-5955	148	28	trial	trial	NOUN
aiua-5955	148	29	.	.	PUNCT
aiua-5955	149	1	diabetes	diabetes	NOUN
aiua-5955	149	2	care	care	NOUN
aiua-5955	149	3	.	.	PUNCT
aiua-5955	150	1	2006	2006	NUM
aiua-5955	150	2	;	;	PUNCT
aiua-5955	150	3	29:2365	29:2365	NUM
aiua-5955	150	4	-	-	SYM
aiua-5955	150	5	70	70	NUM
aiua-5955	150	6	.	.	PUNCT
aiua-5955	151	1	11	11	NUM
aiua-5955	151	2	.	.	PUNCT
aiua-5955	152	1	packer	packer	PROPN
aiua-5955	152	2	l	l	PROPN
aiua-5955	152	3	,	,	PUNCT
aiua-5955	152	4	witt	witt	PROPN
aiua-5955	152	5	eh	eh	INTJ
aiua-5955	152	6	,	,	PUNCT
aiua-5955	152	7	tritschler	tritschler	PROPN
aiua-5955	152	8	hj	hj	PROPN
aiua-5955	152	9	.	.	PROPN
aiua-5955	152	10	alpha	alpha	NOUN
aiua-5955	152	11	-	-	PUNCT
aiua-5955	152	12	lipoic	lipoic	NOUN
aiua-5955	152	13	acid	acid	NOUN
aiua-5955	152	14	as	as	ADP
aiua-5955	152	15	a	a	DET
aiua-5955	152	16	biological	biological	ADJ
aiua-5955	152	17	antioxidant	antioxidant	NOUN
aiua-5955	152	18	.	.	PUNCT
aiua-5955	153	1	free	free	ADJ
aiua-5955	153	2	radic	radic	ADJ
aiua-5955	153	3	biol	biol	PROPN
aiua-5955	153	4	med	me	VERB
aiua-5955	153	5	.	.	PUNCT
aiua-5955	153	6	1995	1995	NUM
aiua-5955	153	7	;	;	PUNCT
aiua-5955	153	8	19:227	19:227	NUM
aiua-5955	153	9	-	-	SYM
aiua-5955	153	10	50	50	NUM
aiua-5955	153	11	.	.	PUNCT
aiua-5955	154	1	12	12	NUM
aiua-5955	154	2	.	.	PUNCT
aiua-5955	155	1	kunt	kunt	PROPN
aiua-5955	155	2	t	t	PROPN
aiua-5955	155	3	,	,	PUNCT
aiua-5955	155	4	forst	forst	PROPN
aiua-5955	155	5	t	t	PROPN
aiua-5955	155	6	,	,	PUNCT
aiua-5955	155	7	wilhelm	wilhelm	PROPN
aiua-5955	155	8	a	a	PROPN
aiua-5955	155	9	,	,	PUNCT
aiua-5955	155	10	et	et	PROPN
aiua-5955	155	11	al	al	PROPN
aiua-5955	155	12	.	.	PUNCT
aiua-5955	155	13	alpha	alpha	NOUN
aiua-5955	155	14	-	-	PUNCT
aiua-5955	155	15	lipoic	lipoic	NOUN
aiua-5955	155	16	acid	acid	NOUN
aiua-5955	155	17	reduces	reduce	VERB
aiua-5955	155	18	expression	expression	NOUN
aiua-5955	155	19	of	of	ADP
aiua-5955	155	20	vascular	vascular	ADJ
aiua-5955	155	21	cell	cell	NOUN
aiua-5955	155	22	adhesion	adhesion	NOUN
aiua-5955	155	23	molecule-1	molecule-1	PROPN
aiua-5955	155	24	and	and	CCONJ
aiua-5955	155	25	endothelial	endothelial	ADJ
aiua-5955	155	26	adhesion	adhesion	NOUN
aiua-5955	155	27	of	of	ADP
aiua-5955	155	28	human	human	ADJ
aiua-5955	155	29	monocytes	monocyte	NOUN
aiua-5955	155	30	after	after	ADP
aiua-5955	155	31	stimulation	stimulation	NOUN
aiua-5955	155	32	with	with	ADP
aiua-5955	155	33	advanced	advanced	ADJ
aiua-5955	155	34	glycation	glycation	NOUN
aiua-5955	155	35	end	end	NOUN
aiua-5955	155	36	products	product	NOUN
aiua-5955	155	37	.	.	PUNCT
aiua-5955	156	1	clin	clin	PROPN
aiua-5955	156	2	sci	sci	PROPN
aiua-5955	156	3	(	(	PUNCT
aiua-5955	156	4	lond	lond	PROPN
aiua-5955	156	5	)	)	PUNCT
aiua-5955	156	6	.	.	PUNCT
aiua-5955	156	7	1999	1999	NUM
aiua-5955	156	8	;	;	PUNCT
aiua-5955	156	9	96:75	96:75	NUM
aiua-5955	156	10	-	-	SYM
aiua-5955	156	11	82	82	NUM
aiua-5955	156	12	.	.	NOUN
aiua-5955	156	13	13	13	NUM
aiua-5955	156	14	.	.	PUNCT
aiua-5955	157	1	kim	kim	PROPN
aiua-5955	157	2	hs	hs	PROPN
aiua-5955	157	3	,	,	PUNCT
aiua-5955	157	4	kim	kim	PROPN
aiua-5955	157	5	hj	hj	PROPN
aiua-5955	157	6	,	,	PUNCT
aiua-5955	157	7	park	park	NOUN
aiua-5955	157	8	kg	kg	PROPN
aiua-5955	157	9	,	,	PUNCT
aiua-5955	157	10	et	et	PROPN
aiua-5955	157	11	al	al	PROPN
aiua-5955	157	12	.	.	PUNCT
aiua-5955	157	13	alpha	alpha	NOUN
aiua-5955	157	14	-	-	PUNCT
aiua-5955	157	15	lipoic	lipoic	NOUN
aiua-5955	157	16	acid	acid	NOUN
aiua-5955	157	17	inhibits	inhibit	VERB
aiua-5955	157	18	matrix	matrix	NOUN
aiua-5955	157	19	metalloproteinase-9	metalloproteinase-9	NUM
aiua-5955	157	20	expression	expression	NOUN
aiua-5955	157	21	by	by	ADP
aiua-5955	157	22	inhibiting	inhibit	VERB
aiua-5955	157	23	nf	nf	ADJ
aiua-5955	157	24	-	-	PUNCT
aiua-5955	157	25	kappab	kappab	NOUN
aiua-5955	157	26	transcriptional	transcriptional	ADJ
aiua-5955	157	27	activity	activity	NOUN
aiua-5955	157	28	.	.	PUNCT
aiua-5955	158	1	exp	exp	NOUN
aiua-5955	158	2	mol	mol	ADP
aiua-5955	158	3	med	med	PROPN
aiua-5955	158	4	.	.	PUNCT
aiua-5955	158	5	2007	2007	NUM
aiua-5955	158	6	;	;	PUNCT
aiua-5955	158	7	39:106	39:106	NUM
aiua-5955	158	8	-	-	SYM
aiua-5955	158	9	13	13	NUM
aiua-5955	158	10	.	.	PUNCT
aiua-5955	158	11	14	14	NUM
aiua-5955	158	12	.	.	PUNCT
aiua-5955	159	1	chaudhary	chaudhary	PROPN
aiua-5955	159	2	p	p	PROPN
aiua-5955	159	3	,	,	PUNCT
aiua-5955	159	4	marracci	marracci	PROPN
aiua-5955	159	5	gh	gh	PROPN
aiua-5955	159	6	,	,	PUNCT
aiua-5955	159	7	bourdette	bourdette	PROPN
aiua-5955	159	8	dn	dn	PROPN
aiua-5955	159	9	.	.	PUNCT
aiua-5955	159	10	lipoic	lipoic	ADJ
aiua-5955	159	11	acid	acid	NOUN
aiua-5955	159	12	inhibits	inhibit	VERB
aiua-5955	159	13	expression	expression	NOUN
aiua-5955	159	14	of	of	ADP
aiua-5955	159	15	icam-1	icam-1	NUM
aiua-5955	159	16	and	and	CCONJ
aiua-5955	159	17	vcam-1	vcam-1	NUM
aiua-5955	159	18	by	by	ADP
aiua-5955	159	19	cns	cns	NOUN
aiua-5955	159	20	endothelial	endothelial	ADJ
aiua-5955	159	21	cells	cell	NOUN
aiua-5955	159	22	and	and	CCONJ
aiua-5955	159	23	t	t	NOUN
aiua-5955	159	24	cell	cell	NOUN
aiua-5955	159	25	migration	migration	NOUN
aiua-5955	159	26	into	into	ADP
aiua-5955	159	27	the	the	DET
aiua-5955	159	28	spinal	spinal	ADJ
aiua-5955	159	29	cord	cord	NOUN
aiua-5955	159	30	in	in	ADP
aiua-5955	159	31	experimental	experimental	ADJ
aiua-5955	159	32	autoimmune	autoimmune	ADJ
aiua-5955	159	33	encephalomyelitis	encephalomyelitis	NOUN
aiua-5955	159	34	.	.	PUNCT
aiua-5955	160	1	j	j	PROPN
aiua-5955	160	2	neuroimmunol	neuroimmunol	PROPN
aiua-5955	160	3	.	.	PUNCT
aiua-5955	161	1	2006	2006	NUM
aiua-5955	161	2	;	;	PUNCT
aiua-5955	161	3	175:87	175:87	NUM
aiua-5955	161	4	-	-	SYM
aiua-5955	161	5	96	96	NUM
aiua-5955	161	6	.	.	NOUN
aiua-5955	161	7	15	15	NUM
aiua-5955	161	8	.	.	PUNCT
aiua-5955	162	1	sola	sola	PROPN
aiua-5955	162	2	s	s	PROPN
aiua-5955	162	3	,	,	PUNCT
aiua-5955	162	4	mir	mir	PROPN
aiua-5955	162	5	mq	mq	PROPN
aiua-5955	162	6	,	,	PUNCT
aiua-5955	162	7	cheema	cheema	PROPN
aiua-5955	162	8	fa	fa	PROPN
aiua-5955	162	9	,	,	PUNCT
aiua-5955	162	10	et	et	PROPN
aiua-5955	162	11	al	al	PROPN
aiua-5955	162	12	.	.	PROPN
aiua-5955	162	13	irbesartan	irbesartan	PROPN
aiua-5955	162	14	and	and	CCONJ
aiua-5955	162	15	lipoic	lipoic	ADJ
aiua-5955	162	16	acid	acid	NOUN
aiua-5955	162	17	improve	improve	VERB
aiua-5955	162	18	endothelial	endothelial	ADJ
aiua-5955	162	19	function	function	NOUN
aiua-5955	162	20	and	and	CCONJ
aiua-5955	162	21	reduce	reduce	VERB
aiua-5955	162	22	markers	marker	NOUN
aiua-5955	162	23	of	of	ADP
aiua-5955	162	24	inflammation	inflammation	NOUN
aiua-5955	162	25	in	in	ADP
aiua-5955	162	26	the	the	DET
aiua-5955	162	27	metabolic	metabolic	NOUN
aiua-5955	162	28	syndrome	syndrome	NOUN
aiua-5955	162	29	:	:	PUNCT
aiua-5955	162	30	results	result	NOUN
aiua-5955	162	31	of	of	ADP
aiua-5955	162	32	the	the	DET
aiua-5955	162	33	irbesartan	irbesartan	ADJ
aiua-5955	162	34	and	and	CCONJ
aiua-5955	162	35	lipoic	lipoic	ADJ
aiua-5955	162	36	acid	acid	NOUN
aiua-5955	162	37	in	in	ADP
aiua-5955	162	38	endothelial	endothelial	ADJ
aiua-5955	162	39	dysfunction	dysfunction	NOUN
aiua-5955	162	40	(	(	PUNCT
aiua-5955	162	41	island	island	NOUN
aiua-5955	162	42	)	)	PUNCT
aiua-5955	162	43	study	study	NOUN
aiua-5955	162	44	.	.	PUNCT
aiua-5955	163	1	circulation	circulation	NOUN
aiua-5955	163	2	.	.	PUNCT
aiua-5955	164	1	2005	2005	NUM
aiua-5955	164	2	;	;	PUNCT
aiua-5955	164	3	111:343	111:343	NUM
aiua-5955	164	4	-	-	SYM
aiua-5955	164	5	8	8	NUM
aiua-5955	164	6	.	.	NUM
aiua-5955	165	1	16	16	NUM
aiua-5955	165	2	.	.	PUNCT
aiua-5955	166	1	paladini	paladini	PROPN
aiua-5955	166	2	a	a	PROPN
aiua-5955	166	3	,	,	PUNCT
aiua-5955	166	4	fusco	fusco	PROPN
aiua-5955	166	5	m	m	PROPN
aiua-5955	166	6	,	,	PUNCT
aiua-5955	166	7	coaccioli	coaccioli	PROPN
aiua-5955	166	8	s	s	PROPN
aiua-5955	166	9	,	,	PUNCT
aiua-5955	166	10	et	et	PROPN
aiua-5955	166	11	al	al	PROPN
aiua-5955	166	12	.	.	PUNCT
aiua-5955	166	13	chronic	chronic	ADJ
aiua-5955	166	14	pain	pain	NOUN
aiua-5955	166	15	in	in	ADP
aiua-5955	166	16	the	the	DET
aiua-5955	166	17	elderly	elderly	ADJ
aiua-5955	166	18	:	:	PUNCT
aiua-5955	166	19	the	the	DET
aiua-5955	166	20	case	case	NOUN
aiua-5955	166	21	for	for	ADP
aiua-5955	166	22	new	new	ADJ
aiua-5955	166	23	therapeutic	therapeutic	ADJ
aiua-5955	166	24	strategies	strategy	NOUN
aiua-5955	166	25	.	.	PUNCT
aiua-5955	167	1	pain	pain	NOUN
aiua-5955	167	2	physician	physician	NOUN
aiua-5955	167	3	.	.	PUNCT
aiua-5955	168	1	2015	2015	NUM
aiua-5955	168	2	;	;	PUNCT
aiua-5955	168	3	18	18	NUM
aiua-5955	168	4	:	:	PUNCT
aiua-5955	168	5	e863	e863	PROPN
aiua-5955	168	6	-	-	PUNCT
aiua-5955	168	7	e876	e876	PROPN
aiua-5955	168	8	17	17	NUM
aiua-5955	168	9	.	.	PUNCT
aiua-5955	169	1	bettoni	bettoni	PROPN
aiua-5955	169	2	i	i	PRON
aiua-5955	169	3	,	,	PUNCT
aiua-5955	169	4	comelli	comelli	PROPN
aiua-5955	169	5	f	f	PROPN
aiua-5955	169	6	,	,	PUNCT
aiua-5955	169	7	colombo	colombo	VERB
aiua-5955	169	8	a	a	NOUN
aiua-5955	169	9	,	,	PUNCT
aiua-5955	169	10	et	et	PROPN
aiua-5955	169	11	al	al	PROPN
aiua-5955	169	12	.	.	PUNCT
aiua-5955	170	1	non	non	ADJ
aiua-5955	170	2	-	-	ADJ
aiua-5955	170	3	neural	neural	ADJ
aiua-5955	170	4	cell	cell	NOUN
aiua-5955	170	5	modulation	modulation	NOUN
aiua-5955	170	6	relieves	relieve	VERB
aiua-5955	170	7	neuropathic	neuropathic	ADJ
aiua-5955	170	8	pain	pain	NOUN
aiua-5955	170	9	:	:	PUNCT
aiua-5955	170	10	efficacy	efficacy	NOUN
aiua-5955	170	11	of	of	ADP
aiua-5955	170	12	the	the	DET
aiua-5955	170	13	endogenous	endogenous	ADJ
aiua-5955	170	14	lipid	lipid	NOUN
aiua-5955	170	15	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	170	16	.	.	PUNCT
aiua-5955	171	1	cns	cns	PROPN
aiua-5955	171	2	neurol	neurol	PROPN
aiua-5955	171	3	disord	disord	NOUN
aiua-5955	171	4	drug	drug	NOUN
aiua-5955	171	5	targets	target	NOUN
aiua-5955	171	6	.	.	PUNCT
aiua-5955	172	1	2013	2013	NUM
aiua-5955	172	2	;	;	PUNCT
aiua-5955	172	3	12:34	12:34	NUM
aiua-5955	172	4	-	-	SYM
aiua-5955	172	5	44	44	NUM
aiua-5955	172	6	.	.	PUNCT
aiua-5955	173	1	18	18	NUM
aiua-5955	173	2	.	.	PUNCT
aiua-5955	174	1	luongo	luongo	PROPN
aiua-5955	174	2	l	l	PROPN
aiua-5955	174	3	,	,	PUNCT
aiua-5955	174	4	guida	guida	PROPN
aiua-5955	174	5	f	f	PROPN
aiua-5955	174	6	,	,	PUNCT
aiua-5955	174	7	boccella	boccella	PROPN
aiua-5955	174	8	s	s	PROPN
aiua-5955	174	9	,	,	PUNCT
aiua-5955	174	10	et	et	PROPN
aiua-5955	174	11	al	al	PROPN
aiua-5955	174	12	.	.	PROPN
aiua-5955	174	13	palmitoylethanolamide	palmitoylethanolamide	PROPN
aiua-5955	174	14	reduces	reduce	VERB
aiua-5955	174	15	formalininduced	formalininduced	ADJ
aiua-5955	174	16	neuropathic	neuropathic	ADJ
aiua-5955	174	17	-	-	PUNCT
aiua-5955	174	18	like	like	ADJ
aiua-5955	174	19	behaviour	behaviour	NOUN
aiua-5955	174	20	through	through	ADP
aiua-5955	174	21	spinal	spinal	ADJ
aiua-5955	174	22	glial	glial	ADJ
aiua-5955	174	23	/	/	SYM
aiua-5955	174	24	microglial	microglial	ADJ
aiua-5955	174	25	phenotypical	phenotypical	ADJ
aiua-5955	174	26	changes	change	NOUN
aiua-5955	174	27	in	in	ADP
aiua-5955	174	28	mice	mouse	NOUN
aiua-5955	174	29	.	.	PUNCT
aiua-5955	175	1	cns	cns	PROPN
aiua-5955	175	2	neurol	neurol	PROPN
aiua-5955	175	3	disord	disord	NOUN
aiua-5955	175	4	drug	drug	NOUN
aiua-5955	175	5	targets	target	NOUN
aiua-5955	175	6	.	.	PUNCT
aiua-5955	176	1	2013	2013	NUM
aiua-5955	176	2	;	;	PUNCT
aiua-5955	176	3	12:45	12:45	NUM
aiua-5955	176	4	-	-	SYM
aiua-5955	176	5	54	54	NUM
aiua-5955	176	6	.	.	PUNCT
aiua-5955	177	1	19	19	NUM
aiua-5955	177	2	.	.	NOUN
aiua-5955	177	3	cantarella	cantarella	NOUN
aiua-5955	177	4	g	g	PROPN
aiua-5955	177	5	,	,	PUNCT
aiua-5955	177	6	scollo	scollo	PROPN
aiua-5955	177	7	m	m	PROPN
aiua-5955	177	8	,	,	PUNCT
aiua-5955	177	9	lempereur	lempereur	PROPN
aiua-5955	177	10	l	l	PROPN
aiua-5955	177	11	,	,	PUNCT
aiua-5955	177	12	et	et	PROPN
aiua-5955	177	13	al	al	PROPN
aiua-5955	177	14	.	.	PUNCT
aiua-5955	177	15	endocannabinoids	endocannabinoid	NOUN
aiua-5955	177	16	inhibit	inhibit	VERB
aiua-5955	177	17	release	release	NOUN
aiua-5955	177	18	of	of	ADP
aiua-5955	177	19	nerve	nerve	NOUN
aiua-5955	177	20	growth	growth	NOUN
aiua-5955	177	21	factor	factor	NOUN
aiua-5955	177	22	by	by	ADP
aiua-5955	177	23	inflammation	inflammation	NOUN
aiua-5955	177	24	-	-	PUNCT
aiua-5955	177	25	activated	activate	VERB
aiua-5955	177	26	mast	mast	NOUN
aiua-5955	177	27	cells	cell	NOUN
aiua-5955	177	28	.	.	PUNCT
aiua-5955	178	1	biochem	biochem	PROPN
aiua-5955	178	2	pharmacol	pharmacol	PROPN
aiua-5955	178	3	.	.	PUNCT
aiua-5955	179	1	2011	2011	NUM
aiua-5955	179	2	;	;	PUNCT
aiua-5955	179	3	82:380	82:380	NUM
aiua-5955	179	4	-	-	SYM
aiua-5955	179	5	388	388	NUM
aiua-5955	179	6	.	.	NOUN
aiua-5955	179	7	20	20	NUM
aiua-5955	179	8	.	.	PUNCT
aiua-5955	179	9	domínguez	domínguez	PROPN
aiua-5955	179	10	cm	cm	PROPN
aiua-5955	179	11	,	,	PUNCT
aiua-5955	179	12	martín	martín	NOUN
aiua-5955	179	13	a	a	PROPN
aiua-5955	179	14	,	,	PUNCT
aiua-5955	179	15	ferrer	ferrer	PROPN
aiua-5955	179	16	fg	fg	PROPN
aiua-5955	179	17	,	,	PUNCT
aiua-5955	179	18	et	et	PROPN
aiua-5955	179	19	al	al	PROPN
aiua-5955	179	20	.	.	PROPN
aiua-5955	179	21	n	n	CCONJ
aiua-5955	179	22	-	-	PUNCT
aiua-5955	179	23	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-5955	179	24	in	in	ADP
aiua-5955	179	25	the	the	DET
aiua-5955	179	26	treatment	treatment	NOUN
aiua-5955	179	27	of	of	ADP
aiua-5955	179	28	neuropathic	neuropathic	ADJ
aiua-5955	179	29	pain	pain	NOUN
aiua-5955	179	30	associated	associate	VERB
aiua-5955	179	31	with	with	ADP
aiua-5955	179	32	lumbosciatica	lumbosciatica	PROPN
aiua-5955	179	33	.	.	PUNCT
aiua-5955	180	1	pain	pain	NOUN
aiua-5955	180	2	manage	manage	NOUN
aiua-5955	180	3	.	.	PUNCT
aiua-5955	181	1	2012	2012	NUM
aiua-5955	181	2	;	;	PUNCT
aiua-5955	181	3	2:119	2:119	NUM
aiua-5955	181	4	-	-	SYM
aiua-5955	181	5	124	124	NUM
aiua-5955	181	6	.	.	PUNCT
aiua-5955	182	1	21archivio	21archivio	NUM
aiua-5955	182	2	italiano	italiano	PROPN
aiua-5955	182	3	di	di	X
aiua-5955	182	4	urologia	urologia	PROPN
aiua-5955	182	5	e	e	PROPN
aiua-5955	182	6	andrologia	andrologia	NOUN
aiua-5955	182	7	2017	2017	NUM
aiua-5955	182	8	;	;	PUNCT
aiua-5955	182	9	89	89	NUM
aiua-5955	182	10	,	,	PUNCT
aiua-5955	182	11	1	1	NUM
aiua-5955	182	12	palmitoylethanolamide	palmitoylethanolamide	ADJ
aiua-5955	182	13	-	-	PUNCT
aiua-5955	182	14	alphalipoic	alphalipoic	NOUN
aiua-5955	182	15	acid	acid	NOUN
aiua-5955	182	16	in	in	ADP
aiua-5955	182	17	cp	cp	PROPN
aiua-5955	182	18	/	/	SYM
aiua-5955	182	19	cpp	cpp	PROPN
aiua-5955	182	20	correspondence	correspondence	NOUN
aiua-5955	182	21	bruno	bruno	PROPN
aiua-5955	182	22	giammusso	giammusso	PROPN
aiua-5955	182	23	,	,	PUNCT
aiua-5955	182	24	md	md	PROPN
aiua-5955	182	25	(	(	PUNCT
aiua-5955	182	26	corresponding	correspond	VERB
aiua-5955	182	27	author	author	NOUN
aiua-5955	182	28	)	)	PUNCT
aiua-5955	182	29	bgiammusso@hotmail.it	bgiammusso@hotmail.it	PROPN
aiua-5955	182	30	policlinico	policlinico	NOUN
aiua-5955	182	31	morgagni	morgagni	NOUN
aiua-5955	182	32	,	,	PUNCT
aiua-5955	182	33	via	via	ADP
aiua-5955	182	34	vivante	vivante	NOUN
aiua-5955	182	35	,	,	PUNCT
aiua-5955	182	36	3	3	NUM
aiua-5955	182	37	95123	95123	NUM
aiua-5955	182	38	catania	catania	PROPN
aiua-5955	182	39	,	,	PUNCT
aiua-5955	182	40	italy	italy	PROPN
aiua-5955	182	41	rosaria	rosaria	PROPN
aiua-5955	182	42	di	di	PROPN
aiua-5955	182	43	mauro	mauro	PROPN
aiua-5955	182	44	rosariadimauro@tiscali	rosariadimauro@tiscali	VERB
aiua-5955	182	45	biometec	biometec	ADJ
aiua-5955	182	46	,	,	PUNCT
aiua-5955	182	47	section	section	NOUN
aiua-5955	182	48	of	of	ADP
aiua-5955	182	49	pharmacology	pharmacology	NOUN
aiua-5955	182	50	,	,	PUNCT
aiua-5955	182	51	university	university	PROPN
aiua-5955	182	52	of	of	ADP
aiua-5955	182	53	catania	catania	PROPN
aiua-5955	182	54	school	school	PROPN
aiua-5955	182	55	of	of	ADP
aiua-5955	182	56	medicine	medicine	NOUN
aiua-5955	182	57	,	,	PUNCT
aiua-5955	182	58	catania	catania	PROPN
aiua-5955	182	59	,	,	PUNCT
aiua-5955	182	60	italy	italy	PROPN
aiua-5955	182	61	renato	renato	PROPN
aiua-5955	182	62	bernardini	bernardini	PROPN
aiua-5955	182	63	renato.bernardini@gmail.com	renato.bernardini@gmail.com	X
aiua-5955	182	64	biometec	biometec	NOUN
aiua-5955	182	65	,	,	PUNCT
aiua-5955	182	66	section	section	NOUN
aiua-5955	182	67	of	of	ADP
aiua-5955	182	68	pharmacology	pharmacology	NOUN
aiua-5955	182	69	,	,	PUNCT
aiua-5955	182	70	university	university	PROPN
aiua-5955	182	71	of	of	ADP
aiua-5955	182	72	catania	catania	PROPN
aiua-5955	182	73	school	school	PROPN
aiua-5955	182	74	of	of	ADP
aiua-5955	182	75	medicine	medicine	NOUN
aiua-5955	182	76	,	,	PUNCT
aiua-5955	182	77	catania	catania	PROPN
aiua-5955	182	78	,	,	PUNCT
aiua-5955	182	79	italy	italy	PROPN
aiua-5955	182	80	giammusso_stesura	giammusso_stesura	PROPN
aiua-5955	182	81	seveso	seveso	PROPN
aiua-5955	182	82	04/04/17	04/04/17	PROPN
aiua-5955	182	83	09:06	09:06	NUM
aiua-5955	182	84	pagina	pagina	NOUN
aiua-5955	182	85	21	21	NUM